Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Autosomal dominant centronuclear myopathy ORPHA:169189	12/105	1.205576708365891E-6	0.0036432528126817227	0	0	6.521477519638977	88.87829881499756	SPSB3;STARD3;IQSEC1;RASA4;SH2D3C;ARID5A;DYRK1B;TUBGCP6;TCAP;ABCA7;RASGRP2;SH2B2
Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395	11/101	5.397128352779335E-6	0.008155060941049574	0	0	6.162273901808786	74.74618577773653	KIAA0513;SNX29;ATG16L2;USP20;RASA4;SH2D3C;PLEKHM1;TUBGCP6;ABCA7;CLK3;C2CD2L
Autosomal dominant spastic paraplegia type 12 ORPHA:100993	10/101	3.339825221062559E-5	0.01441850259721579	0	0	5.5259431290359124	56.95593444833053	SEMA6C;CTIF;CDC34;FXR2;TMCC2;EVI5L;GAS2L1;PPFIA3;PDLIM7;SH2B2
Charcot-Marie-Tooth disease type 4G ORPHA:99953	10/101	3.339825221062559E-5	0.01441850259721579	0	0	5.5259431290359124	56.95593444833053	DRAP1;FXR2;PNMA1;USP20;SNPH;TSPAN5;KATNB1;TMCC2;EVI5L;GAS2L1
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135	10/101	3.339825221062559E-5	0.01441850259721579	0	0	5.5259431290359124	56.95593444833053	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031	10/101	3.339825221062559E-5	0.01441850259721579	0	0	5.5259431290359124	56.95593444833053	DRAP1;FXR2;PNMA1;USP20;SNPH;TSPAN5;KATNB1;TMCC2;EVI5L;GAS2L1
Otospondylomegaepiphyseal dysplasia ORPHA:1427	10/101	3.339825221062559E-5	0.01441850259721579	0	0	5.5259431290359124	56.95593444833053	APC2;SEMA6C;ACAP3;NUMBL;KIFC2;SGSM2;TAOK2;EVI5L;RAB11FIP3;PPFIA3
Mosaic variegated aneuploidy syndrome ORPHA:1052	10/103	3.959177967532478E-5	0.014955794772353936	0	0	5.406551380113069	54.80561145742678	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;NDC80;ZWINT
21q22.11q22.12 microdeletion syndrome ORPHA:261323	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Adult-onset autosomal dominant leukodystrophy ORPHA:99027	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Atrial septal defect, sinus venosus type ORPHA:99105	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	MIDN;CEBPB;ITPRIP;ZNF628;MAPKAPK2;KLF4;TRAM2;VASN;LMF2
Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	ACAP3;KIFC2;CLSTN3;TMEM129;SGSM2;TAOK2;TUBGCP6;WDR6;RAB11FIP3
Autosomal recessive spastic paraplegia type 46 ORPHA:320391	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	ACAP3;KIFC2;CLSTN3;TMEM129;SGSM2;TAOK2;TUBGCP6;WDR6;RAB11FIP3
Classic glucose transporter type 1 deficiency syndrome ORPHA:71277	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	CCNA2;CCNB2;CCNB1;CDH3;TUBB3;CCNE1;PPP1R13L;NXPH4;KIF20A
Congenital dyserythropoietic anemia type III ORPHA:98870	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
Currarino syndrome ORPHA:1552	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	CCNB2;CCNB1;PRSS16;KIF20A;RHPN2;TLCD1;CDC25C;CENPA;ZWINT
Familial lipase maturation factor 1 deficiency ORPHA:535453	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	SPSB3;ACAP3;IGSF8;USP20;NOXA1;SGSM2;DYRK1B;TUBGCP6;LMF2
Filippi syndrome ORPHA:3255	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	CCNA2;CCNB2;CCNB1;CDH3;TUBB3;CCNE1;PPP1R13L;NXPH4;KIF20A
Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	KIAA0513;RNF24;IQSEC1;ZNF516;PLEKHM1;AATK;TMCC2;EVI5L;FRY
Idiopathic CD4 lymphocytopenia ORPHA:228000	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PGS1;SPSB3;STARD3;PITPNM1;STK11IP;UNC119;ADAM8;ABCA7;SH2B2
Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	KIAA0513;SNX29;HERC1;USP20;IQSEC1;SEC16A;PLEKHM1;DYRK1B;ABCA7
Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	APC2;ACOT7;DEAF1;GPRIN1;CAMK2N2;LMTK3;KATNB1;SYNGR3;PPFIA3
Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	CCNA2;CCNB2;CCNB1;CDH3;TUBB3;CCNE1;PPP1R13L;NXPH4;KIF20A
Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	SPSB3;TREX1;ARID5A;B3GALT4;ADAM8;ISG15;TCIRG1;CORO1A;OASL
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	APC2;SEMA6C;ACAP3;CTIF;SNPH;TPPP;EVI5L;RGS11;RAB11FIP3
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	DAZAP2;CCND3;TREX1;ARID5A;B3GALT4;IFI44;ISG15;TCIRG1;OASL
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
Spinocerebellar ataxia type 21 ORPHA:98773	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	APC2;SEMA6C;ACAP3;CTIF;NUMBL;TUBB3;CAMK2N2;EVI5L;RAB11FIP3
Stromme syndrome ORPHA:506307	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Susceptibility to infection due to TYK2 deficiency ORPHA:331226	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	ATG16L2;USP20;STK11IP;ARID5A;TUBGCP6;ADAM8;ABCA7;TCIRG1;LMF2
VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934	9/101	1.8605792631239126E-4	0.015539489095157828	0	0	4.906393204426065	42.14323138039584	DAZAP2;NXF1;SNX29;ATG16L2;USP20;PLEKHM1;ATP6V0D1;CLK3;C2CD2L
Crisponi syndrome ORPHA:1545	9/102	2.0054271168469732E-4	0.015539489095157828	0	0	4.853387511402272	41.3240869533116	RPUSD1;ZNF628;TNFSF9;SLC16A3;VASN;LMF2;PDLIM7;IER3;FSTL3
Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512	9/102	2.0054271168469732E-4	0.015539489095157828	0	0	4.853387511402272	41.3240869533116	PLK4;CCNA2;CCNB2;CCNB1;CCNE1;OIP5;CDC25C;CENPA;ZWINT
Paroxysmal exertion-induced dyskinesia ORPHA:98811	9/102	2.0054271168469732E-4	0.015539489095157828	0	0	4.853387511402272	41.3240869533116	BRSK2;NUMBL;PRRT2;TUBB3;CAMK2N2;LMTK3;CKB;SYNGR3;PPFIA3
1p36 deletion syndrome ORPHA:1606	9/105	2.4973378968217607E-4	0.018407207619988684	0	0	4.700996143958869	38.995303857725936	APC2;ACAP3;CLSTN3;IQSEC1;SGSM2;LMTK3;AATK;TPPP;RAB11FIP3
Ear-patella-short stature syndrome ORPHA:2554	9/105	2.4973378968217607E-4	0.018407207619988684	0	0	4.700996143958869	38.995303857725936	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80;ZWINT
Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924	8/100	8.665815847855409E-4	0.04141768386321118	0	0	4.350055741360089	30.67204422975062	SEMA6C;ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6;EVI5L;RAB11FIP3
Adult-onset dystonia-parkinsonism ORPHA:199351	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PAN2;ACAP3;ATG16L2;KIFC2;USP20;SGSM2;TUBGCP6;ABCA7
Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	EHD1;SPSB3;STARD3;CCND3;RPUSD1;TCIRG1;LMF2;YIF1B
Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PPP1R13L;SERPINH1;TRIP10;TNKS1BP1;TRIM47;GAS2L1;NOL3;FSTL3
Barth syndrome ORPHA:111	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	SPSB3;STARD3;ATG16L2;USP20;STK11IP;TUBGCP6;ABCA7;LMF2
Charcot-Marie-Tooth disease type 2P ORPHA:300319	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	STARD3;ACAP3;KIFC2;STK11IP;SGSM2;TAOK2;ZNF653;LMF2
Charcot-Marie-Tooth disease type 4B3 ORPHA:363981	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	ACAP3;KIFC2;PITPNM1;TAOK2;TUBGCP6;EVI5L;ZNF598;LMF2
Citrullinemia type II ORPHA:247585	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	CCNA2;CCNB2;CCNB1;KIF20A;TLCD1;CDC25C;ZWINT;SLC19A2
Congenital thrombotic thrombocytopenic purpura ORPHA:93583	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	SEMA6C;ACAP3;KIFC2;SGSM2;TAOK2;TNKS1BP1;RAB11FIP3;PPFIA3
Incontinentia pigmenti ORPHA:464	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	EHD1;SPSB3;STARD3;CCND3;RPUSD1;TCIRG1;LMF2;YIF1B
Infantile neuroaxonal dystrophy ORPHA:35069	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PAN2;ACAP3;ATG16L2;KIFC2;USP20;SGSM2;TUBGCP6;ABCA7
Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80
Megaconial congenital muscular dystrophy ORPHA:280671	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PGS1;SPSB3;NXF1;ATG16L2;TUBGCP6;ADAM8;ABCA7;TCIRG1
Microcephaly-micromelia syndrome ORPHA:572768	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CENPA;ZWINT
Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PLK4;CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CENPA;ZWINT
Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	CCNA2;CCNB2;CCNB1;KIF20A;TLCD1;CDC25C;ZWINT;SLC19A2
Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PGS1;NXF1;OSBPL7;ATG16L2;USP20;SH2D3C;CORO1A;REC8
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;ZWINT
Proximal myopathy with focal depletion of mitochondria ORPHA:521305	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	PGS1;SPSB3;NXF1;ATG16L2;TUBGCP6;ADAM8;ABCA7;TCIRG1
Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	CDA;CEBPB;ITPRIP;PLIN3;TCIRG1;KLF4;SLC16A3;AGPAT2
X-linked intellectual disability, Snyder type ORPHA:3063	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612	8/101	9.251214684312198E-4	0.04141768386321118	0	0	4.303060380479735	30.059396250496107	EHD1;SPSB3;STARD3;CCND3;RPUSD1;TCIRG1;LMF2;YIF1B
Antley-Bixler syndrome ORPHA:83	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	C11ORF52;PTPRU;ENTPD2;CDH1;TNKS1BP1;BAIAP2;HS6ST1;SYT7
Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	ACAP3;RPUSD1;ZNF628;TAOK2;EVI5L;RAB11FIP3;ZNF653;ZNF598
Familial isolated pituitary adenoma ORPHA:314777	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	FGD3;SPSB3;CD52;USP20;SH2D3C;ARID5A;RASGRP2;CORO1A
Intermediate osteopetrosis ORPHA:210110	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	EHD1;STARD3;ATG16L2;PLEKHM1;ADAM8;ABCA7;TCIRG1;LMF2
Large congenital melanocytic nevus ORPHA:626	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	PLK4;CCNA2;CCNB2;CCNB1;CCNE1;KIF20A;CENPA;ZWINT
Lymphangioleiomyomatosis ORPHA:538	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	DDX17;SEMA6C;ACAP3;KIFC2;SEC16A;SGSM2;TAOK2;TUBGCP6
Oculocutaneous albinism type 2 ORPHA:79432	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	ACAP3;BRSK2;NUMBL;KIFC2;GPRIN1;SGSM2;TAOK2;PPFIA3
Tuberous sclerosis complex ORPHA:805	8/102	9.867879676211796E-4	0.04141768386321118	0	0	4.257064920894708	29.46338201720907	DDX17;SEMA6C;ACAP3;KIFC2;SEC16A;SGSM2;TAOK2;TUBGCP6
NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969	8/103	0.00105170061778335	0.042949179282990316	0	0	4.212037786774629	28.883403792388528	SEMA6C;CTIF;NUAK1;TAOK2;DYRK1B;CDC42BPB;SYNPO;RAB11FIP3
Small cell lung cancer ORPHA:70573	8/103	0.00105170061778335	0.042949179282990316	0	0	4.212037786774629	28.883403792388528	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;ZWINT
Autosomal recessive spondylocostal dysostosis ORPHA:2311	8/105	0.001191754625989197	0.04738792736499149	0	0	4.124768702088289	27.76929822807152	BRSK2;TUBB3;GPRIN1;NXPH4;CAMK2N2;CKB;SYNGR3;PPFIA3
Multiple endocrine neoplasia type 1 ORPHA:652	8/105	0.001191754625989197	0.04738792736499149	0	0	4.124768702088289	27.76929822807152	CDKN1A;CDKN2B;RPUSD1;ZNF628;TMED1;ZNF598;AGPAT2;LMF2
ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;IGSF8;KIFC2;PITPNM1;TAOK2;KATNB1;EVI5L
Acromelic frontonasal dysplasia ORPHA:1827	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	SPAG9;DOCK4;SNX18;TSC22D2;ZNF516;KCTD12;CBL
Albers Schonberg osteopetrosis ORPHA:53	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	STARD3;ACAP3;KIFC2;STK11IP;TUBGCP6;ZNF598;LMF2
Autosomal dominant spastic ataxia type 1 ORPHA:251282	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PGS1;NXF1;ATG16L2;SPOCK2;TUBGCP6;RASGRP2;CORO1A
Autosomal dominant spastic paraplegia type 6 ORPHA:100988	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PREPL;PNMA1;GPRIN1;CAMK2N2;SPIN1;VWA5B2;SYNGR3
Autosomal recessive spastic paraplegia type 44 ORPHA:320401	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	APC2;ACAP3;CTIF;TAOK2;EVI5L;RAB11FIP3;ZNF653
Autosomal recessive spastic paraplegia type 63 ORPHA:401805	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PGS1;STARD3;PITPNM1;USP20;UNC119;KATNB1;LMF2
Autosomal recessive spastic paraplegia type 78 ORPHA:513436	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;IGSF8;KIFC2;PITPNM1;TAOK2;KATNB1;EVI5L
BAP1-related tumor predisposition syndrome ORPHA:289539	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;ZNF628;KATNB1;EVI5L;ZNF653;ZNF598;LMF2
Bilateral frontoparietal polymicrogyria ORPHA:101070	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ENTPD2;HIP1R;ATP2C2;BAIAP2;PDZK1IP1;CLU;BAIAP3
CLN11 disease ORPHA:314629	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PLIN3;TCIRG1;IFI30;ATP6V0D1;AGPAT2;LMF2;PDLIM7
Cerebellar-facial-dental syndrome ORPHA:444072	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6;EVI5L;RAB11FIP3
Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PLK4;CCNA2;CCNB2;OIP5;CDC25C;CENPA;NDC80
Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PTPRU;LMTK3;TNKS1BP1;CDC42BPB;HS6ST1;PPFIA3;SYT7
Combined immunodeficiency due to GINS1 deficiency ORPHA:505227	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;NDC80
Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	KIAA0513;MAFB;KCNE3;CHN2;CD14;FRY;ITM2B
DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;IGSF8;KIFC2;SGSM2;DYRK1B;EVI5L;RAB11FIP3
Distal monosomy 1q ORPHA:36367	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	DDX17;ATP8A1;IQSEC1;SPOCK2;KCTD12;FRY;TMEM170B
Focal dermal hypoplasia ORPHA:2092	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	DRAP1;IGSF8;SMYD5;RPUSD1;ZNF628;LMF2;RRP9
Heme oxygenase-1 deficiency ORPHA:562509	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CDA;CDKN1A;CEBPB;CD14;TCIRG1;IFI30;KLF4
Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	BRSK2;TUBB3;GPRIN1;CAMK2N2;SYNGR3;NES;PPFIA3
Hyper-IgM syndrome type 5 ORPHA:101092	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CENPA;ZWINT
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PLK4;CCNA2;CCNB1;OIP5;KIF20A;CENPA;ZWINT
Kufor-Rakeb syndrome ORPHA:306674	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;IGSF8;KIFC2;PITPNM1;TAOK2;KATNB1;EVI5L
LIPE-related familial partial lipodystrophy ORPHA:435660	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	SPSB3;SNPH;SH2D3C;TUBGCP6;EVI5L;RASGRP2;CORO1A
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CCNA2;CCNB2;CCNB1;OIP5;KIF20A;CENPA;ZWINT
MASA syndrome ORPHA:2466	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	BRSK2;TUBB3;GPRIN1;CAMK2N2;SYNGR3;NES;PPFIA3
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	DRAP1;TREX1;ISG15;NMI;TCIRG1;MRPL54;OASL
Monosomy 22q13.3 ORPHA:48652	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CTIF;PTPRU;NUAK1;TNKS1BP1;CDC42BPB;NES;SYT7
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	VAT1;P4HA2;SERPINH1;TRIP10;TNKS1BP1;GAS2L1;FSTL3
Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	APC2;ACAP3;CTIF;TAOK2;EVI5L;RAB11FIP3;ZNF653
Pontocerebellar hypoplasia type 9 ORPHA:369920	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PGS1;STARD3;PITPNM1;USP20;UNC119;KATNB1;LMF2
Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PLK4;CCNA2;CCNB2;CCNB1;OIP5;CENPA;ZWINT
Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CCNA2;CCNB2;CCNB1;CCNE1;KIF20A;CENPA;ZWINT
Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	SPSB3;DGAT1;TMEM129;TMED1;AGPAT2;LMF2;MRPL54
Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	APC2;SEMA6C;CTIF;FXR2;EVI5L;HS6ST1;ZNF697
Steinert myotonic dystrophy ORPHA:273	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	SEMA6C;ACAP3;NUMBL;TAOK2;TNKS1BP1;EVI5L;RAB11FIP3
Thrombomodulin-related bleeding disorder ORPHA:436169	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	CDA;CEBPB;MAFB;DHRS9;KCTD12;CD14;KLF4
X-linked complicated corpus callosum dysgenesis ORPHA:1497	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	BRSK2;TUBB3;GPRIN1;CAMK2N2;SYNGR3;NES;PPFIA3
X-linked complicated spastic paraplegia type 1 ORPHA:306617	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	BRSK2;TUBB3;GPRIN1;CAMK2N2;SYNGR3;NES;PPFIA3
X-linked dominant chondrodysplasia, Chassaing-Lacombe type ORPHA:163966	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	PAN2;SEMA6C;ACAP3;USP20;CLSTN3;SGSM2;TUBGCP6
Young adult-onset distal hereditary motor neuropathy ORPHA:314485	7/101	0.004063505237738164	0.10406705786817567	0	0	3.7154051259726835	20.455940625184112	ACAP3;IGSF8;KIFC2;SGSM2;DYRK1B;EVI5L;RAB11FIP3
Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242	7/102	0.0042902113029724765	0.10540665493969777	0	0	3.676107147664558	20.040001426013404	AOC3;SPSB3;DGAT1;ATG16L2;CD14;TCIRG1;AGPAT2
D-2-hydroxyglutaric aciduria ORPHA:79315	7/102	0.0042902113029724765	0.10540665493969777	0	0	3.676107147664558	20.040001426013404	SPSB3;ACAP3;DGAT1;TMEM129;NOXA1;TUBGCP6;LMF2
Hydrolethalus ORPHA:2189	7/102	0.0042902113029724765	0.10540665493969777	0	0	3.676107147664558	20.040001426013404	CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA;ZWINT
Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813	7/102	0.0042902113029724765	0.10540665493969777	0	0	3.676107147664558	20.040001426013404	EHD1;TREX1;ARID5A;ADAM8;TCIRG1;IFI30;OASL
Marinesco-Sjogren syndrome ORPHA:559	7/102	0.0042902113029724765	0.10540665493969777	0	0	3.676107147664558	20.040001426013404	SPSB3;TREX1;TCIRG1;ATP6V0D1;WDR45;AGPAT2;MRPL54
Bilateral perisylvian polymicrogyria ORPHA:98889	7/103	0.004526353303087855	0.10686437251508982	0	0	3.637627877237852	19.635328437512907	CTIF;AHNAK2;SGSM2;TNKS1BP1;CDC42BPB;SYNPO;BAIAP2
Cold-induced sweating syndrome ORPHA:157820	7/103	0.004526353303087855	0.10686437251508982	0	0	3.637627877237852	19.635328437512907	VAT1;CYTH3;TUBB3;SERPINH1;VASN;DUSP14;FSTL3
Dedifferentiated liposarcoma ORPHA:99970	7/103	0.004526353303087855	0.10686437251508982	0	0	3.637627877237852	19.635328437512907	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA
Distal hereditary motor neuropathy type 5 ORPHA:139536	7/103	0.004526353303087855	0.10686437251508982	0	0	3.637627877237852	19.635328437512907	PREPL;ACOT7;TUBB3;CAMK2N2;CKB;PPFIA3;SYT7
Well-differentiated liposarcoma ORPHA:99971	7/103	0.004526353303087855	0.10686437251508982	0	0	3.637627877237852	19.635328437512907	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA
Smith-Magenis syndrome ORPHA:819	7/104	0.004772174567393758	0.11179466312142587	0	0	3.599941993830253	19.241521457474846	ACAP3;KIFC2;DEAF1;ZNF628;TAOK2;EVI5L;ZNF598
Aicardi-Goutieres syndrome ORPHA:51	7/107	0.005570162140882759	0.12948484607498228	0	0	3.4914066496163683	18.12155657139	CD52;TREX1;ADAM8;NMI;IFI30;CORO1A;OASL
46,XX gonadal dysgenesis ORPHA:243	7/109	0.006155052098330711	0.14198906443630083	0	0	3.422596660147435	17.4226668799488	PLK4;CCNA2;CCNB1;KIF20A;CDC25C;CENPA;ZWINT
46,XY complete gonadal dysgenesis ORPHA:242	7/110	0.00646410798782235	0.14798889650908442	0	0	3.389193752638244	17.086587265610902	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C;CENPA
Saldino-Mainzer syndrome ORPHA:140969	6/100	0.01488811138109757	0.19914454650015517	0	0	3.1765089014329138	13.364183722388676	PTPRU;SGSM2;TAOK2;TNKS1BP1;CDC42BPB;RAB11FIP3
Van der Woude syndrome ORPHA:888	6/100	0.01488811138109757	0.19914454650015517	0	0	3.1765089014329138	13.364183722388676	C11ORF52;FGFBP1;CDH3;CDH1;ATP2C2;KLK8
2q37 microdeletion syndrome ORPHA:1001	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	HERC1;ATG16L2;IQSEC1;SPOCK2;FRY;LYST
3-phosphoserine phosphatase deficiency, infantile/juvenile form ORPHA:79350	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNB1;OIP5;KIF20A;CDC25C;CENPA;ZWINT
AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SEMA6C;ACAP3;CTIF;NUMBL;EVI5L;RAB11FIP3
Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CD52;SH2D3C;ARID5A;ADAM8;RASGRP2;CORO1A
Adrenomyeloneuropathy ORPHA:139399	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	RPUSD1;ZNF628;TCIRG1;AGPAT2;LMF2;PDLIM7
Alkaptonuria ORPHA:56	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	TMEM45B;VNN1;TRIM15;AKR1C4;SERPINA6;PDZK1IP1
Alpha-mannosidosis, adult form ORPHA:309288	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	STARD3;ARID5A;ADAM8;TCIRG1;IFI30;LMF2
Alpha-mannosidosis, infantile form ORPHA:309282	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	STARD3;ARID5A;ADAM8;TCIRG1;IFI30;LMF2
Apparent mineralocorticoid excess ORPHA:320	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;ENTPD2;CDH1;MARVELD3;RHPN2;SYT7
Autosomal dominant dopa-responsive dystonia ORPHA:98808	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CD52;ADAM8;MTHFS;NMI;IFI30;OASL
Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Autosomal dominant popliteal pterygium syndrome ORPHA:1300	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
Autosomal recessive cerebral atrophy ORPHA:363969	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	TMEM45B;FAM83F;CDH1;MARVELD3;GCNT3;ATP2C2
Autosomal recessive cutis laxa type 2B ORPHA:357064	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNB2;CCNB1;KIF20A;TLCD1;CENPA;ZWINT
Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form ORPHA:89842	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;USP20;TMEM129;TUBGCP6;LMF2
Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CD52;ADAM8;NMI;TCIRG1;IFI30;OASL
Beta-propeller protein-associated neurodegeneration ORPHA:329284	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SPSB3;DAZAP2;UBXN11;TCIRG1;ATP6V0D1;WDR45
Bilateral generalized polymicrogyria ORPHA:208447	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	BRSK2;CAMK2N2;LMTK3;VWA5B2;PPFIA3;SYT7
Birt-Hogg-Dube syndrome ORPHA:122	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	KIAA0513;IQSEC1;SGSM2;PLEKHM1;TUBGCP6;CLK3
Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;SGSM2;TAOK2;SYNPO;RAB11FIP3;VASN
CCDC115-CDG ORPHA:468684	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CDKN2D;SPSB3;DAZAP2;B3GALT4;ATP6V0D1;MRPL54
CLN10 disease ORPHA:228337	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CEBPB;NOXA1;ATP6V0D1;GAS2L1;AGPAT2;LMF2
CLN4B disease ORPHA:228343	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;PITPNM1;TAOK2;EVI5L;ZNF653
Camurati-Engelmann disease ORPHA:1328	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	EHD1;CCND3;ITPRIP;ARID5A;TCIRG1;SH2B3
Charcot-Marie-Tooth disease type 4F ORPHA:99952	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SEMA6C;ZNF628;TAOK2;EVI5L;RAB11FIP3;ZNF653
Classic Hodgkin lymphoma, nodular sclerosis type ORPHA:98843	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	VAT1;CDKN1C;CTIF;TMEM129;GAS2L1;PDLIM7
Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C
Combined oxidative phosphorylation defect type 27 ORPHA:477774	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PGS1;ATG16L2;TUBGCP6;ABCA7;TCIRG1;LMF2
Congenital intrauterine infection-like syndrome ORPHA:1229	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;FAM83F;CDH1;MARVELD3;RHPN2;ATP2C2
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNA2;CCNB1;CCNE1;GPRIN1;NXPH4;SYNGR3
Congenital myopathy with internal nuclei and atypical cores ORPHA:319160	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	KIFC2;STK11IP;TAOK2;RHPN1;ZNF653;ZNF598
Congenital tufting enteropathy ORPHA:92050	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;CDH3;CDH1;MARVELD3;RHPN2;ATP2C2
Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	EHD1;MAPKAPK2;ARID5A;ADAM8;TCIRG1;MAP3K14
Denys-Drash syndrome ORPHA:220	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNA2;CCNB2;KIF20A;CDC25C;CENPA;NDC80
Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
EEM syndrome ORPHA:1897	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	FGFBP1;CDH3;CDH1;MARVELD3;ATP2C2;KLK8
Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	NXF1;STK11IP;SEC16A;SGSM2;TUBGCP6;WDR6
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;ATG16L2;IQSEC1;SGSM2;PLEKHM1;TUBGCP6
Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;SEC16A;TAOK2;TNKS1BP1;LMF2
Familial cortical myoclonus ORPHA:319189	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;P4HA2;TNKS1BP1;TRIM47;NOL3;FSTL3
Familial expansile osteolysis ORPHA:85195	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	TMEM45B;CDX2;CDH1;NEURL3;GCNT3;TNFRSF11A
Familial spontaneous pneumothorax ORPHA:2903	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	KIAA0513;IQSEC1;SGSM2;PLEKHM1;TUBGCP6;CLK3
Frank-Ter Haar syndrome ORPHA:137834	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;NUAK1;AHNAK2;TNKS1BP1;CDC42BPB;NES
Frasier syndrome ORPHA:347	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNA2;CCNB2;KIF20A;CDC25C;CENPA;NDC80
GTP cyclohydrolase I deficiency ORPHA:2102	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CD52;ADAM8;MTHFS;NMI;IFI30;OASL
Gamma-glutamyl transpeptidase deficiency ORPHA:33573	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	FGD3;STARD3;ADAM8;ABCA7;TCIRG1;IFI30
Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PLK4;CCNA2;CCNB1;OIP5;CENPA;ZWINT
Hereditary coproporphyria ORPHA:79273	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNA2;CCNE1;MRPL19;OIP5;CENPA;ZWINT
Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;WFIKKN1;KIFC2;TAOK2;RAB11FIP3;PPFIA3
Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNB1;GPRIN1;NXPH4;CAMK2N2;CENPA;PPFIA3
Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CTIF;CDKN1A;TP53I3;CDC42BPB;GAS2L1;PDLIM7
Hurler syndrome ORPHA:93473	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;NOXA1;SGSM2;TUBGCP6;LMF2
Hurler-Scheie syndrome ORPHA:93476	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;NOXA1;SGSM2;TUBGCP6;LMF2
Hypotrichosis with juvenile macular degeneration ORPHA:1573	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	FGFBP1;CDH3;CDH1;MARVELD3;ATP2C2;KLK8
Infantile inflammatory bowel disease with neurological involvement ORPHA:565788	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	EHD1;CCND3;ITPRIP;ARID5A;TCIRG1;SH2B3
Isolated neonatal sclerosing cholangitis ORPHA:480556	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;CDH1;MARVELD3;RHPN2;CLDN2;SERPINA6
Jawad syndrome ORPHA:313795	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PLK4;CCNA2;CCNB2;CCNB1;KIF20A;CDC25C
Knobloch syndrome ORPHA:1571	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SEMA6C;TAOK2;SERPINH1;TNKS1BP1;RAB11FIP3;VASN
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	VAT1;P4HA2;SERPINH1;TRAM2;PDLIM7;FSTL3
Lethal congenital contracture syndrome type 2 ORPHA:137776	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;CDH1;MARVELD3;RHPN2;ATP2C2;SYT7
Leukonychia totalis ORPHA:2387	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SPSB3;STARD3;IGSF8;PITPNM1;USP20;LMF2
Localized dystrophic epidermolysis bullosa, acral form ORPHA:158673	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Localized dystrophic epidermolysis bullosa, nails only ORPHA:158676	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Localized dystrophic epidermolysis bullosa, pretibial form ORPHA:79410	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
MYH9-related disease ORPHA:182050	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	EHD1;SEC16A;PACSIN2;TCIRG1;TRAM2;LMF2
MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;CDH1;MARVELD3;RHPN2;ATP2C2;SYT7
Meacham syndrome ORPHA:3097	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNA2;CCNB2;KIF20A;CDC25C;CENPA;NDC80
Methylmalonic acidemia with homocystinuria, type cblJ ORPHA:369955	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PAN2;NXF1;SGSM2;TUBGCP6;WDR6;REC8
Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	NXF1;USP20;STK11IP;TUBGCP6;ABCA7;CLK3
Mucolipidosis type IV ORPHA:578	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	STARD3;PLEKHM1;TCIRG1;ATP6V0D1;WDR45;LMF2
Mucopolysaccharidosis type 2, attenuated form ORPHA:217093	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ARL4C;KIAA0513;IQSEC1;SPOCK2;ST3GAL5;ITM2B
Mucopolysaccharidosis type 2, severe form ORPHA:217085	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ARL4C;KIAA0513;IQSEC1;SPOCK2;ST3GAL5;ITM2B
Mucopolysaccharidosis type 6, rapidly progressing ORPHA:276212	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	HTR7P1;SEC23A;ITPRIP;RAB42;TRAM2;SH2B3
Mucopolysaccharidosis type 6, slowly progressing ORPHA:276223	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	HTR7P1;SEC23A;ITPRIP;RAB42;TRAM2;SH2B3
NAD(P)HX dehydratase deficiency ORPHA:555402	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	IGSF8;TMEM129;WDR6;HS6ST1;LMF2;SLC25A25
NIK deficiency ORPHA:447731	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ATG16L2;ARID5A;PLEKHM1;ADAM8;TCIRG1;MAP3K14
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	C11ORF52;FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
Neutral lipid storage myopathy ORPHA:98908	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SPSB3;DGAT1;ZNF628;TCIRG1;AGPAT2;LMF2
Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	TMEM45B;CDX2;CDH1;NEURL3;GCNT3;TNFRSF11A
PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;SEC16A;TAOK2;TNKS1BP1;LMF2
POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6;WDR6
PYCR1-related De Barsy syndrome ORPHA:293633	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNB2;CCNB1;KIF20A;TLCD1;CENPA;ZWINT
Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;SEC16A;TAOK2;TNKS1BP1;LMF2
Pyruvate carboxylase deficiency, benign type ORPHA:353320	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;TNKS1BP1;REEP6;CDC42BPB;BAIAP2;SYT7
Pyruvate carboxylase deficiency, infantile type ORPHA:353308	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;TNKS1BP1;REEP6;CDC42BPB;BAIAP2;SYT7
Pyruvate carboxylase deficiency, severe neonatal type ORPHA:353314	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;TNKS1BP1;REEP6;CDC42BPB;BAIAP2;SYT7
Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	FXR2;SMYD5;TAOK2;TNKS1BP1;WDR6;HS6ST1
Scheie syndrome ORPHA:93474	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;NOXA1;SGSM2;TUBGCP6;LMF2
Self-improving dystrophic epidermolysis bullosa ORPHA:79411	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB;VASN;FSTL3
Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CCNB2;CCNB1;KIF20A;CDC25C;CENPA;ZWINT
Succinic semialdehyde dehydrogenase deficiency ORPHA:22	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PAN2;PREPL;ATP8A1;DIS3L;TPPP;RALGPS1
TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6;WDR6
Triglyceride deposit cardiomyovasculopathy ORPHA:565612	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	SPSB3;DGAT1;ZNF628;TCIRG1;AGPAT2;LMF2
Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	ACAP3;DGAT1;TMEM129;NOXA1;AGPAT2;LMF2
Waldenstrom macroglobulinemia ORPHA:33226	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	CD52;ADAM8;NMI;TCIRG1;IFI30;OASL
X-linked cerebral adrenoleukodystrophy ORPHA:139396	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	RPUSD1;ZNF628;TCIRG1;AGPAT2;LMF2;PDLIM7
X-linked intellectual disability, Siderius type ORPHA:85287	6/101	0.015571771889132521	0.19914454650015517	0	0	3.1429108485499464	13.081723675928975	PAN2;MDC1;DIDO1;SEC16A;UBAP2L;ZBTB5
Benign hereditary chorea ORPHA:1429	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	SLC25A27;PTPRU;BRSK2;NUAK1;CKB;SYT7
CADDS ORPHA:369942	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	DRAP1;RPUSD1;TMED1;AGPAT2;LMF2;YIF1B
CAMOS syndrome ORPHA:83472	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	DIDO1;NXF1;SEC16A;AKAP8;TUBGCP6;CLK3
Cerebellar ataxia-hypogonadism syndrome ORPHA:1173	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	STARD3;PITPNM1;USP20;STK11IP;TUBGCP6;LMF2
Coats plus syndrome ORPHA:313838	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	FGD3;ATG16L2;TUBGCP6;ABCA7;CORO1A;CLK3
Early myoclonic encephalopathy ORPHA:1935	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	IGSF8;KIFC2;RPUSD1;ZNF628;ZNF598;LMF2
Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	KIFC2;PPP1R13L;AHNAK2;TNKS1BP1;TRIM47;CDC42BPB
Familial infantile myoclonic epilepsy ORPHA:352582	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	APC2;BRSK2;CAMK2N2;VWA5B2;PPFIA3;SYT7
Lethal congenital contracture syndrome type 3 ORPHA:137783	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	SEMA6C;ACAP3;CTIF;EVI5L;RGS11;RAB11FIP3
Musculocontractural Ehlers-Danlos syndrome ORPHA:2953	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	ITPRIP;SERPINH1;TNFRSF10B;PLIN3;TRAM2;PDLIM7
Progressive myoclonic epilepsy type 5 ORPHA:402082	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	PTPRU;SGSM2;TAOK2;TNKS1BP1;CDC42BPB;RAB11FIP3
Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	APC2;BRSK2;GPRIN1;CAMK2N2;EVI5L;PPFIA3
Stormorken-Sjaastad-Langslet syndrome ORPHA:3204	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	EHD1;CCND3;TREX1;ARID5A;ADAM8;TCIRG1
Synaptic congenital myasthenic syndromes ORPHA:98915	6/102	0.016276870610700968	0.19914454650015517	0	0	3.1100127551020407	12.807064122663988	SLC25A27;SEMA6C;CTIF;SGSM2;CDC42BPB;RAB11FIP3
Dehydrated hereditary stomatocytosis ORPHA:3202	6/103	0.017003707933492276	0.20472193376499465	0	0	3.0777929728592466	12.539925299215147	CCND3;ATG16L2;ADAM8;NMI;TCIRG1;IFI30
Familial hypercholanemia ORPHA:238475	6/103	0.017003707933492276	0.20472193376499465	0	0	3.0777929728592466	12.539925299215147	C11ORF52;PTPRU;TNKS1BP1;CDC42BPB;SERPINA6;SYT7
Linear nevus sebaceus syndrome ORPHA:2612	6/103	0.017003707933492276	0.20472193376499465	0	0	3.0777929728592466	12.539925299215147	PLK4;CCNA2;SYNCRIP;CCNB1;PTGES3;ZWINT
Takayasu arteritis ORPHA:3287	6/103	0.017003707933492276	0.20472193376499465	0	0	3.0777929728592466	12.539925299215147	CD52;ADAM8;NMI;TCIRG1;IFI30;OASL
Autosomal recessive malignant osteopetrosis ORPHA:667	6/104	0.017752578535848832	0.2120485863056726	0	0	3.046230737192836	12.280039992567207	CD52;ARID5A;ADAM8;TCIRG1;IFI30;CORO1A
Familial congenital mirror movements ORPHA:238722	6/104	0.017752578535848832	0.2120485863056726	0	0	3.046230737192836	12.280039992567207	CCNB1;ACOT7;TUBB3;GPRIN1;KIF20A;PPFIA3
Early-onset posterior subcapsular cataract ORPHA:441447	6/105	0.018523771216229994	0.22038912053325607	0	0	3.0153061224489797	12.027152860686947	MIDN;CDC34;MAPKAPK2;TRIP10;TNKS1BP1;ZNF598
Early-onset autosomal dominant Alzheimer disease ORPHA:1020	6/107	0.02013424758919603	0.23861057339039374	0	0	2.9552939987876337	11.541407336810671	IGSF8;KIFC2;PITPNM1;STK11IP;NOXA1;ABCA7
Early-onset posterior polar cataract ORPHA:98993	6/108	0.020974077959017203	0.24759243590683588	0	0	2.926170468187275	11.308092097763323	PTPRU;FXR2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Cleft lip/palate ORPHA:199306	6/109	0.02183732344882225	0.25677973331650134	0	0	2.8976124430354666	11.080860256734752	C11ORF52;PTPRU;CDH3;CDH1;PPP1R13L;ARHGAP29
Usher syndrome type 1 ORPHA:231169	6/110	0.022724241001187338	0.2661730864557679	0	0	2.869603610675039	10.859507055998051	BRSK2;LMTK3;CIB2;AATK;SYT7;RALGPS1
Familial prostate cancer ORPHA:1331	6/112	0.024570085822547418	0.28448582128635364	0	0	2.8151713515594916	10.433660130055543	PLK4;CCNB2;KIF20A;CDC25C;HOXB13;NDC80
Giant cell glioblastoma ORPHA:251579	6/112	0.024570085822547418	0.28448582128635364	0	0	2.8151713515594916	10.433660130055543	VAT1;SERPINH1;TRIP10;TNKS1BP1;TRAM2;FSTL3
Gliosarcoma ORPHA:251576	6/112	0.024570085822547418	0.28448582128635364	0	0	2.8151713515594916	10.433660130055543	VAT1;SERPINH1;TRIP10;TNKS1BP1;TRAM2;FSTL3
Precursor T-cell acute lymphoblastic leukemia ORPHA:99861	6/123	0.03651229489058322	0.38328446164058755	0	0	2.5490580847723705	8.437653043968659	MDC1;TCERG1;DIDO1;NUP50;UBAP2L;CTCF
Charcot-Marie-Tooth disease type 2B2 ORPHA:101101	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	STARD3;STK11IP;ZNF628;ABCA7;LMF2
Generalized pseudohypoaldosteronism type 1 ORPHA:171876	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	EXOC3L4;GCNT3;TRIM15;CLDN2;SERPINA6
Liddle syndrome ORPHA:526	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
Metachromatic leukodystrophy, adult form ORPHA:309271	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	SPSB3;STARD3;TCIRG1;ATP6V0D1;LMF2
Metachromatic leukodystrophy, juvenile form ORPHA:309263	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	SPSB3;STARD3;TCIRG1;ATP6V0D1;LMF2
Metachromatic leukodystrophy, late infantile form ORPHA:309256	5/100	0.04950612178195298	0.38328446164058755	0	0	2.6124280166064016	7.852067635475972	SPSB3;STARD3;TCIRG1;ATP6V0D1;LMF2
17p11.2 microduplication syndrome ORPHA:1713	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;SEC16A;SGSM2;TAOK2
19p13.3 microduplication syndrome ORPHA:447980	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CYTH3;CTIF;AHNAK2;SYNPO;GAS2L1
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	AKR1C4;PDZK1IP1;CLU;ITM2B;DHRS3
8p11.2 deletion syndrome ORPHA:251066	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CDKN2D;KIAA0513;SNPH;TMCC2;RASGRP2
ACys amyloidosis ORPHA:100008	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MAFB;CD14;ATP6V0D1;GAS2L1;KLF4
Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PIGB;USP16;SCAF11;STK17B;OMA1
Alopecia universalis ORPHA:701	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;AHNAK2;TNKS1BP1;NOL3;SYT7
Ataxia-oculomotor apraxia type 4 ORPHA:459033	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STARD3;STK11IP;ZNF628;ABCA7;LMF2
Atrichia with papular lesions ORPHA:86819	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;AHNAK2;TNKS1BP1;NOL3;SYT7
Atypical Werner syndrome ORPHA:79474	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DDX17;PAN2;SGSM2;TUBGCP6;WDR6
Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TAOK2;TNKS1BP1;CDC42BPB;GAS2L1;RAB11FIP3
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	EXOC3L4;MARVELD3;TRIM15;CLDN2;SERPINA6
Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;NUAK1;AHNAK2;TNKS1BP1;CDC42BPB
Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;NUAK1;AHNAK2;TNKS1BP1;CDC42BPB
Autosomal recessive spastic paraplegia type 62 ORPHA:401785	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CCNB2;CCNB1;KIF20A;TRAM2;ZWINT
Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PITPNM1;ZNF628;DYRK1B;ABCA7;ZNF653
Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;CD52;SH2D3C;RASGRP2;CORO1A
Brachydactyly type B2 ORPHA:140908	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARL4C;CDKN2D;CCND3;SNPH;CCDC102A
CLN3 disease ORPHA:228346	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ATG16L2;PLEKHM1;TCIRG1;IFI30;CLK3
Charcot-Marie-Tooth disease type 2B1 ORPHA:98856	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Charcot-Marie-Tooth disease type 4D ORPHA:99950	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MAFB;MICAL2;CD14;KLF4;NDRG1
Chromophobe renal cell carcinoma ORPHA:319303	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	EXOC3L4;GCNT3;TRIM15;CLDN2;SERPINA6
Classic galactosemia ORPHA:79239	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SPSB3;NXF1;ATG16L2;TUBGCP6;WDR45
Clear cell renal carcinoma ORPHA:319276	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CEBPB;PLEKHM1;CD14;TCIRG1;ATP6V0D1
Cleidocranial dysplasia ORPHA:1452	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STK17B;NMI;LYST;SYTL3;SIRPB1
Combined immunodeficiency due to CD70 deficiency ORPHA:538958	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TOE1;TNFSF9;RHEBL1;ADA;RRP9
Combined immunodeficiency-enteropathy spectrum ORPHA:436252	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PLEKHM1;ADAM8;TCIRG1;IFI30;CORO1A
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STK17B;NMI;IFI30;KLF4;OASL
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DGAT1;TMED1;REEP6;AGPAT2;LMF2
Congenital hereditary endothelial dystrophy type I ORPHA:98975	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	C11ORF52;CDH3;CDH1;MARVELD3;ATP2C2
Congenital insensitivity to pain with severe intellectual disability ORPHA:453510	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SEMA6C;CTIF;PTPRU;ZNF697;FSTL3
Congenital muscular dystrophy due to LMNA mutation ORPHA:157973	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Congenital non-communicating hydrocephalus ORPHA:269510	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;CD52;SH2D3C;ARID3B;CORO1A
Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	VAT1;SERPINH1;TRAM2;LMF2;FSTL3
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ATG16L2;RASA4;SPOCK2;SH2D3C;RASGRP2
Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACOT7;TUBB3;GPRIN1;CAMK2N2;NES
Craniosynostosis-dental anomalies ORPHA:284149	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	NXF1;ATG16L2;USP20;RASA4;TUBGCP6
D-glyceric aciduria ORPHA:941	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SPSB3;STARD3;DGAT1;TCIRG1;LMF2
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Distal 16p11.2 microdeletion syndrome ORPHA:261222	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6
Distal 22q11.2 microdeletion syndrome ORPHA:261330	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	RIMS3;USP20;TAOK2;TMCC2;CBL
Duane retraction syndrome with congenital deafness ORPHA:529574	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MAFB;KCTD12;CD14;KLF4;ITM2B
Dyschromatosis symmetrica hereditaria ORPHA:41	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DDX17;DIDO1;SEC16A;CBL;N4BP1
Dyschromatosis universalis hereditaria ORPHA:241	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;CBS;TNKS1BP1;NOL3;PPFIA3
Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MLLT11;TMEM169;ATP8A1;SPOCK2;PSIP1
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Familial hyperprolactinemia ORPHA:397685	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TMEM45B;C11ORF52;CDH1;MARVELD3;SERPINA6
Familial partial lipodystrophy, Dunnigan type ORPHA:2348	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Familial partial lipodystrophy, Kobberling type ORPHA:79084	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Familial pseudohyperkalemia ORPHA:90044	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;CBS;TNKS1BP1;NOL3;PPFIA3
Fructose-1,6-bisphosphatase deficiency ORPHA:348	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TMEM45B;FGD3;KCNE3;CD14;IFI30
GNE myopathy ORPHA:602	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FARP2;SPAG9;DEPDC7;MBNL2;SH3PXD2A
Galactokinase deficiency ORPHA:79237	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARMC6;RPUSD1;TMED1;AGPAT2;YIF1B
Gelatinous drop-like corneal dystrophy ORPHA:98957	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	C11ORF52;FGFBP1;CDH3;CDH1;ATP2C2
Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	RASA4;SPOCK2;SH2D3C;TCAP;RASGRP2
Grange syndrome ORPHA:79094	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;NXF1;ATG16L2;CORO1A;CLK3
Gray platelet syndrome ORPHA:721	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;ATG16L2;ADAM8;ABCA7;TCIRG1
Heart-hand syndrome, Slovenian type ORPHA:168796	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Hemochromatosis type 4 ORPHA:139491	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	VNN1;KCNE3;CD14;PDZK1IP1;ITM2B
Hemochromatosis type 5 ORPHA:447792	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CDA;ESAM;KCTD12;MYZAP;PDLIM7
Hereditary folate malabsorption ORPHA:90045	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;SLC46A1;RHPN2;CDC42BPB;SYT7
Hermansky-Pudlak syndrome type 7 ORPHA:231531	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CDKN2D;BCL7B;ARID5A;ANP32B;CORO1A
Hermansky-Pudlak syndrome type 8 ORPHA:231537	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DAZAP2;CCND3;SNRNP35;SLC25A44;MED26
Hyperinsulinism due to HNF1A deficiency ORPHA:324575	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	EXOC3L4;GCNT3;TRIM15;CLDN2;SERPINA6
Hyperinsulinism due to HNF4A deficiency ORPHA:263455	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	EXOC3L4;GCNT3;TRIM15;CLDN2;SERPINA6
Ichthyosis-prematurity syndrome ORPHA:88621	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACOT7;ARMC6;RPUSD1;GPRIN1;ZNF598
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;USP20;SGSM2;TUBGCP6
Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	APC2;ACAP3;DEAF1;KATNB1;EVI5L
Intellectual disability-strabismus syndrome ORPHA:363528	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	RPUSD1;ZNF628;ZNF653;ZNF598;LMF2
Interstitial lung disease due to ABCA3 deficiency ORPHA:440402	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	BRSK2;PRRT2;RGS11;RAB11FIP3;PPFIA3
LMNA-related cardiocutaneous progeria syndrome ORPHA:363618	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Lipoyl transferase 2 deficiency ORPHA:447795	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	RPUSD1;OIP5;ZNF689;METTL18;RRP9
MOGS-CDG ORPHA:79330	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STK11IP;RPUSD1;WDR6;ZNF598;LMF2
Malan overgrowth syndrome ORPHA:420179	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CYTH3;CTIF;AHNAK2;SYNPO;GAS2L1
Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	P4HA2;SERPINH1;TRIP10;TNKS1BP1;FSTL3
Marshall-Smith syndrome ORPHA:561	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CYTH3;CTIF;AHNAK2;SYNPO;GAS2L1
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STK17B;NMI;LYST;SYTL3;SIRPB1
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CTIF;NUAK1;AHNAK2;CDC42BPB;ZNF697
Mucolipidosis type III gamma ORPHA:423470	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SPSB3;CD14;TCIRG1;ATP6V0D1;WDR45
Mucopolysaccharidosis type 4A ORPHA:309297	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	STK11IP;PLEKHM1;TCIRG1;SLC16A3;LMF2
Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MAFB;KCTD12;CD14;KLF4;ITM2B
Multiple intestinal atresia ORPHA:2300	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PLEKHM1;ADAM8;TCIRG1;IFI30;CORO1A
Muscular dystrophy, Selcen type ORPHA:199340	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SERPINH1;TRIP10;TNKS1BP1;TRIM47;NOL3
NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	SPSB3;STARD3;ARID5A;TCIRG1;LMF2
Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;ATG16L2;SH2D3C;RASGRP2;CORO1A
Non-immune hydrops fetalis ORPHA:363999	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	NUAK1;AHNAK2;ARHGAP29;TNKS1BP1;SYNPO
Oculofaciocardiodental syndrome ORPHA:2712	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MDC1;TCERG1;DIDO1;UBAP2L;CTCF
Osteogenesis imperfecta type 5 ORPHA:216828	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;ATG16L2;ADAM8;ABCA7;RASGRP2
PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;SEC16A;SGSM2;TAOK2
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PLK4;CCNA2;CCNB2;CCNB1;KIF20A
Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARID5A;PLEKHM1;ADAM8;TCIRG1;IFI30
Perry syndrome ORPHA:178509	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CTIF;FXR2;TAOK2;EVI5L;RAB11FIP3
Polydactyly of a biphalangeal thumb ORPHA:93339	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PGS1;ITPRIP;MEF2B;RASGRP2;SH2B2
Polymicrogyria with optic nerve hypoplasia ORPHA:250972	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CDKN2D;SH2D3C;ESAM;TMCC2;RASGRP2
Progressive familial intrahepatic cholestasis type 4 ORPHA:480483	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	C11ORF52;PTPRU;TRIP10;TNKS1BP1;CDC42BPB
Progressive myoclonic epilepsy type 3 ORPHA:263516	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	MLLT11;TMEM169;IQSEC1;SNPH;ST3GAL5
Proximal 16p11.2 microdeletion syndrome ORPHA:261197	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6
QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DIDO1;NXF1;AKAP8;WDR6;UBAP2L
Quebec platelet disorder ORPHA:220436	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TP53I3;SERPINH1;TRIP10;PLIN3;IER3
RFVT3-related riboflavin transporter deficiency ORPHA:572550	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CCND3;PLEKHM1;ATP6V0D1;WDR45;SIRPB1
Revesz syndrome ORPHA:3088	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	CD52;TREX1;ARID5A;B3GALT4;ADAM8
SHORT syndrome ORPHA:3163	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ATP8A1;HERC1;LPAR6;FRY;LYST
Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	USP20;SPOCK2;SH2D3C;RASGRP2;CORO1A
Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;CD52;SH2D3C;RASGRP2;CORO1A
Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ACAP3;KIFC2;SGSM2;TAOK2;TUBGCP6
Sialuria ORPHA:3166	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FARP2;SPAG9;DEPDC7;MBNL2;SH3PXD2A
Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;NOS1AP;TNKS1BP1;PPFIA3;SYT7
Spinocerebellar ataxia type 40 ORPHA:423275	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FGD3;CD52;SH2D3C;ARID3B;CORO1A
Spinocerebellar ataxia type 5 ORPHA:98766	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	PTPRU;NOS1AP;TNKS1BP1;PPFIA3;SYT7
Spondylo-ocular syndrome ORPHA:85194	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	RPUSD1;TMEM129;CCDC102A;ZNF598;LMF2
Stapes ankylosis with broad thumbs and toes ORPHA:140917	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARL4C;CDKN2D;CCND3;SNPH;CCDC102A
Syndromic congenital sodium diarrhea ORPHA:563708	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	FAM83F;CDH3;CDH1;MARVELD3;ATP2C2
TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARMC6;RPUSD1;ZNF628;ZNF598;LMF2
TMEM199-CDG ORPHA:466703	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	COX19;EMG1;NME6;SNRNP35;ZNF830
TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DAZAP2;PIGB;SCAF11;STK17B;LYST
Tarsal-carpal coalition syndrome ORPHA:1412	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARL4C;CDKN2D;CCND3;SNPH;CCDC102A
Testicular regression syndrome ORPHA:983	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	ARMC6;RPUSD1;ZNF628;ZNF598;RRP9
Van den Ende-Gupta syndrome ORPHA:2460	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	NUMBL;SERPINH1;TNKS1BP1;VASN;LMF2
Variant ABeta2M amyloidosis ORPHA:314652	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	DAZAP2;CD52;STK17B;IFI44;NMI
Vocal cord and pharyngeal distal myopathy ORPHA:600	5/101	0.051273537557714216	0.38328446164058755	0	0	2.5850826972010177	7.679196243377332	TCERG1;BCLAF1;PHF14;CCP110;NAE1
3C syndrome ORPHA:7	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	STARD3;STK11IP;RPUSD1;LMF2;MRPL54
9q33.3q34.11 microdeletion syndrome ORPHA:495818	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	BRSK2;TUBB3;CAMK2N2;NOS1AP;SYT7
Bifid uvula ORPHA:99771	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	C11ORF52;FGFBP1;CDH3;CDH1;KLK8
Blepharo-cheilo-odontic syndrome ORPHA:1997	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	C11ORF52;CDH3;CDH1;MARVELD3;ATP2C2
Cap myopathy ORPHA:171881	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	TRIP10;PLIN3;TRAM2;PDLIM7;FSTL3
Cleft hard palate ORPHA:101023	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	C11ORF52;FGFBP1;CDH3;CDH1;KLK8
Cleft velum ORPHA:99772	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	C11ORF52;FGFBP1;CDH3;CDH1;KLK8
Congenital short bowel syndrome ORPHA:2301	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	SERPINH1;TRAM2;VASN;PDLIM7;FSTL3
Crouzon disease ORPHA:207	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	PTPRU;TAOK2;LMTK3;TNKS1BP1;HS6ST1
Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	DDX17;PAN2;HERC1;SGSM2;TUBGCP6
Dermatofibrosarcoma protuberans ORPHA:31112	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	NUAK1;SERPINH1;TNKS1BP1;CDC42BPB;NES
Desbuquois syndrome ORPHA:1425	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	MIDN;MAPKAPK2;PLEKHM1;N4BP1;LMF2
Ependymoma ORPHA:251636	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	EHD1;ZNF628;ARID5A;TCIRG1;LMF2
Familial multinodular goiter ORPHA:276399	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	SYNCRIP;TAOK2;KEAP1;ZBTB33;HS6ST1
Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	NXF1;ATG16L2;TUBGCP6;ABCA7;CLK3
Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	ATG16L2;UBXN11;PLEKHM1;TUBGCP6;CLK3
Huntington disease ORPHA:399	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	DDX17;HERC1;IQSEC1;ARID3B;CBL
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	PLK4;CCNA2;SYNCRIP;CCNB1;ZWINT
Metaphyseal anadysplasia ORPHA:1040	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	DHRS9;ADAM8;CD14;IFI30;OASL
RELA fusion-positive ependymoma ORPHA:530792	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	EHD1;ZNF628;ARID5A;TCIRG1;LMF2
Shprintzen-Goldberg syndrome ORPHA:2462	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	CTIF;SH3PXD2A;TNKS1BP1;CDC42BPB;VASN
Solitary fibrous tumor/hemangiopericytoma ORPHA:2126	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	STK11IP;TCIRG1;SLC16A3;LMF2;IER3
Submucosal cleft palate ORPHA:155878	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	C11ORF52;FGFBP1;CDH3;CDH1;KLK8
Thyroid ectopia ORPHA:95712	5/102	0.053077491171861335	0.38328446164058755	0	0	2.5583011988143016	7.511178295070451	P4HA2;SERPINH1;TRIP10;IER3;FSTL3
Alopecia-intellectual disability syndrome ORPHA:2850	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	C11ORF52;PTPRU;TNKS1BP1;SERPINA6;SYT7
Dysosteosclerosis ORPHA:1782	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	ADAM8;TNFRSF11A;TCIRG1;IFI30;AGPAT2
Familial focal epilepsy with variable foci ORPHA:98820	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	ATG16L2;USP20;ABCA7;CORO1A;CLK3
Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	CTIF;NUAK1;CDC42BPB;RGS11;NES
Isolated focal cortical dysplasia type IIb ORPHA:269008	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	DDX17;SEC16A;SGSM2;TAOK2;TUBGCP6
Pediatric systemic lupus erythematosus ORPHA:93552	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	CEBPB;ARID5A;CD14;TCIRG1;IFI30
Persistent hyperplastic primary vitreous ORPHA:91495	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	NUAK1;NOS1AP;DIXDC1;NES;SYT7
Prolactinoma ORPHA:2965	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	SPSB3;STARD3;USP20;STK11IP;LMF2
Rare isolated myopia ORPHA:98619	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	RPUSD1;PLIN3;TMED1;AGPAT2;LMF2
Squamous cell carcinoma of salivary glands ORPHA:500481	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the hypopharynx ORPHA:494547	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the larynx ORPHA:494550	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the lip ORPHA:502366	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the oral cavity ORPHA:502363	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Squamous cell carcinoma of the oropharynx ORPHA:500478	5/103	0.05491799202196373	0.38328446164058755	0	0	2.5320662616191516	7.347839193435597	PIGB;ITPRIP;STK17B;TNFRSF10B;RBM7
Autosomal dominant severe congenital neutropenia ORPHA:486	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	ADAM8;NMI;TCIRG1;IFI30;CORO1A
Chronic myelomonocytic leukemia ORPHA:98823	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	DIDO1;NXF1;MAPKAPK2;TRAM2;LMF2
Cleft lip and alveolus ORPHA:141291	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	FGFBP1;CDH3;CDH1;PPP1R13L;KLK8
Epidermodysplasia verruciformis ORPHA:302	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	FGD3;CD52;ADAM8;TCIRG1;CORO1A
Isolated cleft lip ORPHA:199302	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	FGFBP1;CDH3;CDH1;PPP1R13L;KLK8
Li-Fraumeni syndrome ORPHA:524	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	CCNB2;KIF20A;CDC25C;CENPA;NDC80
Primary pigmented nodular adrenocortical disease ORPHA:189439	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	SLC25A27;CTIF;PREPL;DOCK4;DIXDC1
Systemic-onset juvenile idiopathic arthritis ORPHA:85414	5/104	0.0567950348020415	0.3891940933600213	0	0	2.5063613231552164	7.189012155076352	CDKN1A;ISG15;TCIRG1;IFI30;IER3
Coloboma of choroid and retina ORPHA:98942	5/105	0.058708599657933416	0.39779683445353087	0	0	2.4811704834605597	7.034537789872301	PTPRU;TUBB3;GPRIN1;CKB;PPFIA3
Coloboma of iris ORPHA:98944	5/105	0.058708599657933416	0.39779683445353087	0	0	2.4811704834605597	7.034537789872301	PTPRU;TUBB3;GPRIN1;CKB;PPFIA3
Congenital muscular dystrophy with intellectual disability ORPHA:370968	5/105	0.058708599657933416	0.39779683445353087	0	0	2.4811704834605597	7.034537789872301	ACAP3;SGSM2;TAOK2;WDR6;RAB11FIP3
Herpes simplex virus encephalitis ORPHA:1930	5/105	0.058708599657933416	0.39779683445353087	0	0	2.4811704834605597	7.034537789872301	TREX1;NMI;TCIRG1;IFI30;OASL
Uveal melanoma ORPHA:39044	5/105	0.058708599657933416	0.39779683445353087	0	0	2.4811704834605597	7.034537789872301	DDX17;ACAP3;SGSM2;TUBGCP6;KCTD12
Wolf-Hirschhorn syndrome ORPHA:280	5/106	0.060658652372370996	0.41009048650851265	0	0	2.4564784722747084	6.884263706133068	ACAP3;KIFC2;TAOK2;WDR6;ZNF598
Adult hepatocellular carcinoma ORPHA:210159	5/109	0.06672718284187514	0.4491081214880772	0	0	2.3852515169309063	6.457216637748734	DDX17;DIDO1;SEC16A;SGSM2;TAOK2
Nephroblastoma ORPHA:654	5/109	0.06672718284187514	0.4491081214880772	0	0	2.3852515169309063	6.457216637748734	PLK4;CCNA2;CCNB2;KIF20A;NDC80
NON RARE IN EUROPE: Hypodontia ORPHA:2227	5/110	0.06882256264768498	0.4621817429362311	0	0	2.3624136677571794	6.322347310649927	C11ORF52;PTPRU;CDH3;ENTPD2;SYT7
Idiopathic pulmonary fibrosis ORPHA:2032	5/113	0.07532486223028899	0.5047266821728011	0	0	2.296437659033079	5.93846153494032	SEC16A;TAOK2;TNKS1BP1;ATP2C2;CDC42BPB
Non-specific syndromic intellectual disability ORPHA:528084	5/120	0.09173872702052277	0.5867963421058087	0	0	2.1558800752295606	5.1499893180179726	SPAG9;TCERG1;BCLAF1;SPIN1;CCP110
Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636	6/172	0.12943757958438695	0.5867963421058087	0	0	1.7921072043275141	3.664064478068853	SLC25A27;PNPT1;NOS1AP;CIB2;S1PR2;SYT7
Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	NEURL3;GCNT3;CLDN2;SERPINA6
Exfoliative ichthyosis ORPHA:289586	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	DHRS9;NMI;IFI30;OASL
Immunodeficiency by defective expression of MHC class I ORPHA:34592	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	NMI;TCIRG1;IFI30;OASL
Lethal acantholytic erosive disorder ORPHA:158687	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	C11ORF52;PTPRU;CDH1;TNKS1BP1
Localized junctional epidermolysis bullosa ORPHA:251393	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	FGFBP1;CDH3;PPP1R13L;ATP2C2
Multiple osteochondromas ORPHA:321	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	P4HA2;SERPINH1;TNKS1BP1;TRAM2
Neu-Laxova syndrome ORPHA:2671	4/100	0.13877421767633108	0.5867963421058087	0	0	2.0628172588832485	4.0738722438248915	CCNB1;ACOT7;CBS;KIF20A
15q24 microdeletion syndrome ORPHA:94065	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MDC1;DIDO1;CTCF;CBL
1p31p32 microdeletion syndrome ORPHA:401986	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SLC25A27;MBNL2;DIXDC1;ARHGAP29
1q44 microdeletion syndrome ORPHA:238769	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PLK4;TCERG1;SYNCRIP;BCLAF1
5-oxoprolinase deficiency ORPHA:33572	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DGAT1;NOXA1;GAS2L1;AGPAT2
ABri amyloidosis ORPHA:97345	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;LPAR6;CD14;ITM2B
ADan amyloidosis ORPHA:97346	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;LPAR6;CD14;ITM2B
Aarskog-Scott syndrome ORPHA:915	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TUBB3;GPRIN1;SERPINH1;TNKS1BP1
Achondroplasia ORPHA:15	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Acquired partial lipodystrophy ORPHA:79087	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNB1;KIF20A;CENPA;ZWINT
Acute intermittent porphyria ORPHA:79276	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;OIP5;ZWINT;RRP9
Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PLK4;CCNA2;CCNB1;ZWINT
Acute neonatal citrullinemia type I ORPHA:247546	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;PTPRU;TNKS1BP1;SYT7
Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VAT1;TP53I3;P4HA2;SERPINH1
Adult-onset citrullinemia type I ORPHA:247573	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;PTPRU;TNKS1BP1;SYT7
Alagille syndrome due to 20p12 microdeletion ORPHA:261600	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUAK1;AHNAK2;TNKS1BP1;CDC42BPB
Alagille syndrome due to a JAG1 point mutation ORPHA:261619	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUAK1;AHNAK2;TNKS1BP1;CDC42BPB
Alazami syndrome ORPHA:319671	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NSA2;BCLAF1;USP16;CETN3
Alpers-Huttenlocher syndrome ORPHA:726	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK11IP;TUBGCP6;ZNF598;LMF2
Aneurysm-osteoarthritis syndrome ORPHA:284984	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PPP1R13L;SYNPO;CCDC102A;TRAM2
Arnold-Chiari malformation type II ORPHA:1136	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SPSB3;USP20;DYRK1B;KATNB1
Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STARD3;PITPNM1;STK11IP;LMF2
Athabaskan brainstem dysgenesis syndrome ORPHA:69739	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNE1;TNFSF9;CENPA;ZWINT
Atypical Gaucher disease due to saposin C deficiency ORPHA:309252	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MAFB;CD14;ATP6V0D1;ITM2B
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IFI44;ISG15;NMI;OASL
Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PIGB;STK17B;NMI;OASL
Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SPAG9;PREPL;DOCK4;DIXDC1
Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TMEM129;TMED1;AGPAT2;LMF2
Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MDC1;DIDO1;SEC16A;UBAP2L
Autosomal dominant Kenny-Caffey syndrome ORPHA:93325	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;IFI44;NMI;TCIRG1
Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PREPL;NOS1AP;CDC42BPB;SYT7
Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;VWA5B2;PPFIA3;SYT7
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VNN1;DHRS9;CD14;ITM2B
Autosomal dominant omodysplasia ORPHA:93328	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VAT1;SERPINH1;PDLIM7;FSTL3
Autosomal dominant spastic paraplegia type 13 ORPHA:100994	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNA2;CCNB1;KIF20A;ZWINT
Autosomal dominant spastic paraplegia type 31 ORPHA:101011	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PREPL;NOS1AP;CKB;SYT7
Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;TMEM129;ZNF598
Autosomal recessive ataxia, Beauce type ORPHA:88644	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SNX29;HERC1;FRY;LYST
Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RPUSD1;ISG15;LMF2;MRPL54
Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DRAP1;CDC34;RPUSD1;TMEM129
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SNX29;PLEKHM1;CORO1A;C2CD2L
Autosomal recessive dopa-responsive dystonia ORPHA:101150	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TUBB3;CAMK2N2;PPFIA3;SYT7
Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;VWA5B2;PPFIA3;SYT7
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VNN1;DHRS9;CD14;ITM2B
Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SNX29;HERC1;FRY;LYST
Autosomal recessive spastic paraplegia type 26 ORPHA:101006	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TUBB3;GPRIN1;CAMK2N2;PPFIA3
Autosomal recessive spastic paraplegia type 39 ORPHA:139480	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STARD3;PITPNM1;STK11IP;LMF2
Autosomal recessive spastic paraplegia type 48 ORPHA:306511	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	EHD1;STK11IP;TCIRG1;LMF2
Autosomal recessive spastic paraplegia type 67 ORPHA:401820	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SPAG9;PREPL;DIXDC1;SPIN1
Ayme-Gripp syndrome ORPHA:1272	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MAFB;LPAR6;CD14;ITM2B
B4GALT1-CDG ORPHA:79332	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NMI;TCIRG1;SLC16A3;IER3
BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MTMR1;SNX18;ITPRIP;CBL
Baller-Gerold syndrome ORPHA:1225	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KIF20A;ZNF598;CENPA;ZWINT
Bartsocas-Papas syndrome ORPHA:1234	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;FGFBP1;CDH1;RHPN2
Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDKN1C;MAFB;AATK;CKB
Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;CDH1;ARHGAP29;ATP2C2
Bilateral multicystic dysplastic kidney ORPHA:97364	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GCNT3;TRIM15;CLDN2;SERPINA6
Bosley-Salih-Alorainy syndrome ORPHA:69737	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNE1;TNFSF9;CENPA;ZWINT
CEDNIK syndrome ORPHA:66631	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;BCL7B;ATG4A;SNRNP35
CHAND syndrome ORPHA:1401	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;FGFBP1;CDH1;RHPN2
CLCN4-related X-linked intellectual disability syndrome ORPHA:485350	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CTIF;TMCC2;CDC42BPB;CLU
COG1-CDG ORPHA:263508	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IQSEC1;SGSM2;TUBGCP6;C2CD2L
Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Carnitine-acylcarnitine translocase deficiency ORPHA:159	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CRADD;MTHFS;ATG4A;MRPL54
Carvajal syndrome ORPHA:65282	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;PTPRU;CDH1;SYT7
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDA;TCIRG1;IFI30;ATP6V0D1
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;NES;SYT7
Charcot-Marie-Tooth disease type 1C ORPHA:101083	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;ADAM8;IFI30;OASL
Charcot-Marie-Tooth disease type 4B1 ORPHA:99955	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SYNCRIP;CCNB1;SPIN1;NAE1
Charcot-Marie-Tooth disease type 4C ORPHA:99949	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MBNL2;AHNAK2;ARHGAP29;MICAL2
Charcot-Marie-Tooth disease type 4H ORPHA:99954	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DOCK4;MAFB;TBC1D8;FRY
Cholangiocarcinoma ORPHA:70567	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;CDH1;MARVELD3;SYT7
Chudley-McCullough syndrome ORPHA:314597	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PLK4;CCNA2;CCNB2;KIF20A
Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DRAP1;RPUSD1;ZNF628;ZNF598
Classic Bartter syndrome ORPHA:93605	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;CIB2;CKB;NES
Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VAT1;SERPINH1;TNKS1BP1;FSTL3
Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUAK1;P4HA2;AHNAK2;ARHGAP29
Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	EHD1;CCND3;ARID5A;TCIRG1
Combined immunodeficiency due to STIM1 deficiency ORPHA:317430	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	USP20;ARID5A;PLEKHM1;ABCA7
Combined oxidative phosphorylation defect type 23 ORPHA:444013	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;RCCD1;ZNF598
Congenital bile acid synthesis defect type 1 ORPHA:79301	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GDF15;TRIM47;NOL3;AGPAT2
Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ZNF628;ZNF653;MED26;ZNF598
Congenital factor XII deficiency ORPHA:330	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RPUSD1;REEP6;ZNF598;AGPAT2
Congenital hereditary endothelial dystrophy type II ORPHA:293603	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TRIP10;TNKS1BP1;TLCD1
Congenital isolated ACTH deficiency ORPHA:199296	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ADAM8;NMI;TCIRG1;TBX19
Corneal dystrophy-perceptive deafness syndrome ORPHA:1490	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TRIP10;TNKS1BP1;TLCD1
Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome ORPHA:459061	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ACAP3;SGSM2;TUBGCP6;WDR6
Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDA;DHRS9;KCTD12;KLF4
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDA;DHRS9;KCTD12;KLF4
DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TCERG1;PREPL;BCLAF1;NAE1
DOORS syndrome ORPHA:79500	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;GDF11;PREPL;BRSK2
Dent disease type 1 ORPHA:93622	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FARP2;SPAG9;ZNF697;SLC19A2
Dentatorubral pallidoluysian atrophy ORPHA:101	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUMBL;TNKS1BP1;CDC42BPB;RAB11FIP3
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;VWA5B2;PPFIA3;SYT7
Diencephalic-mesencephalic junction dysplasia ORPHA:319192	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	AOC3;SH2D3C;ESAM;FRY
Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TRIP10;TNKS1BP1;TLCD1;NOL3
Early-onset Lafora body disease ORPHA:324290	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARL4C;CDKN2D;PLEKHM1;LYST
Encephalopathy due to prosaposin deficiency ORPHA:139406	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MAFB;CD14;ATP6V0D1;ITM2B
Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;PTPRU;CDH1;SYT7
External auditory canal aplasia/hypoplasia ORPHA:141074	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SNX29;IQSEC1;LYST;C2CD2L
F12-related hereditary angioedema with normal C1Inh ORPHA:100054	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RPUSD1;REEP6;ZNF598;AGPAT2
Familial atypical multiple mole melanoma syndrome ORPHA:404560	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDKN2B;RPUSD1;TNFSF9;TLCD1
Familial gastric type 1 neuroendocrine tumor ORPHA:464756	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;VWA5B2;SYNGR3;PPFIA3
Familial hypocalciuric hypercalcemia type 3 ORPHA:101050	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DRAP1;TMED1;MRPL54;YIF1B
Familial lambdoid synostosis ORPHA:3267	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ZNF628;TAOK2;ZNF653;ZNF598
Familial normophosphatemic tumoral calcinosis ORPHA:306658	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;IFI44;NMI;OASL
Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VNN1;MICAL2;CD14;ITM2B
Floating-Harbor syndrome ORPHA:2044	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MDC1;DIDO1;SEC16A;UBAP2L
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;GDF11;PREPL;BRSK2
Frontorhiny ORPHA:391474	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TAOK2;WDR6;ZNF653;ZNF598
Fuhrmann syndrome ORPHA:2854	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARL4C;SNPH;SPOCK2;LMTK3
Galactose mutarotase deficiency ORPHA:570422	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD52;KCNE3;NMI;IFI30
Galactosialidosis ORPHA:351	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDA;TCIRG1;IFI30;ATP6V0D1
Generalized glucocorticoid resistance syndrome ORPHA:786	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;IFI44;NMI;LYST
Genetic hyperferritinemia without iron overload ORPHA:254704	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD14;TCIRG1;IFI30;ATP6V0D1
Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ITPRIP;TCIRG1;SH2B3;SIRPB1
Haim-Munk syndrome ORPHA:2342	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KCNE3;DHRS9;NMI;IFI30
Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RIOK3;TBPL1;RAB9A;ATG4A
Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNB2;GDF15;OIP5;ZWINT
Hereditary hyperferritinemia-cataract syndrome ORPHA:163	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD14;TCIRG1;IFI30;ATP6V0D1
Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;WDR45;SRSF8;ITM2B
Hereditary pediatric Behcet-like disease ORPHA:476102	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;ARID5A;NMI;TCIRG1
Hereditary sensory and autonomic neuropathy type 4 ORPHA:642	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	USP20;SH2D3C;GNG8;RASGRP2
Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TRIM47;TMED1;REEP6;AGPAT2
Hyperbiliverdinemia ORPHA:276405	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DRAP1;RAB9A;TMED1;MRPL54
Hyperprolinemia type 2 ORPHA:79101	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;REEP6;HS6ST1
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;SMYD5;RPUSD1;RRP9
Hypocalcemic vitamin D-resistant rickets ORPHA:93160	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NMI;TCIRG1;IFI30;OASL
Hypochondroplasia ORPHA:429	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;CDH3;PPP1R13L;KLK8
Idiopathic bronchiectasis ORPHA:60033	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FAM83F;CDH1;MARVELD3;ATP2C2
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NMI;TCIRG1;N4BP1;OASL
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;PIGB;STK17B;NMI
Infant acute respiratory distress syndrome ORPHA:70587	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GGTLC1;PRRT2;AATK;TPPP
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IFI44;NMI;IFI30;OASL
Intellectual disability-developmental delay-contractures syndrome ORPHA:3454	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MLLT11;CIB2;TSPAN5;MAPRE2
Intermediate DEND syndrome ORPHA:99989	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;VWA5B2;PPFIA3;SYT7
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDKN1C;MAFB;AATK;CKB
Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PAN2;USP20;TUBGCP6;COQ10A
Isolated biliary atresia ORPHA:30391	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NUAK1;AHNAK2;TNKS1BP1
Isolated cloverleaf skull syndrome ORPHA:2343	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ZNF628;TAOK2;ZNF653;ZNF598
Isolated congenital breast hypoplasia/aplasia ORPHA:180188	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;CDC42BPB;SYT7
Juvenile Huntington disease ORPHA:248111	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DDX17;HERC1;SEC16A;TAOK2
L-ferritin deficiency ORPHA:440731	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD14;TCIRG1;IFI30;ATP6V0D1
Laron syndrome with immunodeficiency ORPHA:220465	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD52;ATG16L2;SH2D3C;RASGRP2
Lateral meningocele syndrome ORPHA:2789	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;NES;SYT7
Laurence-Moon syndrome ORPHA:2377	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STARD3;PITPNM1;STK11IP;LMF2
Lethal brain and heart developmental defects ORPHA:580933	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RPUSD1;ZNF628;ZNF598;LMF2
Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK11IP;RPUSD1;ZNF598;LMF2
Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;RHPN2;VWA5B2;PPFIA3
Lipoyl transferase 1 deficiency ORPHA:401862	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PIGB;OMA1;ZNF830;METTL18
Low isolated anorectal malformation ORPHA:171215	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;CDH1;MARVELD3;SYT7
Mullerian aplasia and hyperandrogenism ORPHA:247768	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FAM83F;CDH3;CDH1;ATP2C2
MAN1B1-CDG ORPHA:397941	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK11IP;TAOK2;WDR6;LMF2
MIRAGE syndrome ORPHA:494433	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;IFI44;NMI;OASL
Mazabraud syndrome ORPHA:57782	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
McCune-Albright syndrome ORPHA:562	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Medullary sponge kidney ORPHA:1309	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GCNT3;TRIM15;CLDN2;SERPINA6
Melanoma and neural system tumor syndrome ORPHA:252206	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDKN2B;RPUSD1;TNFSF9;TLCD1
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VNN1;DHRS9;CD14;ITM2B
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IFI44;ISG15;NMI;OASL
Methylmalonic acidemia with homocystinuria, type cblX ORPHA:369962	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MDC1;SEC16A;UBAP2L;ZNF598
Microduplication Xp11.22p11.23 syndrome ORPHA:217377	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CTIF;CDC42BPB;GAS2L1;BAIAP2
Microphthalmia with limb anomalies ORPHA:1106	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SLC25A27;NUAK1;CLU;SYT7
Mitochondrial DNA depletion syndrome, myopathic form ORPHA:254875	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MICAL2;CD14;NDRG1;ITM2B
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TOE1;SMYD5;UBAP2L;RRP9
Monostotic fibrous dysplasia ORPHA:93277	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Mucopolysaccharidosis type 7 ORPHA:584	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	LPCAT3;TCIRG1;IFI30;AGPAT2
Muenke syndrome ORPHA:53271	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Multiple epiphyseal dysplasia type 5 ORPHA:93311	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUAK1;TUBB3;P4HA2;SERPINH1
Multiple myeloma ORPHA:29073	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	P4HA2;SERPINH1;TNKS1BP1;CDC42BPB
NEK9-related lethal skeletal dysplasia ORPHA:464366	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DDX17;PAN2;IPO8;TUBGCP6
NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SLC25A27;NUAK1;ARHGAP29;SYNPO
NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DRAP1;RPUSD1;ZNF628;ZNF598
NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VNN1;MICAL2;CD14;ITM2B
Neuralgic amyotrophy ORPHA:2901	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PITPNM1;ZNF628;ZNF598;LMF2
Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	RPUSD1;TMEM129;TMED1;LMF2
Neuroferritinopathy ORPHA:157846	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD14;TCIRG1;IFI30;ATP6V0D1
Neuropathy with hearing impairment ORPHA:139512	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FGFBP1;CDH3;ATP2C2;KLK8
Neutral lipid storage disease with ichthyosis ORPHA:98907	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CDA;RIOK3;ATG4A;NMI
Neutrophil immunodeficiency syndrome ORPHA:183707	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD52;ADAM8;NMI;CORO1A
Nevus comedonicus syndrome ORPHA:64754	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DDX17;PAN2;IPO8;TUBGCP6
Obesity due to pro-opiomelanocortin deficiency ORPHA:71526	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CD52;SH2D3C;ARID5A;RASGRP2
Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;ZNF598;RRP9
Orofaciodigital syndrome type 5 ORPHA:2919	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PIGB;STK17B;OMA1;NMI
Osteocraniostenosis ORPHA:2763	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK17B;IFI44;NMI;TCIRG1
POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NUMBL;TUBB3;TNKS1BP1
Pancreatic agenesis-holoprosencephaly syndrome ORPHA:556955	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DIDO1;IPO8;NUP50;UBAP2L
Papillon-Lefevre ORPHA:678	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KCNE3;DHRS9;NMI;IFI30
Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNA2;CCNB1;KIF20A;ZWINT
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;CDH1;MARVELD3;SYT7
Peutz-Jeghers syndrome ORPHA:2869	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ACAP3;CDC34;ZNF653;ZNF598
Phocomelia, Schinzel type ORPHA:2879	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARL4C;SNPH;SPOCK2;LMTK3
Pierson syndrome ORPHA:2670	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;CDC42BPB;NES
Pityriasis rubra pilaris ORPHA:2897	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ATG16L2;RDH13;CLK3;C2CD2L
Polyendocrine-polyneuropathy syndrome ORPHA:453533	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SPAG9;DOCK4;HERC1;TMEM170B
Polyglucosan body myopathy type 1 ORPHA:397937	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SPSB3;STARD3;TCIRG1;LMF2
Polyostotic fibrous dysplasia ORPHA:93276	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Primary dystonia, DYT4 type ORPHA:98805	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;BRSK2;RIMS3;SYNGR3
Primary intraosseous venous malformation ORPHA:140436	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PGS1;NXF1;USP20;IQSEC1
Primary peritoneal carcinoma ORPHA:168829	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PLK4;CCNA2;CDC25C;NDC80
Progressive myoclonic epilepsy type 8 ORPHA:424027	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	BRSK2;TUBB3;CAMK2N2;CKB
Progressive myoclonic epilepsy type 9 ORPHA:457265	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CCNB1;KIF20A;CENPA;ZWINT
Progressive myoclonic epilepsy with dystonia ORPHA:352596	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;GDF11;PREPL;BRSK2
Progressive osseous heteroplasia ORPHA:2762	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Proteasome-associated autoinflammatory syndrome ORPHA:324977	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TREX1;IFI44;NMI;TCIRG1
Pseudohypoaldosteronism type 2B ORPHA:88939	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	P4HA2;GDF15;SERPINH1;TRAM2
Pseudohypoaldosteronism type 2D ORPHA:300525	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ATP8A1;HERC1;SPOCK2;FRY
Pseudohypoparathyroidism type 1A ORPHA:79443	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Pseudohypoparathyroidism type 1C ORPHA:79444	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
Pseudopseudohypoparathyroidism ORPHA:79445	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PNMA1;CAMK2N2;EVI5L;RAB11FIP3
RAPADILINO syndrome ORPHA:3021	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KIF20A;ZNF598;CENPA;ZWINT
RFVT2-related riboflavin transporter deficiency ORPHA:572543	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;ZNF598;RRP9
Ramon syndrome ORPHA:3019	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PGS1;NXF1;USP20;IQSEC1
Recessive mitochondrial ataxia syndrome ORPHA:94125	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK11IP;TUBGCP6;ZNF598;LMF2
Renal dysplasia, bilateral ORPHA:93173	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GCNT3;TRIM15;CLDN2;SERPINA6
Renal dysplasia, unilateral ORPHA:93172	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GCNT3;TRIM15;CLDN2;SERPINA6
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;SLC25A27;NOS1AP;SYT7
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DAZAP2;LPAR6;CD14;ITM2B
Right sided atrial isomerism ORPHA:97548	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;BRSK2;CAMK2N2;CKB
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	APC2;GDF11;PREPL;BRSK2
Rothmund-Thomson syndrome type 2 ORPHA:221016	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KIF20A;ZNF598;CENPA;ZWINT
SERKAL syndrome ORPHA:139466	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FAM83F;CDH3;CDH1;ATP2C2
SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	MDC1;DIDO1;CTCF;CBL
Sanfilippo syndrome type B ORPHA:79270	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TMEM129;TMED1;AGPAT2;LMF2
Schnyder corneal dystrophy ORPHA:98967	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TOE1;EMG1;ZNF689;RRP9
Sebocystomatosis ORPHA:841	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FGFBP1;CDH3;PPP1R13L;KLK8
Seizures-scoliosis-macrocephaly syndrome ORPHA:466926	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	VAT1;SERPINH1;TNKS1BP1;TRAM2
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GDF15;TRIP10;TNKS1BP1;CDC42BPB
Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	CTIF;CDC42BPB;GAS2L1;BAIAP2
Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ZNF628;TAOK2;ZNF653;ZNF598
Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;PTPRU;CDH1;SYT7
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SLC23A2;ST3GAL5;C2CD2L;HERPUD1
Spinocerebellar ataxia type 13 ORPHA:98768	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	KIFC2;IQSEC1;LMTK3;AATK
Spinocerebellar ataxia with epilepsy ORPHA:254881	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STK11IP;TUBGCP6;ZNF598;LMF2
Spondyloepimetaphyseal dysplasia, matrilin-3 type ORPHA:156728	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	NUAK1;TUBB3;P4HA2;SERPINH1
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IFI44;ISG15;NMI;OASL
Systemic primary carnitine deficiency ORPHA:158	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SLC46A1;ENTPD2;CDH1;ATP2C2
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;TMED1;RRP9
Tangier disease ORPHA:31150	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	DOCK4;MAFB;CD14;FRY
Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SEMA6C;DYRK1B;TCAP;COQ10A
Thanatophoric dysplasia type 1 ORPHA:1860	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Thanatophoric dysplasia type 2 ORPHA:93274	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;CKB;SYT7
Transketolase deficiency ORPHA:488618	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	ARMC6;RPUSD1;ZNF598;RRP9
Tricho-dento-osseous syndrome ORPHA:3352	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;CDH3;PPP1R13L;KLK8
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	STARD3;PITPNM1;STK11IP;LMF2
USP18 deficiency ORPHA:481665	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IFI44;ISG15;NMI;OASL
Unilateral multicystic dysplastic kidney ORPHA:97363	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	GCNT3;TRIM15;CLDN2;SERPINA6
WHIM syndrome ORPHA:51636	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	FGD3;CD52;SH2D3C;CORO1A
Wilson disease ORPHA:905	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NOS1AP;RHPN2;SYT7
Wolfram-like syndrome ORPHA:411590	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;NUAK1;TNKS1BP1;CDC42BPB
X-linked creatine transporter deficiency ORPHA:52503	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	PTPRU;TNKS1BP1;CKB;CDC42BPB
X-linked intellectual disability, Cabezas type ORPHA:85293	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	IPO8;SEC23A;CHM;ZBTB33
X-linked intellectual disability-short stature-overweight syndrome ORPHA:457240	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	TCERG1;BCLAF1;SCAF11;PHF14
X-linked recessive ocular albinism ORPHA:54	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	C11ORF52;CDH3;CDH1;SYT7
XYLT1-CDG ORPHA:370930	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	SNX29;RASA4;SH2D3C;RASGRP2
Xanthinuria type II ORPHA:93602	4/101	0.14238249449079193	0.5867963421058087	0	0	2.0414464388508033	3.9792654216858714	P4HA2;GDF15;RHPN2;TLCD1
3M syndrome ORPHA:2616	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PTPRU;SERPINH1;TNKS1BP1;NES
Acute myeloid leukemia with t(6;9)(p23;q34) ORPHA:402014	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	TCERG1;ARHGAP11B;NUP50;CTCF
Angiocentric glioma ORPHA:251671	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	BCLAF1;CCP110;TMEM170B;CBL
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	STARD3;STK11IP;TCIRG1;LMF2
Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	SEMA6C;BRSK2;NES;PPFIA3
Autosomal recessive Robinow syndrome ORPHA:1507	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PTPRU;NUAK1;SERPINH1;NES
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	P4HA2;AHNAK2;SERPINH1;TNKS1BP1
Autosomal recessive progressive external ophthalmoplegia ORPHA:254886	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	TAOK2;PLEKHM1;TUBGCP6;LMF2
Carpenter syndrome ORPHA:65759	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PTPRU;TNKS1BP1;CDC42BPB;NES
Congenital bilateral absence of vas deferens ORPHA:48	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	FAM83F;CDH1;MARVELD3;GCNT3
Cystic leukoencephalopathy without megalencephaly ORPHA:85136	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CD52;MTHFS;IFI30;CORO1A
Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	VAT1;SERPINH1;TRAM2;FSTL3
Hyperostosis corticalis generalisata ORPHA:3416	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PTPRU;SERPINH1;TNKS1BP1;NES
Infantile Krabbe disease ORPHA:206436	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	KIAA0513;CD14;ATP6V0D1;ITM2B
Isolated focal cortical dysplasia type IIa ORPHA:269001	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	ACAP3;SEC16A;SGSM2;TAOK2
Microvillus inclusion disease ORPHA:2290	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDH1;MARVELD3;RHPN2;ATP2C2
NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PLK4;CCNA2;OIP5;NDC80
NON RARE IN EUROPE: Vitiligo ORPHA:3435	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	SNPH;SH2D3C;TMCC2;RASGRP2
Neuroendocrine tumor of stomach ORPHA:100075	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	TCERG1;BCLAF1;PSIP1;CTCF
Niemann-Pick disease type C, adult neurologic onset ORPHA:216986	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDKN1A;PLIN3;SLC16A3;IER3
Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDKN1A;PLIN3;SLC16A3;IER3
Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDKN1A;PLIN3;SLC16A3;IER3
Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDKN1A;PLIN3;SLC16A3;IER3
Niemann-Pick disease type C, severe perinatal form ORPHA:216972	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	CDKN1A;PLIN3;SLC16A3;IER3
Nodular fasciitis ORPHA:477742	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	FCHSD1;ATG16L2;PLEKHM1;SH2B3
Paroxysmal non-kinesigenic dyskinesia ORPHA:98810	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	PRRT2;CKB;RGS11;GAS2L1
Progressive familial intrahepatic cholestasis type 1 ORPHA:79306	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	C11ORF52;CDH1;MARVELD3;ATP2C2
Proximal symphalangism ORPHA:3250	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	TSPAN5;PLIN3;TRAM2;PDLIM7
Schneckenbecken dysplasia ORPHA:3144	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	SEC16A;MAPKAPK2;TAOK2;TRAM2
Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	STK11IP;TUBGCP6;ZNF598;LMF2
Spondylocarpotarsal synostosis ORPHA:3275	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	DIDO1;SEC16A;TNKS1BP1;TRAM2
Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	NUAK1;SPIN1;TNKS1BP1;CDC42BPB
Truncus arteriosus ORPHA:3384	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	VAT1;SERPINH1;VASN;PDLIM7
Yunis-Varon syndrome ORPHA:3472	4/102	0.14602759796203985	0.5867963421058087	0	0	2.0205117580026934	3.887383090706561	STARD3;KAT5;STK11IP;ATP6V0D1
46,XX ovotesticular disorder of sex development ORPHA:2138	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PTPRU;TUBB3;NES;SYT7
Acrocallosal syndrome ORPHA:36	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PTPRU;SERPINH1;TNKS1BP1;NES
Acute myeloblastic leukemia with maturation ORPHA:98834	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	TCERG1;SYNCRIP;BCLAF1;PSIP1
Atypical juvenile parkinsonism ORPHA:391411	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	SPAG9;PREPL;NOS1AP;BTRC
Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PLK4;TCERG1;ARHGAP11B;TUBGCP6
Congenital fibrosis of extraocular muscles ORPHA:45358	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	BRSK2;TUBB3;CAMK2N2;NES
Familial Chilblain lupus ORPHA:481662	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	TREX1;IFI44;NMI;TCIRG1
Familial cerebral cavernous malformation ORPHA:221061	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PIGB;SCAF11;STK17B;NMI
Familial platelet disorder with associated myeloid malignancy ORPHA:71290	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	SCAF11;STK17B;NMI;LYST
Gorlin syndrome ORPHA:377	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	DDX17;APC2;SEMA6C;CLSTN3
Hereditary diffuse gastric cancer ORPHA:26106	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	C11ORF52;CDH1;TNKS1BP1;CDC42BPB
Idiopathic central precocious puberty ORPHA:169615	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	APC2;BRSK2;TMEM169;SYNGR3
Isolated scaphocephaly ORPHA:35093	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	NUMBL;SERPINH1;TNKS1BP1;VASN
Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	ARID5A;ADAM8;TCIRG1;IFI30
Muir-Torre syndrome ORPHA:587	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PLK4;CCNA2;CCNB1;NDC80
Myxofibrosarcoma ORPHA:79105	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	SERPINH1;TNKS1BP1;UBAP2L;TRAM2
NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	TMEM45B;FAM83F;MARVELD3;GCNT3
Ollier disease ORPHA:296	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	C11ORF52;REEP6;NES;SYT7
Osteosarcoma ORPHA:668	4/103	0.14970879542143564	0.5867963421058087	0	0	2.0	3.7981264712645557	PLK4;CCNA2;CCNB2;NDC80
Aplasia cutis congenita ORPHA:1114	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	PTPRU;AHNAK2;TNKS1BP1;CDC42BPB
Familial hemophagocytic lymphohistiocytosis ORPHA:540	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	FGD3;CD52;ADAM8;CORO1A
Familial thyroid dyshormonogenesis ORPHA:95716	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	TMEM45B;FAM83F;MARVELD3;GCNT3
Hypocalcified amelogenesis imperfecta ORPHA:100032	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	FGFBP1;CDH3;CDH1;ATP2C2
Juvenile amyotrophic lateral sclerosis ORPHA:300605	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	MDC1;DIDO1;IPO8;UBAP2L
Permanent neonatal diabetes mellitus ORPHA:99885	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	BRSK2;RGS11;VWA5B2;SYT7
Silver-Russell syndrome due to a point mutation ORPHA:397590	4/104	0.15342534705912156	0.5959529547720634	0	0	1.9798984771573604	3.711401205144879	CDKN1C;NUAK1;SERPINH1;NES
Chronic mucocutaneous candidiasis ORPHA:1334	4/105	0.15717650652503862	0.606625035400596	0	0	1.9601950042720009	3.6271171182418223	PLEKHM1;CD14;TCIRG1;IFI30
Fetal and neonatal alloimmune thrombocytopenia ORPHA:853	4/105	0.15717650652503862	0.606625035400596	0	0	1.9601950042720009	3.6271171182418223	CDA;GAS2L1;SH2B3;PDLIM7
Isolated split hand-split foot malformation ORPHA:2440	4/105	0.15717650652503862	0.606625035400596	0	0	1.9601950042720009	3.6271171182418223	NXPH4;LMTK3;BTRC;PPFIA3
Joubert syndrome with ocular defect ORPHA:220493	4/105	0.15717650652503862	0.606625035400596	0	0	1.9601950042720009	3.6271171182418223	TCERG1;BCLAF1;CCP110;CEP41
Myoclonus-dystonia syndrome ORPHA:36899	4/105	0.15717650652503862	0.606625035400596	0	0	1.9601950042720009	3.6271171182418223	ACOT7;TUBB3;GPRIN1;CAMK2N2
Familial exudative vitreoretinopathy ORPHA:891	4/106	0.16096152154733762	0.6196505963261838	0	0	1.9408778739922365	3.5451879977769343	PTPRU;SERPINH1;TNKS1BP1;NES
Juvenile myelomonocytic leukemia ORPHA:86834	4/106	0.16096152154733762	0.6196505963261838	0	0	1.9408778739922365	3.5451879977769343	SYNCRIP;IPO8;SPIN1;CBL
Juvenile nephronophthisis ORPHA:93592	4/107	0.16477963434276044	0.6335420546867965	0	0	1.9219358336208172	3.465531385676449	KLHL29;PTPRU;TNKS1BP1;CDC42BPB
Coffin-Siris syndrome ORPHA:1465	4/108	0.1686300823274817	0.6467006456772204	0	0	1.9033580632565403	3.388068380860525	MDC1;TCERG1;UBAP2L;CTCF
Colobomatous microphthalmia ORPHA:98938	4/108	0.1686300823274817	0.6467006456772204	0	0	1.9033580632565403	3.388068380860525	PTPRU;NUAK1;TUBB3;NES
22q11.2 deletion syndrome ORPHA:567	4/109	0.17251209851989976	0.6599133692748571	0	0	1.8851341551849166	3.31272345703853	ZNF628;SEC16A;TAOK2;ZNF598
Familial pancreatic carcinoma ORPHA:1333	4/109	0.17251209851989976	0.6599133692748571	0	0	1.8851341551849166	3.31272345703853	PLK4;CCNA2;SYNCRIP;NDC80
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form ORPHA:293899	4/111	0.18036774902317398	0.6873535151929783	0	0	1.849708240428863	3.168101591598294	PTPRU;NUAK1;CDC42BPB;SYT7
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form ORPHA:293888	4/111	0.18036774902317398	0.6873535151929783	0	0	1.849708240428863	3.168101591598294	PTPRU;NUAK1;CDC42BPB;SYT7
Familial melanoma ORPHA:618	4/111	0.18036774902317398	0.6873535151929783	0	0	1.849708240428863	3.168101591598294	CDKN2B;ARMC6;RPUSD1;RRP9
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form ORPHA:293910	4/112	0.18433983220340006	0.7007232363756918	0	0	1.83248730964467	3.0986889652435656	PTPRU;NUAK1;CDC42BPB;SYT7
Tetralogy of Fallot ORPHA:3303	4/112	0.18433983220340006	0.7007232363756918	0	0	1.83248730964467	3.0986889652435656	PTPRU;NUAK1;SERPINH1;NES
Acute promyelocytic leukemia ORPHA:520	4/113	0.18834038235896305	0.7150309491065155	0	0	1.8155823592418385	3.03112275320218	HERC1;SCAF11;STK17B;LYST
Early infantile epileptic encephalopathy ORPHA:1934	4/116	0.20050501567558157	0.7593059616185558	0	0	1.766678752719362	2.8389043841261508	APC2;BRSK2;PRRT2;TPPP
Fanconi anemia ORPHA:84	4/116	0.20050501567558157	0.7593059616185558	0	0	1.766678752719362	2.8389043841261508	PLK4;CCNA2;CCNB2;NDC80
Early-onset nuclear cataract ORPHA:98991	4/118	0.20874275393088557	0.7895126437786436	0	0	1.735506278386321	2.718935471184226	PTPRU;NUAK1;SERPINH1;NES
Differentiated thyroid carcinoma ORPHA:146	4/129	0.25558242034155804	0.7929682744768703	0	0	1.5818883248730964	2.1580284045349947	TCERG1;SYNCRIP;BCLAF1;SPIN1
Autosomal dominant non-syndromic intellectual disability ORPHA:178469	4/133	0.27312671683572887	0.7929682744768703	0	0	1.5325227245897768	1.9889377646818138	PREPL;BRSK2;DEAF1;CDH15
Autosomal recessive distal renal tubular acidosis ORPHA:402041	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	C11ORF52;CDH3;ATP2C2
Bruck syndrome ORPHA:2771	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	NUAK1;P4HA2;SERPINH1
Combined immunodeficiency with granulomatosis ORPHA:157949	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	PLK4;CCNA2;KIF20A
DEND syndrome ORPHA:79134	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	BRSK2;VWA5B2;SYT7
Intermediate generalized junctional epidermolysis bullosa ORPHA:79402	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	FGFBP1;AHNAK2;ATP2C2
Joubert syndrome with Jeune asphyxiating thoracic dystrophy ORPHA:397715	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	BCLAF1;SCAF11;CCP110
Pachyonychia congenita ORPHA:2309	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	FGFBP1;CDH3;KLK8
Rotor syndrome ORPHA:3111	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	AKR1C4;CLDN2;SERPINA6
Self-improving collodion baby ORPHA:281122	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	FGFBP1;PPP1R13L;KLK8
Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	PLK4;CCNA2;KIF20A
Singleton-Merten dysplasia ORPHA:85191	3/100	0.3205584705097863	0.7929682744768703	0	0	1.5272086650137022	1.7374909179476994	IFI44;NMI;OASL
12q15q21.1 microdeletion syndrome ORPHA:289513	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;USP16;SCAF11
16p13.2 microdeletion syndrome ORPHA:500055	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TCERG1;BCLAF1;CTCF
1p21.3 microdeletion syndrome ORPHA:293948	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	IFI44;LYST;SIRPB1
20p12.3 microdeletion syndrome ORPHA:261295	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;SERPINH1;SPRY2
3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form ORPHA:79351	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;CBS;KIF20A
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUMBL;SERPINH1;NES
6q terminal deletion syndrome ORPHA:75857	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PAN2;USP16;OMA1
8q24.3 microdeletion syndrome ORPHA:508488	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Aland Islands eye disease ORPHA:178333	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;CD52;RASGRP2
ABeta amyloidosis, Arctic type ORPHA:324723	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
ABeta amyloidosis, Dutch type ORPHA:100006	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
ABeta amyloidosis, Iowa type ORPHA:324708	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
ABeta amyloidosis, Italian type ORPHA:324713	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
ABetaA21G amyloidosis ORPHA:324718	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
ABetaL34V amyloidosis ORPHA:324703	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
AKT2-related familial partial lipodystrophy ORPHA:79085	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;ZNF628;ZNF598
ALDH18A1-related De Barsy syndrome ORPHA:35664	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;ZWINT
ALG8-CDG ORPHA:79325	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;OIP5;ZWINT
APC-related attenuated familial adenomatous polyposis ORPHA:247806	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Acatalasemia ORPHA:926	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DAZAP2;NMI;IFI30
Acetazolamide-responsive myotonia ORPHA:99736	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;SEMA6C;TCAP
Acral self-healing collodion baby ORPHA:281127	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;PPP1R13L;KLK8
Acrocapitofemoral dysplasia ORPHA:63446	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDX2;TRIM15;CLDN2
Acrokeratosis verruciformis of Hopf ORPHA:79151	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Acromesomelic dysplasia, Hunter-Thompson type ORPHA:968	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;TRAM2;VASN
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;ZNF598;LMF2
Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CEBPB;MAFB;CD14
Adrenocortical carcinoma ORPHA:1501	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB2;KIF20A;ZWINT
Adult Krabbe disease ORPHA:206448	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KCNE3;LPAR6;ITM2B
Adult polyglucosan body disease ORPHA:206583	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Adult-onset cervical dystonia, DYT23 type ORPHA:420492	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF628;UBAP2L;ZNF598
Alpha-1-antitrypsin deficiency ORPHA:60	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	VNN1;CD14;IFI30
Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Amish lethal microcephaly ORPHA:99742	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TOE1;EIF4A3;RHEBL1
Amish nemaline myopathy ORPHA:98902	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	OIP5;CENPA;PDLIM7
Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;TRAM2;VASN
Anterior segment developmental anomaly ORPHA:88632	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACOT7;NXPH4;CAMK2N2
Apert syndrome ORPHA:87	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
Arnold-Chiari malformation type I ORPHA:268882	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TUBB3;P4HA2;SERPINH1
Aromatic L-amino acid decarboxylase deficiency ORPHA:35708	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TRIM15;CLDN2;SERPINA6
Aspartylglucosaminuria ORPHA:93	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RAB9A;ATG4A;METTL18
Atelosteogenesis type I ORPHA:1190	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AHNAK2;TNKS1BP1;CDC42BPB
Atelosteogenesis type III ORPHA:56305	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AHNAK2;TNKS1BP1;CDC42BPB
Atrial septal defect, ostium primum type ORPHA:99106	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;DIXDC1;ARHGAP29
Atrophoderma vermiculata ORPHA:79100	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CTIF;SH3PXD2A;CDC42BPB
Auditory neuropathy-optic atrophy syndrome ORPHA:542585	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency ORPHA:308410	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;TMED1;YIF1B
Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SH2D3C;CORO1A;SH2B3
Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SH2D3C;CORO1A;SH2B3
Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;CAMK2N2
Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PITPNM1;TUBGCP6;ABCA7
Autosomal dominant brachyolmia ORPHA:93304	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PITPNM1;TUBGCP6;ABCA7
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SH2D3C;CORO1A;SH2B3
Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DOCK4;SNX18;KCTD12
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SH2D3C;CORO1A;SH2B3
Autosomal dominant keratitis ORPHA:2334	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;VWA5B2
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;CD14;IFI30
Autosomal dominant multiple pterygium syndrome ORPHA:65743	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NXF1;ATG16L2;TUBGCP6
Autosomal dominant osteopetrosis type 1 ORPHA:2783	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;TNKS1BP1
Autosomal dominant spastic paraplegia type 9A ORPHA:447753	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;ZWINT
Autosomal dominant spastic paraplegia type 9B ORPHA:447757	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;ZWINT
Autosomal dominant striatal neurodegeneration ORPHA:228169	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SLC25A27;PREPL;DIXDC1
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;CAMK2N2
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency ORPHA:404493	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RAB9A;MTHFS;NMI
Autosomal recessive extra-oral halitosis ORPHA:562538	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PDZK1IP1;CLU
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;CAMK2N2
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;PDZK1IP1;ABCG1
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;CD14;IFI30
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STK17B;NMI;LYST
Autosomal recessive spastic paraplegia type 15 ORPHA:100996	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SNX29;HERC1;PLEKHM1
Autosomal recessive spastic paraplegia type 35 ORPHA:171629	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ENTPD2;CDH1;ATP2C2
Autosomal recessive spastic paraplegia type 54 ORPHA:320380	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;HERC1;CCP110
Autosomal recessive spastic paraplegia type 61 ORPHA:401780	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTGES3;SPIN1;NAE1
Autosomal recessive spastic paraplegia type 71 ORPHA:401840	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TCERG1;BCLAF1;CHM
Autosomal recessive spastic paraplegia type 9B ORPHA:447760	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;ZWINT
Autosomal spastic paraplegia type 58 ORPHA:397946	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome ORPHA:567502	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DDX17;BCLAF1;PSIP1
B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:75496	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;LMF2;RRP9
BENTA disease ORPHA:464336	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;ADAM8;CORO1A
Bathing suit ichthyosis ORPHA:100976	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;PPP1R13L;KLK8
Becker nevus syndrome ORPHA:64755	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	EHD1;CCND3;PDLIM7
Biotinidase deficiency ORPHA:79241	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CRADD;LPCAT3;TMED1
Birdshot chorioretinopathy ORPHA:179	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARID5A;TCIRG1;OASL
Bjornstad syndrome ORPHA:123	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;SMYD5;RRP9
Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TUBB3;CBS;SERPINH1
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TUBB3;CBS;SERPINH1
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TUBB3;CBS;SERPINH1
Bloom syndrome ORPHA:125	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLK4;CCNA2;NDC80
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;ARHGAP29;VASN
Boomerang dysplasia ORPHA:1263	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AHNAK2;TNKS1BP1;CDC42BPB
Brachydactyly type B1 ORPHA:572385	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;NES
Brachydactyly-short stature-retinitis pigmentosa syndrome ORPHA:166035	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NSA2;CETN3;NAE1
CIDEC-related familial partial lipodystrophy ORPHA:435651	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;TRIM15;CLDN2
CLN2 disease ORPHA:228349	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DAZAP2;NXF1;TCIRG1
COG6-CGD ORPHA:464443	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;SEC23A;CHM
COG7-CDG ORPHA:79333	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PAN2;STK11IP;SEC16A
Campomelic dysplasia ORPHA:140	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;SYT7
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SYNCRIP;BCLAF1;PSIP1
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	APC2;BRSK2;RIMS3
Cerebrotendinous xanthomatosis ORPHA:909	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MAFB;CD14;ITM2B
Charcot-Marie-Tooth disease type 1B ORPHA:101082	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SH2D3C;CORO1A;SH2B3
Charcot-Marie-Tooth disease type 2H ORPHA:101102	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;CAMK2N2
Charcot-Marie-Tooth disease type 2S ORPHA:443073	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STK11IP;ZNF628;TUBGCP6
Charcot-Marie-Tooth disease type 4A ORPHA:99948	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;CAMK2N2
Cherubism ORPHA:184	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ATG16L2;ADAM8;SIRPB1
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DAZAP2;NXF1;TCIRG1
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder ORPHA:500180	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DIDO1;TAOK2;ZNF598
Chondrosarcoma ORPHA:55880	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;SERPINH1;ARHGAP29
Choroid plexus carcinoma ORPHA:251899	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB2;KIF20A;ZWINT
Christianson syndrome ORPHA:85278	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;CHM;ZBTB33
Chronic infantile diarrhea due to guanylate cyclase 2C overactivity ORPHA:314373	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;VNN1;KCNE3
Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;SERPINH1;ARHGAP29
Coffin-Lowry syndrome ORPHA:192	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SCAF11;STK17B;LYST
Combined immunodeficiency due to OX40 deficiency ORPHA:431149	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;ARID5A;CORO1A
Combined oxidative phosphorylation defect type 15 ORPHA:319524	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PIGB;NME6;SNUPN
Combined oxidative phosphorylation defect type 24 ORPHA:444458	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MRPL19;OIP5;NAE1
Complex lethal osteochondrodysplasia ORPHA:457378	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ATP8A1;TMEM170B;LYST
Congenital bile acid synthesis defect type 4 ORPHA:79095	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;MRPL19;REEP6
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;ZNF598;RRP9
Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEMA6C;CTIF;NES
Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ATG4A;NMI;OASL
Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;SERPINH1;TRAM2
Congenital primary aphakia ORPHA:83461	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACOT7;NXPH4;CAMK2N2
Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome ORPHA:508542	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DDX17;BCLAF1;SCAF11
Cranio-osteoarthropathy ORPHA:1525	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;CDH1;PDZK1IP1
Craniofrontonasal dysplasia ORPHA:1520	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SERPINH1;TRIP10;TNKS1BP1
Craniolenticulosutural dysplasia ORPHA:50814	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;ARHGAP29;CHM
Craniosynostosis, Boston type ORPHA:1541	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;SERPINH1
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
DDX41-related hematologic malignancy predisposition syndrome ORPHA:488647	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLK4;CCNA2;NDC80
DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TBPL1;RBM7;RBX1
Darier disease ORPHA:218	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Dent disease type 2 ORPHA:93623	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Developmental malformations-deafness-dystonia syndrome ORPHA:79107	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	EHD1;CCND3;PDLIM7
Dihydropyrimidine dehydrogenase deficiency ORPHA:1675	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	IFI44;LYST;SIRPB1
Disseminated superficial actinic porokeratosis ORPHA:79152	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;SERPINH1;NES
Dubin-Johnson syndrome ORPHA:234	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AKR1C4;CLDN2;SERPINA6
Ectodermal dysplasia-syndactyly syndrome ORPHA:247820	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;ATP2C2
Embryonal rhabdomyosarcoma ORPHA:99757	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DGAT1;TCIRG1;AGPAT2
Endosteal hyperostosis, Worth type ORPHA:2790	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;TNKS1BP1
Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FAM83F;CDH1;MARVELD3
Epithelial basement membrane dystrophy ORPHA:98956	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Epithelial recurrent erosion dystrophy ORPHA:293381	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;ATP2C2;KLK8
Essential fructosuria ORPHA:2056	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACOT7;ARMC6;REEP6
Ethylmalonic encephalopathy ORPHA:51188	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLIN3;AGPAT2;MRPL54
Exercise-induced hyperinsulinism ORPHA:165991	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNA2;CCNB1;MRPL19
FGFR2-related bent bone dysplasia ORPHA:313855	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
FTH1-related iron overload ORPHA:247790	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;CEBPB;IER3
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;AHNAK2;ARHGAP29
Familial Alzheimer-like prion disease ORPHA:280397	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Familial LCAT deficiency ORPHA:79293	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;TUBGCP6;LMF2
Familial adenomatous polyposis due to 5q22.2 microdeletion ORPHA:261584	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Familial clubfoot due to 5q31 microdeletion ORPHA:293144	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;TLCD1
Familial clubfoot due to PITX1 point mutation ORPHA:293150	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;TLCD1
Familial congenital nasolacrimal duct obstruction ORPHA:451612	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;SYT7
Familial digital arthropathy-brachydactyly ORPHA:85169	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Familial hypocalciuric hypercalcemia type 2 ORPHA:101049	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Familial scaphocephaly syndrome, McGillivray type ORPHA:168624	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;RHPN2
Familial steroid-resistant nephrotic syndrome with sensorineural deafness ORPHA:280406	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RWDD2B;SNRNP35;COQ10A
Farber disease ORPHA:333	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KCNE3;CD14;ITM2B
Fatal familial insomnia ORPHA:466	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ENTPD2;CDH1;ATP2C2
Ferro-cerebro-cutaneous syndrome ORPHA:397922	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;USP16;ZBTB33
Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PITPNM1;TUBGCP6;ABCA7
Fish-eye disease ORPHA:79292	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;TUBGCP6;LMF2
Foveal hypoplasia-presenile cataract syndrome ORPHA:2253	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;VWA5B2
Fowler vasculopaty ORPHA:221126	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD14;TCIRG1;IFI30
Fucosidosis ORPHA:349	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	LPCAT3;IFI30;AGPAT2
GM3 synthase deficiency ORPHA:370933	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SNX29;ST3GAL5;LYST
GMPPB-related  limb-girdle muscular dystrophy R19 ORPHA:363623	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;LMF2
GRACILE syndrome ORPHA:53693	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;SMYD5;RRP9
Gamma-aminobutyric acid transaminase deficiency ORPHA:2066	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KIAA0513;CHN2;RALGPS1
Gardner syndrome ORPHA:79665	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Gastric adenocarcinoma and proximal polyposis of the stomach ORPHA:314022	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Gerstmann-Straussler-Scheinker syndrome ORPHA:356	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PNMA1;GPRIN1;EVI5L
Glucose-galactose malabsorption ORPHA:35710	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;FAM83F;CDH1
Glutaryl-CoA dehydrogenase deficiency ORPHA:25	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;MRPL54;RRP9
Glycogen storage disease due to acid maltase deficiency, infantile onset ORPHA:308552	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NOXA1;AGPAT2;LMF2
Glycogen storage disease due to acid maltase deficiency, late-onset ORPHA:420429	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NOXA1;AGPAT2;LMF2
Glycogen storage disease due to aldolase A deficiency ORPHA:57	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;TMED1;YIF1B
Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form ORPHA:308712	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form ORPHA:308684	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form ORPHA:308698	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form ORPHA:308670	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form ORPHA:308655	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form ORPHA:308638	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form ORPHA:308621	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;BAG2;TRAM2
Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;CEBPB;KLF4
Granular corneal dystrophy type I ORPHA:98962	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Granular corneal dystrophy type II ORPHA:98963	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Griscelli syndrome type 1 ORPHA:79476	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;SNX29;HERC1
Griscelli syndrome type 2 ORPHA:79477	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;STK17B;NMI
Guttmacher syndrome ORPHA:2957	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDX2;KIF20A;HOXB13
Hand-foot-genital syndrome ORPHA:2438	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDX2;KIF20A;HOXB13
Harlequin ichthyosis ORPHA:457	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH3;CDH1
Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	EVI5L;GAS2L1;NOL3
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	VNN1;CD14;IFI30
Hereditary hypotrichosis with recurrent skin vesicles ORPHA:217407	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH3;KLK8
Huntington disease-like 1 ORPHA:157941	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Hyperimmunoglobulinemia D with periodic fever ORPHA:343	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;REEP6;RRP9
Hyperinsulinism due to UCP2 deficiency ORPHA:276556	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;CD52;CORO1A
Hyperkalemic periodic paralysis ORPHA:682	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;SEMA6C;TCAP
Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;SYT7;CLGN
Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome ORPHA:363523	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;SEC23A;CHM
Hypoinsulinemic hypoglycemia and body hemihypertrophy ORPHA:293964	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;ZNF628;ZNF598
Hypomyelination with brain stem and spinal cord involvement and leg spasticity ORPHA:363412	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NSA2;CETN3;NAE1
Hypomyelination-congenital cataract syndrome ORPHA:85163	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;ERI1;CHM
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ESAM;SYNPO;NES
Ichthyosis-hypotrichosis syndrome ORPHA:91132	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;CDH1;ATP2C2
Infantile nephropathic cystinosis ORPHA:411629	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STARD3;TMED1;ATP6V0D1
Infantile-onset X-linked spinal muscular atrophy ORPHA:1145	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC16A;WDR6;UBAP2L
Infantile-onset ascending hereditary spastic paralysis ORPHA:293168	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;DIXDC1
Inherited Creutzfeldt-Jakob disease ORPHA:282166	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLK4;ARHGAP11B;NDC80
Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome ORPHA:508498	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency ORPHA:314376	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;VNN1;KCNE3
Isolated Pierre Robin syndrome ORPHA:718	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;SYT7
Isolated congenital digital clubbing ORPHA:217059	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;CDH1;PDZK1IP1
Isolated optic nerve hypoplasia/aplasia ORPHA:137902	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;VWA5B2
Jackson-Weiss syndrome ORPHA:1540	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
Juvenile nephropathic cystinosis ORPHA:411634	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STARD3;TMED1;ATP6V0D1
Keipert syndrome ORPHA:2662	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;CDC42BPB;NES
Keratoderma hereditarium mutilans ORPHA:494	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH1;KLK8
Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNA2;CCNB1;MRPL19
Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DIDO1;SEC16A;TUBGCP6
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH1;KLK8
Kuru ORPHA:454745	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Kuskokwim syndrome ORPHA:1149	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;SERPINH1;NES
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;P4HA2;ARHGAP29
LAMA5-related multisystemic syndrome ORPHA:521450	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
LRP5-related primary osteoporosis ORPHA:498481	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;TNKS1BP1
Larsen syndrome ORPHA:503	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AHNAK2;TNKS1BP1;CDC42BPB
Larsen-like syndrome, B3GAT3 type ORPHA:284139	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;LMF2;YIF1B
Late-infantile/juvenile Krabbe disease ORPHA:206443	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KCNE3;LPAR6;ITM2B
Late-onset junctional epidermolysis bullosa ORPHA:79406	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;ATP2C2;KLK8
Lattice corneal dystrophy type I ORPHA:98964	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Legius syndrome ORPHA:137605	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPRY2;CDC42BPB;NES
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MRPL19;TLCD1;WARS2
Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;AHNAK2
Lethal osteosclerotic bone dysplasia ORPHA:1832	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CTIF;CDC42BPB;GAS2L1
Leukocyte adhesion deficiency type II ORPHA:99843	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;AGPAT2;LMF2
Leydig cell hypoplasia due to LHB deficiency ORPHA:325448	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TLCD1;ZNF598;RRP9
Lissencephaly due to LIS1 mutation ORPHA:95232	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;SPIN1
Lymphedema-posterior choanal atresia syndrome ORPHA:99141	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;ARHGAP29
MEGDEL syndrome ORPHA:352328	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TRIM13;CHM;SUGT1
MPDU1-CDG ORPHA:79323	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMED1;MRPL54;RRP9
MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PPP1R13L;TNKS1BP1;ATP2C2
Macrocephaly-developmental delay syndrome ORPHA:397612	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Macrocephaly-intellectual disability-left ventricular non compaction syndrome ORPHA:466791	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	UBAP2L;KIF20A;ZWINT
Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNE1;TRIP10;CIB2
Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome ORPHA:363649	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;ZNF598
Melnick-Needles syndrome ORPHA:2484	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;CD14;IFI30
Metabolic myopathy due to lactate transporter defect ORPHA:171690	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNA2;CCNB1;MRPL19
Metaphyseal chondrodysplasia, Spahr type ORPHA:2501	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH3;ATP2C2
Metatropic dysplasia ORPHA:2635	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency ORPHA:308425	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ATG4A;EBAG9;METTL18
Methylmalonic aciduria due to transcobalamin receptor defect ORPHA:280183	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Mevalonic aciduria ORPHA:29	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;REEP6;RRP9
Microcephalic osteodysplastic primordial dwarfism type II ORPHA:2637	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TCERG1;DIDO1;HERC1
Microcephalic primordial dwarfism, Dauber type ORPHA:319675	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	HERC1;SCAF11;LYST
Mirror-image polydactyly ORPHA:498494	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;TLCD1
Monosomy 9q22.3 ORPHA:77301	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BRSK2;PSIP1;RALGPS1
Morning glory disc anomaly ORPHA:35737	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;BRSK2;VWA5B2
Mulibrey nanism ORPHA:2576	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;CAMK2N2;SPIN1
Multiple congenital anomalies-hypotonia-seizures syndrome type 2 ORPHA:300496	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;USP16;ZBTB33
Multiple endocrine neoplasia type 4 ORPHA:276152	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DDX17;SPOCK2;TXNIP
Multiple epiphyseal dysplasia, Al-Gazali type ORPHA:166024	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TUBB3;SERPINH1;TNKS1BP1
Muscle filaminopathy ORPHA:171445	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;SERPINH1;NES
Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Myhre syndrome ORPHA:2588	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DDX17;HERC1;ANGEL2
Myopathic Ehlers-Danlos syndrome ORPHA:536516	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;ARHGAP29
Myotonia fluctuans ORPHA:99734	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;SEMA6C;TCAP
Myotonia permanens ORPHA:99735	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;SEMA6C;TCAP
NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NMI;SLC16A3;MICA
NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Nance-Horan syndrome ORPHA:627	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;AHNAK2;CDC42BPB
Navajo neurohepatopathy ORPHA:255229	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CERS5;SNUPN;YIF1B
Naxos disease ORPHA:34217	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;ENTPD2;TNKS1BP1
Netherton syndrome ORPHA:634	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH3;KLK8
Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;RHPN2
Neuroectodermal melanolysosomal disease ORPHA:33445	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;SNX29;HERC1
Neuronal intestinal pseudoobstruction ORPHA:99811	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
Nicolaides-Baraitser syndrome ORPHA:3051	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SNX29;HERC1;LYST
Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome ORPHA:231720	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	GPRIN1;NXPH4;CAMK2N2
Obesity due to CEP19 deficiency ORPHA:397615	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDKN2D;PIGB;RNF24
Ocular cystinosis ORPHA:411641	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STARD3;TMED1;ATP6V0D1
Oculocerebrorenal syndrome of Lowe ORPHA:534	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Odonto-onycho-dermal dysplasia ORPHA:2721	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;ADAM8;MAP3K14
Opsismodysplasia ORPHA:2746	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC16A;TAOK2;ZNF598
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;RRP9
Osteoporosis-pseudoglioma syndrome ORPHA:2788	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;TNKS1BP1
Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;SERPINH1;TNKS1BP1
Otopalatodigital syndrome type 1 ORPHA:90650	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
Otopalatodigital syndrome type 2 ORPHA:90652	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NMI;TCIRG1;IFI30
POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FXR2;SMYD5;TNKS1BP1
PRUNE1-related neurological syndrome ORPHA:544469	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TADA1;CTCF;METTL18
PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;RPUSD1;YIF1B
Papilloma of choroid plexus ORPHA:2807	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB2;KIF20A;ZWINT
Paramyotonia congenita of Von Eulenburg ORPHA:684	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AOC3;SEMA6C;TCAP
Parastremmatic dwarfism ORPHA:2646	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Parietal foramina with clavicular hypoplasia ORPHA:251290	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;SERPINH1
Paroxysmal nocturnal hemoglobinuria ORPHA:447	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;USP16;ZBTB33
Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;MICAL2;KLF4
Perlman syndrome ORPHA:2849	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DIDO1;HERC1;TUBGCP6
Persistent polyclonal B-cell lymphocytosis ORPHA:300324	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;ADAM8;CORO1A
Peters plus syndrome ORPHA:709	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC23A;MRPL19;SPIN1
Pfeiffer syndrome type 2 ORPHA:93259	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
Pfeiffer syndrome type 3 ORPHA:93260	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDH3;CDH1;SYT7
Phakomatosis cesiomarmorata ORPHA:79484	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;CDC42BPB
Polymicrogyria due to TUBB2B mutation ORPHA:300573	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BRSK2;TUBB3;NES
Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	VAT1;IGSF8;ACOT7
Pontocerebellar hypoplasia type 10 ORPHA:411493	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TOE1;EIF4A3;METTL18
Pontocerebellar hypoplasia type 8 ORPHA:324569	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;TMED1;LMF2
Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH1;KLK8
Porphyria variegata ORPHA:79473	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STK11IP;WDR6;ABCA7
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NUAK1;SERPINH1;NES
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;TNKS1BP1;SYT7
PrP systemic amyloidosis ORPHA:397606	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Primary lateral sclerosis ORPHA:35689	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;SGSM2;TUBGCP6
Progressive familial intrahepatic cholestasis type 5 ORPHA:480476	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TRIM15;CLDN2;SERPINA6
Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TOE1;EIF4A3;RHEBL1
Prolidase deficiency ORPHA:742	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SAT2;TMED1;MRPL54
Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	P4HA2;ARHGAP29;VASN
Purine nucleoside phosphorylase deficiency ORPHA:760	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TOE1;EIF4A3;PPIF
RIN2 syndrome ORPHA:217335	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	AHNAK2;SYNPO;KLF4
RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DAZAP2;CD14;ITM2B
Rapid-onset dystonia-parkinsonism ORPHA:71517	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	APC2;BRSK2;RIMS3
Recurrent Neisseria infections due to factor D deficiency ORPHA:169467	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CEBPB;CD14;IFI30
Reis-Bucklers corneal dystrophy ORPHA:98961	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;SMYD5;RRP9
Richieri Costa-Pereira syndrome ORPHA:3102	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	EIF4A3;ZWINT;RRP9
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency ORPHA:353284	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DDX17;HERC1;CBL
S-adenosylhomocysteine hydrolase deficiency ORPHA:88618	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;ZWINT;RRP9
STING-associated vasculopathy with onset in infancy ORPHA:425120	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	IFI44;NMI;TCIRG1
STT3A-CDG ORPHA:370921	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CCNB1;KIF20A;ZWINT
SYNGAP1-related developmental and epileptic encephalopathy ORPHA:544254	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CLSTN3;SGSM2;LMTK3
Sanfilippo syndrome type A ORPHA:79269	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STARD3;TCIRG1;LMF2
Scalp-ear-nipple syndrome ORPHA:2036	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;AHNAK2
Scapuloperoneal spinal muscular atrophy ORPHA:431255	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Schopf-Schulz-Passarge syndrome ORPHA:50944	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;ADAM8;MAP3K14
Schilbach-Rott syndrome ORPHA:2353	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BRSK2;PSIP1;RALGPS1
Serrated polyposis syndrome ORPHA:157798	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TMEM45B;FGD3;CDH1
Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;ADAM8;CORO1A
Severe combined immunodeficiency due to DCLRE1C deficiency ORPHA:275	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PIGB;SCAF11;STK17B
Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TOE1;ARID5A;ADA
Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;ZBTB33;ZBTB5
Short stature-brachydactyly-obesity-global developmental delay syndrome ORPHA:464288	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ARMC6;TUBGCP6;WDR6
Spastic paraplegia type 7 ORPHA:99013	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ACAP3;SGSM2;TUBGCP6
Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome ORPHA:521390	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	STK11IP;ZNF628;TUBGCP6
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KCNE3;CD14;ITM2B
Spinocerebellar ataxia type 1 ORPHA:98755	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	KIAA0513;FRY;LYST
Spinocerebellar ataxia type 10 ORPHA:98761	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTGES3;MRPL19;NAE1
Spinocerebellar ataxia type 14 ORPHA:98763	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BRSK2;LMTK3;VWA5B2
Spinocerebellar ataxia type 18 ORPHA:98771	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RIOK3;ZFAND2A;TBPL1
Spinocerebellar ataxia type 4 ORPHA:98765	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	RPUSD1;ZNF598;RRP9
Spinocerebellar ataxia with axonal neuropathy type 1 ORPHA:94124	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLK4;NUP50;NDC80
Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	OIP5;CENPA;ZWINT
Spondyloepimetaphyseal dysplasia, Missouri type ORPHA:93356	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH3;ATP2C2
Spondyloepiphyseal dysplasia, Maroteaux type ORPHA:263482	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Spondylometaphyseal dysplasia, Kozlowski type ORPHA:93314	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	C11ORF52;PTPRU;SERPINH1
Spondylometaphyseal dysplasia, Sedaghatian type ORPHA:93317	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DRAP1;TMED1;MRPL54
Sporadic fatal insomnia ORPHA:586130	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	MBNL2;AHNAK2;NDRG1
Sporadic porphyria cutanea tarda ORPHA:443057	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NMI;SLC16A3;MICA
Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DHRS9;CD14;IFI30
Succinyl-CoA:3-oxoacid CoA transferase deficiency ORPHA:832	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PREPL;PSIP1;NAE1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PTPRU;NUAK1;NES
Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SCAF11;STK17B;LYST
Symptomatic form of hemochromatosis type 1 ORPHA:465508	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	NMI;SLC16A3;MICA
Syndromic X-linked intellectual disability due to JARID1C mutation ORPHA:85279	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SEC16A;TAOK2;ZNF598
T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CD52;RASGRP2;CORO1A
Temtamy preaxial brachydactyly syndrome ORPHA:363417	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ITPRIP;ERI1;CBL
Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
Thiel-Behnke corneal dystrophy ORPHA:98960	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	CDA;KLF4;SLC16A3
Transaldolase deficiency ORPHA:101028	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TCIRG1;IFI30;ATP6V0D1
Turcot syndrome with polyposis ORPHA:99818	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	SPAG9;PREPL;HERC1
Tyrosinemia type 1 ORPHA:882	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PPIF;MTHFS;YIF1B
VACTERL with hydrocephalus ORPHA:3412	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	PLK4;CCNA2;NDC80
X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TRIM15;CLDN2;SERPINA6
X-linked Ehlers-Danlos syndrome ORPHA:75497	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
X-linked centronuclear myopathy ORPHA:596	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	DAZAP2;RIOK3;STK17B
X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	ZNF598;LMF2;PDLIM7
X-linked progressive cerebellar ataxia ORPHA:1175	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	TRIM15;CLDN2;SERPINA6
X-linked severe congenital neutropenia ORPHA:86788	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;CD52;CORO1A
X-linked thrombocytopenia with normal platelets ORPHA:852	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGD3;CD52;CORO1A
Xanthinuria type I ORPHA:93601	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	FGFBP1;CDH1;MARVELD3
Xq25 microduplication syndrome ORPHA:521258	3/101	0.32601283645300594	0.7929682744768703	0	0	1.5115474037716352	1.6941703281889957	BCLAF1;SCAF11;ZBTB33
Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635	4/145	0.32675545041927023	0.7929682744768703	0	0	1.4012312344745652	1.5673377332870249	PTPRU;TNKS1BP1;RHPN2;CDC42BPB
17q12 microdeletion syndrome ORPHA:261265	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CDX2;RHPN2;CLDN2
2p21 microdeletion syndrome without cystinuria ORPHA:369881	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	PREPL;MRPL19;NAE1
Acromegaly ORPHA:963	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	DRAP1;SPSB3;MRPL54
Acute basophilic leukemia ORPHA:86849	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGD3;CD52;CORO1A
Acute megakaryoblastic leukemia without Down syndrome ORPHA:329469	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	MIDN;TAOK2;RAB11FIP3
Alveolar soft tissue sarcoma ORPHA:163699	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	STARD3;ZNF628;LMF2
Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	PREPL;HERC1;CCP110
Autosomal dominant hypocalcemia ORPHA:428	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	TNKS1BP1;CDC42BPB;SYT7
Bladder exstrophy ORPHA:93930	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGFBP1;CDH3;KLK8
Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CCNB1;KIF20A;TLCD1
Cenani-Lenz syndrome ORPHA:3258	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	SPAG9;PREPL;DIXDC1
Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	TOE1;RHEBL1;NDC80
Congenital dyserythropoietic anemia type I ORPHA:98869	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	TUBGCP6;WDR6;ZNF598
Congenital erythropoietic porphyria ORPHA:79277	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CCND3;USP20;YIF1B
Congenital factor XIII deficiency ORPHA:331	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	VNN1;CD14;AKR1C4
Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	SPAG9;PREPL;SPIN1
Congenitally uncorrected transposition of the great arteries ORPHA:860	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	APC2;SPAG9;BRSK2
Craniometaphyseal dysplasia ORPHA:1522	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	NUAK1;SH3PXD2A;SYNPO
Desmoplastic small round cell tumor ORPHA:83469	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	TCERG1;UBAP2L;ZWINT
Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGD3;CLDN9;PDZK1IP1
Familial avascular necrosis of femoral head ORPHA:86820	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	PTPRU;SERPINH1;NES
Familial isolated congenital asplenia ORPHA:101351	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CCNB1;CENPA;ZWINT
Familial primary localized cutaneous amyloidosis ORPHA:353220	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	P4HA2;AHNAK2;ARHGAP29
Fibrolamellar hepatocellular carcinoma ORPHA:401920	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	MIDN;ZNF628;LMF2
Geroderma osteodysplastica ORPHA:2078	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CCNB1;KIF20A;ZWINT
Hypoplastic left heart syndrome ORPHA:2248	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	NUAK1;SERPINH1;NES
IMAGe syndrome ORPHA:85173	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CDKN1C;SEMA6C;WFIKKN1
Insulinoma ORPHA:97279	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	RPUSD1;ZNF628;ZNF598
Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGFBP1;AHNAK2;ATP2C2
Loeys-Dietz syndrome ORPHA:60030	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	SNX18;ITPRIP;STK17B
Lymphomatoid papulosis ORPHA:98842	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	ZNF598;ZWINT;RRP9
MEDNIK syndrome ORPHA:171851	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	ACOT7;RPUSD1;ZNF598
Microlissencephaly ORPHA:1083	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	RPUSD1;KATNB1;ZNF598
Multiple benign circumferential skin creases on limbs ORPHA:2505	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	MLLT11;ACOT7;MAPRE2
NUT midline carcinoma ORPHA:443167	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	MDC1;MIDN;ARID3B
Neonatal severe primary hyperparathyroidism ORPHA:417	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FAM83F;CDH1;MARVELD3
Nephrogenic diabetes insipidus ORPHA:223	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGD3;KCNK7;ABCA7
Neurofibromatosis-Noonan syndrome ORPHA:638	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	TAOK2;EVI5L;RAB11FIP3
Palmoplantar keratoderma-deafness syndrome ORPHA:2202	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGFBP1;CDH1;KLK8
Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CD52;KCNK7;ATG16L2
Papillary renal cell carcinoma ORPHA:319298	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	P4HA2;AHNAK2;ARHGAP29
Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	EXOC3L4;TRIM15;SERPINA6
Primary cutaneous anaplastic large cell lymphoma ORPHA:300865	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	ZNF598;ZWINT;RRP9
Pulmonary venoocclusive disease ORPHA:31837	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	SEC23A;ARHGAP29;CDC42BPB
RAS-associated autoimmune leukoproliferative disease ORPHA:268114	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	PLK4;SYNCRIP;ZBTB33
Recurrent infection due to specific granule deficiency ORPHA:169142	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	ADAM8;TCIRG1;CORO1A
Roussy-Levy syndrome ORPHA:3115	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	VAT1;SPRY2;NES
Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	C11ORF52;CDH1;KLK8
Short rib-polydactyly syndrome, Majewski type ORPHA:93269	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	PREPL;DIXDC1;CCP110
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	CD52;NMI;IFI30
Uncombable hair syndrome ORPHA:1410	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	FGFBP1;ATP2C2;KLK8
X-linked Emery-Dreifuss muscular dystrophy ORPHA:98863	3/102	0.33146693382837744	0.7929682744768703	0	0	1.4962025316455696	1.6521475642534402	DRAP1;CIB2;PDLIM7
Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	HERC1;LPAR6;FRY
Antenatal Bartter syndrome ORPHA:93604	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SH2D3C;FRY;ITM2B
Autosomal recessive centronuclear myopathy ORPHA:169186	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SEMA6C;RASA4;SNPH
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	NUAK1;KCNQ1OT1;NES
Butterfly-shaped pigment dystrophy ORPHA:99001	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	PTPRU;NUAK1;NES
Chronic myeloid leukemia ORPHA:521	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SEC16A;TAOK2;ZNF598
Duane retraction syndrome ORPHA:233	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	NUAK1;MAFB;NES
Erythrokeratodermia variabilis ORPHA:317	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	FGFBP1;AHNAK2;KLK8
Familial advanced sleep-phase syndrome ORPHA:164736	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	IQSEC1;SEC16A;SGSM2
Familial infantile bilateral striatal necrosis ORPHA:225154	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	MDC1;SEC16A;UBAP2L
Familial isolated hyperparathyroidism ORPHA:99879	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	MDC1;TCERG1;UBAP2L
Familial medullary thyroid carcinoma ORPHA:99361	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SH2D3C;ARID3B;RASGRP2
Hereditary isolated aplastic anemia ORPHA:397692	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	RPUSD1;KATNB1;YIF1B
Idiopathic juvenile osteoporosis ORPHA:85193	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	FGFBP1;CLIC3;NXPH4
Inherited congenital spastic tetraplegia ORPHA:210141	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SLC25A27;PREPL;DIXDC1
Isolated hemihyperplasia ORPHA:2128	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	NUAK1;KCNQ1OT1;NES
NON RARE IN EUROPE: Paget disease of bone ORPHA:280110	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	TNFRSF11A;ZNF598;AGPAT2
Primary sclerosing cholangitis ORPHA:171	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	ATG16L2;RASA4;TUBGCP6
Retinopathy of prematurity ORPHA:90050	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	PTPRU;TNKS1BP1;NES
Saethre-Chotzen syndrome ORPHA:794	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	PTPRU;NUAK1;SYT7
Sotos syndrome ORPHA:821	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	DDX17;APC2;HERC1
Tubular aggregate myopathy ORPHA:2593	3/103	0.336919677176804	0.7929682744768703	0	0	1.4811645569620253	1.6113748050762697	SPSB3;USP20;ARID5A
Atypical glycine encephalopathy ORPHA:289863	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	PTPRU;CBS;SYT7
Autosomal thrombocytopenia with normal platelets ORPHA:168629	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	TCERG1;BCLAF1;NAE1
Cardiofaciocutaneous syndrome ORPHA:1340	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	MTMR1;CTCF;CBL
Complete hydatidiform mole ORPHA:254688	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	CD52;RASGRP2;CORO1A
Congenital muscular dystrophy without intellectual disability ORPHA:370980	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	FXR2;TAOK2;WDR6
Distal hereditary motor neuropathy type 2 ORPHA:139525	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	NUAK1;P4HA2;SYNPO
Early-onset anterior polar cataract ORPHA:98988	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	TRIM15;SERPINA6;SYT7
Extraskeletal Ewing sarcoma ORPHA:370334	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	BCLAF1;SCAF11;NUP50
Familial bicuspid aortic valve ORPHA:402075	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	SERPINH1;TNKS1BP1;NES
Familial progressive cardiac conduction defect ORPHA:871	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	PTPRU;NUAK1;NES
Familial short QT syndrome ORPHA:51083	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	CDKN1C;AATK;FRY
ICF syndrome ORPHA:2268	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	PLK4;CCNA2;NDC80
Infantile glycine encephalopathy ORPHA:289860	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	PTPRU;CBS;SYT7
Male infertility due to globozoospermia ORPHA:171709	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	PREPL;DIXDC1;SPIN1
Schwannomatosis ORPHA:93921	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	ARMC6;SMYD5;RPUSD1
Squamous cell carcinoma of the esophagus ORPHA:99977	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	LPAR6;STK17B;LYST
Systemic mastocytosis with associated hematologic neoplasm ORPHA:98849	3/104	0.34237000296284037	0.795266832401002	0	0	1.466424363955383	1.5718063798209392	DDX17;DIDO1;BCLAF1
Aggressive systemic mastocytosis ORPHA:98850	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	SERTAD2;STK17B;CBL
Autosomal agammaglobulinemia ORPHA:33110	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	CD52;SH2D3C;CORO1A
Familial isolated restrictive cardiomyopathy ORPHA:75249	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	SERPINH1;KIF20A;NES
NON RARE IN EUROPE: Aldosterone-producing adenoma ORPHA:85142	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	PREPL;NOS1AP;SYT7
Osteogenesis imperfecta type 2 ORPHA:216804	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	SERPINH1;TRAM2;VASN
Peters anomaly ORPHA:708	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	PTPRU;NUAK1;SERPINH1
Pontocerebellar hypoplasia type 2 ORPHA:2524	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	TOE1;EIF4A3;METTL18
Skeletal Ewing sarcoma ORPHA:319	3/105	0.3478168695524085	0.8029813443753846	0	0	1.4519731943410275	1.5333986526751149	SERPINH1;SPRY2;NES
Atrial septal defect, ostium secundum type ORPHA:99103	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	NUAK1;SERPINH1;NES
Autosomal dominant polycystic kidney disease ORPHA:730	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	SERPINH1;TNKS1BP1;TRAM2
Bilateral striopallidodentate calcinosis ORPHA:1980	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	NUAK1;DIXDC1;NES
Congenital generalized lipodystrophy ORPHA:528	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	KLF4;AGPAT2;FSTL3
Essential thrombocythemia ORPHA:3318	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	STK17B;SH2B3;SIRPB1
Hypoplastic amelogenesis imperfecta ORPHA:100031	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	FGFBP1;GCNT3;IER3
Jeune syndrome ORPHA:474	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	PREPL;DIXDC1;CCP110
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406	3/106	0.35325925736766534	0.8105918570729571	0	0	1.4378026299619024	1.4961099140371212	EXOC3L4;TRIM15;SERPINA6
Osteogenesis imperfecta type 3 ORPHA:216812	3/107	0.35869616851766006	0.8211968342881582	0	0	1.423904576436222	1.4599002805066403	SERPINH1;TNKS1BP1;VASN
Renal agenesis, unilateral ORPHA:93100	3/107	0.35869616851766006	0.8211968342881582	0	0	1.423904576436222	1.4599002805066403	PTPRU;NUAK1;SYT7
Seckel syndrome ORPHA:808	3/107	0.35869616851766006	0.8211968342881582	0	0	1.423904576436222	1.4599002805066403	PLK4;CCNA2;NDC80
Hereditary breast cancer ORPHA:227535	3/108	0.36412662699491405	0.8329982337461243	0	0	1.4102712477396022	1.4247315986319773	PLK4;CDH1;NDC80
Omenn syndrome ORPHA:39041	3/109	0.3695496785367434	0.8447648476081987	0	0	1.3968951516598997	1.3905673557944145	CD52;STK17B;ADA
Common variable immunodeficiency ORPHA:1572	3/110	0.3749643903900506	0.8564946241562607	0	0	1.3837690760676682	1.3573725967315935	CD52;ADAM8;CORO1A
46,XY partial gonadal dysgenesis ORPHA:251510	3/111	0.3803698513965226	0.8668760866668862	0	0	1.370886075949367	1.3251138437866414	KIF20A;CDC25C;CLGN
Dyskeratosis congenita ORPHA:1775	3/111	0.3803698513965226	0.8668760866668862	0	0	1.370886075949367	1.3251138437866414	TOE1;EIF4A3;RRP9
Young-onset Parkinson disease ORPHA:2828	3/111	0.3803698513965226	0.8668760866668862	0	0	1.370886075949367	1.3251138437866414	PREPL;DOCK4;TMCC2
Oligodontia ORPHA:99798	3/112	0.3857651716975682	0.8778481542696168	0	0	1.3582394611543376	1.2937590232165819	PTPRU;CDH3;RHPN2
Walker-Warburg syndrome ORPHA:899	3/112	0.3857651716975682	0.8778481542696168	0	0	1.3582394611543376	1.2937590232165819	PTPRU;NUAK1;TNKS1BP1
Joubert syndrome ORPHA:475	3/116	0.40722799065374093	0.8922466888454011	0	0	1.3098913408759942	1.176782903174656	TUBGCP5;CCP110;CEP41
Total early-onset cataract ORPHA:98994	3/116	0.40722799065374093	0.8922466888454011	0	0	1.3098913408759942	1.176782903174656	PTPRU;TNKS1BP1;CDC42BPB
Autosomal recessive primary microcephaly ORPHA:2512	3/119	0.4231781562673433	0.8922466888454011	0	0	1.2758184199039722	1.0971553796593858	PLK4;CCNA2;NDC80
NON RARE IN EUROPE: Primary ovarian failure ORPHA:619	3/121	0.43373030541558855	0.8922466888454011	0	0	1.2540656511478223	1.0475616126117124	TCERG1;ARHGAP11B;PSIP1
Autosomal recessive non-syndromic intellectual disability ORPHA:88616	3/140	0.5297434888040138	0.8922466888454011	0	0	1.0790908250947058	0.6856137072956933	CRADD;IQSEC1;UBAP2L
3-methylcrotonyl-CoA carboxylase deficiency ORPHA:6	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	MRPL19;TLCD1
Acute myeloid leukemia with t(8;16)(p11;p13) translocation ORPHA:370026	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	HERC1;CBL
Annular epidermolytic ichthyosis ORPHA:281139	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	KCNK7;CLIC3
Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Autosomal dominant epidermolytic ichthyosis ORPHA:312	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	KCNK7;CLIC3
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form ORPHA:79399	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;KLK8
Autosomal dominant generalized epidermolysis bullosa simplex, severe form ORPHA:79396	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;KLK8
Autosomal dominant optic atrophy, classic form ORPHA:98673	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	BCLAF1;NAE1
C3 glomerulopathy ORPHA:329918	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Congenital reticular ichthyosiform erythroderma ORPHA:281190	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	KCNK7;CLIC3
Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;KLK8
Familial afibrinogenemia ORPHA:98880	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Familial dysfibrinogenemia ORPHA:98881	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Familial hypodysfibrinogenemia ORPHA:248408	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Familial hypofibrinogenemia ORPHA:101041	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	AKR1C4;SERPINA6
Familial porencephaly ORPHA:99810	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	NUAK1;NES
Hereditary site-specific ovarian cancer syndrome ORPHA:213524	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	PLK4;NDC80
KID syndrome ORPHA:477	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;KLK8
Localized epidermolysis bullosa simplex ORPHA:79400	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;KLK8
Noonan syndrome-like disorder with loose anagen hair ORPHA:2701	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	UBE2Q2;RIOK3
Partial pancreatic agenesis ORPHA:2805	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	CDX2;VWA5B2
Severe generalized junctional epidermolysis bullosa ORPHA:79404	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	FGFBP1;AHNAK2
Simpson-Golabi-Behmel syndrome ORPHA:373	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	PTPRU;NES
X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018	2/100	0.5946543219467495	0.8922466888454011	0	0	1.005153576582148	0.5224537141229435	PTPRU;NUAK1
15q14 microdeletion syndrome ORPHA:261190	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;DIXDC1
17q11 microdeletion syndrome ORPHA:97685	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;PREPL
17q11.2 microduplication syndrome ORPHA:139474	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;PREPL
22q11.2 duplication syndrome ORPHA:1727	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;TNKS1BP1
3-hydroxy-3-methylglutaryl-CoA synthase deficiency ORPHA:35701	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;SERPINA6
3-methylglutaconic aciduria type 1 ORPHA:67046	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	OMA1;EBAG9
3-methylglutaconic aciduria type 8 ORPHA:505208	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL54;RRP9
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency ORPHA:753	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
5p13 microduplication syndrome ORPHA:329802	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
5q35 microduplication syndrome ORPHA:228415	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
AA amyloidosis ORPHA:85445	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;FGFBP1
AApoAII amyloidosis ORPHA:238269	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
ADNP syndrome ORPHA:404448	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DIDO1;UBAP2L
AFib amyloidosis ORPHA:93562	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
AGel amyloidosis ORPHA:85448	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KLF4;ITM2B
AICA-ribosiduria ORPHA:250977	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ANP32B;ZWINT
ALG1-CDG ORPHA:79327	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;RRP9
ALG12-CDG ORPHA:79324	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;LMF2
ALG13-CDG ORPHA:324422	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;ANGEL2
ALG6-CDG ORPHA:79320	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	OMA1;METTL18
ALG9-CDG ORPHA:79328	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TUBGCP5;SUGT1
ALys amyloidosis ORPHA:93561	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KCNE3;CD14
ANE syndrome ORPHA:157954	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;ARHGAP11B
AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEMA6C;RALGPS1
Absence of fingerprints-congenital milia syndrome ORPHA:1658	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
Acute infantile liver failure-multisystemic involvement syndrome ORPHA:370088	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;NAE1
Acute myeloid leukaemia with myelodysplasia-related features ORPHA:86845	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;LYST
Adenine phosphoribosyltransferase deficiency ORPHA:976	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;MRPL54
Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;NOL3
Adult hypophosphatasia ORPHA:247676	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Alpha-B crystallin-related late-onset myopathy ORPHA:399058	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DIXDC1;SYNPO
Alpha-N-acetylgalactosaminidase deficiency type 1 ORPHA:79279	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCIRG1;IFI30
Alpha-N-acetylgalactosaminidase deficiency type 2 ORPHA:79280	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCIRG1;IFI30
Alpha-N-acetylgalactosaminidase deficiency type 3 ORPHA:79281	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCIRG1;IFI30
Amyotrophic lateral sclerosis type 4 ORPHA:357043	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;DIXDC1
Argininosuccinic aciduria ORPHA:23	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AGPAT2;LMF2
Aromatase deficiency ORPHA:91	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;GDF15
Aromatase excess syndrome ORPHA:178345	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;GDF15
Ataxia-pancytopenia syndrome ORPHA:2585	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	IFI44;NMI
Ataxia-telangiectasia ORPHA:100	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;ANGEL2
Ataxia-telangiectasia variant ORPHA:370109	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;ANGEL2
Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIF20A;CDC25C
Attenuated Chediak-Higashi syndrome ORPHA:352723	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Atypical pantothenate kinase-associated neurodegeneration ORPHA:216873	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RNF24;NUP50
Autism spectrum disorder-epilepsy-arthrogryposis syndrome ORPHA:370943	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;GCNT3
Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome ORPHA:444463	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Autosomal dominant Charcot-Marie-Tooth disease type 2A2 ORPHA:99947	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FXR2;TAOK2
Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC16A;TNKS1BP1
Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
Autosomal dominant Charcot-Marie-Tooth disease type 2O ORPHA:284232	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;CDC42BPB
Autosomal dominant aplasia and myelodysplasia ORPHA:314399	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SYNCRIP;NSA2
Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PLK4;NDC80
Autosomal dominant deafness-onychodystrophy syndrome ORPHA:79499	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;SIRPB1
Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
Autosomal dominant focal dystonia, DYT25 type ORPHA:329466	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TPPP;RALGPS1
Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering ORPHA:402003	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;VWA5B2
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome ORPHA:457193	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TNKS1BP1;CDC42BPB
Autosomal dominant optic atrophy and cataract ORPHA:67036	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RDH13;SLC25A44
Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Autosomal dominant slowed nerve conduction velocity ORPHA:140481	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;ARHGAP29
Autosomal dominant spastic paraplegia type 4 ORPHA:100985	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Autosomal dominant vitreoretinochoroidopathy ORPHA:3086	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Autosomal erythropoietic protoporphyria ORPHA:79278	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;ATG4A
Autosomal recessive Charcot-Marie-Tooth disease type 2X ORPHA:466775	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Autosomal recessive Kenny-Caffey syndrome ORPHA:93324	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;OIP5
Autosomal recessive bestrophinopathy ORPHA:139455	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Autosomal recessive cerebelloparenchymal disorder type 3 ORPHA:1170	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;RRP9
Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;VWA5B2
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ACOT7;YIF1B
Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome ORPHA:254343	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PNPT1;SUGT1
Autosomal recessive spastic paraplegia type 11 ORPHA:2822	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Autosomal recessive spastic paraplegia type 45 ORPHA:320396	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RIOK3;N4BP1
Autosomal recessive spastic paraplegia type 60 ORPHA:401800	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Autosomal recessive spastic paraplegia type 66 ORPHA:401815	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;VASN
Autosomal recessive spastic paraplegia type 69 ORPHA:401830	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;CHM
Autosomal recessive spastic paraplegia type 76 ORPHA:488594	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AGPAT2;LMF2
Autosomal recessive spastic paraplegia type 77 ORPHA:466722	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GTF3C6;MRPL54
Autosomal recessive spondylometaphyseal dysplasia, Megarbane type ORPHA:401979	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;RRP9
Autosomal spastic paraplegia type 72 ORPHA:401849	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;TUBB3
B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;ZNF598
BRESEK syndrome ORPHA:85284	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;MRPL19
Bamforth-Lazarus syndrome ORPHA:1226	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;AHNAK2
Bannayan-Riley-Ruvalcaba syndrome ORPHA:109	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Beckwith-Wiedemann syndrome due to NSD1 mutation ORPHA:238613	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Best vitelliform macular dystrophy ORPHA:1243	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Beta-ketothiolase deficiency ORPHA:134	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ECI2;MRPL19
Bietti crystalline dystrophy ORPHA:41751	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPAR6;LYST
Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;TNFRSF10B
Blau syndrome ORPHA:90340	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGD3;ADAM8
Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCND3;SH2B3
Blepharophimosis-intellectual disability syndrome, MKB type ORPHA:293707	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DIDO1;SEC16A
Bowen-Conradi syndrome ORPHA:1270	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;EMG1
Brachydactyly-syndactyly, Zhao type ORPHA:93409	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
Brachytelephalangic chondrodysplasia punctata ORPHA:79345	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CLDN2;SERPINA6
Brain calcification, Rajab type ORPHA:178506	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;MRPL19
Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;SERPINA6
Brain dopamine-serotonin vesicular transport disease ORPHA:352649	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;KCNE3
Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome ORPHA:500150	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Brain-lung-thyroid syndrome ORPHA:209905	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GGTLC1;CKB
Branchio-oculo-facial syndrome ORPHA:1297	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIF20A;TLCD1
Brody myopathy ORPHA:53347	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCAP;OIP5
Buschke-Ollendorff syndrome ORPHA:1306	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
C1 inhibitor deficiency ORPHA:459353	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MAFB;CD14
C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GTF3C6;RBX1
CLN13 disease ORPHA:352709	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	IGSF8;RGS11
CODAS syndrome ORPHA:1458	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;ZNF598
COG2-CDG ORPHA:435934	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TADA1;OMA1
COL4A1-related familial vascular leukoencephalopathy ORPHA:36383	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
CTCF-related neurodevelopmental disorder ORPHA:363611	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUP50;CTCF
Caffey disease ORPHA:1310	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;VASN
Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;LYST
Carney complex ORPHA:1359	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;CHM
Carnitine palmitoyl transferase 1A deficiency ORPHA:156	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCIRG1;KLF4
Carnitine palmitoyl transferase II deficiency, myopathic form ORPHA:228302	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPCAT3;MARVELD3
Carnitine palmitoyl transferase II deficiency, neonatal form ORPHA:228308	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPCAT3;MARVELD3
Carnitine palmitoyl transferase II deficiency, severe infantile form ORPHA:228305	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPCAT3;MARVELD3
Caroli disease ORPHA:53035	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;AHNAK2
Cerebrocostomandibular syndrome ORPHA:1393	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	EIF4A3;RRP9
Cernunnos-XLF deficiency ORPHA:169079	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;METTL18
Chediak-Higashi syndrome ORPHA:167	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Charcot-Marie-Tooth disease type 1D ORPHA:101084	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;ARID5A
Charcot-Marie-Tooth disease type 2T ORPHA:495274	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPON2;SNX18
Charcot-Marie-Tooth disease type 4B2 ORPHA:99956	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;DOCK4
Charcot-Marie-Tooth disease type 4E ORPHA:99951	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;ARID5A
Childhood-onset basal ganglia degeneration syndrome ORPHA:497906	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ZNF628;LMF2
Childhood-onset hypophosphatasia ORPHA:247667	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Cholesteryl ester storage disease ORPHA:75234	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD14;IFI30
Chondrodysplasia with joint dislocations, gPAPP type ORPHA:280586	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;SPIN1
Chondrodysplasia-disorder of sex development syndrome ORPHA:1422	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CYP2U1;AHNAK2
Choroideremia ORPHA:180	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;CHM
Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GGTLC1;TPPP
Chuvash erythrocytosis ORPHA:238557	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARHGAP11B;CBL
Classic homocystinuria ORPHA:394	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TUBB3;CBS
Classic pantothenate kinase-associated neurodegeneration ORPHA:216866	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RNF24;NUP50
Cohen syndrome ORPHA:193	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Combined immunodeficiency due to CD27 deficiency ORPHA:238505	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Combined immunodeficiency due to DOCK8 deficiency ORPHA:217390	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGD3;CD52
Combined immunodeficiency due to IL21R deficiency ORPHA:357329	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Combined immunodeficiency due to MALT1 deficiency ORPHA:397964	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;STK17B
Combined immunodeficiency due to Moesin deficiency ORPHA:504530	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ITPRIP;SH2B3
Combined immunodeficiency due to TFRC deficiency ORPHA:476113	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;ZWINT
Combined immunodeficiency due to ZAP70 deficiency ORPHA:911	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Combined malonic and methylmalonic acidemia ORPHA:289504	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;CLK3
Combined oxidative phosphorylation defect type 11 ORPHA:324535	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;WARS2
Combined oxidative phosphorylation defect type 13 ORPHA:319514	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PNPT1;NAE1
Combined oxidative phosphorylation defect type 14 ORPHA:319519	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GTF3C6;MRPL54
Combined oxidative phosphorylation defect type 17 ORPHA:369913	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;RRP9
Combined oxidative phosphorylation defect type 9 ORPHA:319509	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;NAE1
Congenital analbuminemia ORPHA:86816	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Congenital bile acid synthesis defect type 2 ORPHA:79303	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;TLCD1
Congenital chloride diarrhea ORPHA:53689	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;TRIM15
Congenital contractural arachnodactyly ORPHA:115	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;ZNF697
Congenital factor II deficiency ORPHA:325	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Congenital factor V deficiency ORPHA:326	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	VNN1;CD14
Congenital factor XI deficiency ORPHA:329	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Congenital high-molecular-weight kininogen deficiency ORPHA:483	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPON2;SNX18
Congenital muscular dystrophy with intellectual disability and severe epilepsy ORPHA:329178	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;YIF1B
Congenital myopathy, Paradas type ORPHA:199329	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDA;CD14
Congenital sucrase-isomaltase deficiency ORPHA:35122	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;TRIM15
Corpus callosum agenesis-neuronopathy syndrome ORPHA:1496	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Corticosteroid-binding globulin deficiency ORPHA:199247	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Costello syndrome ORPHA:3071	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;ZNF598
Craniofacial dysplasia-osteopenia syndrome ORPHA:314555	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;TNKS1BP1
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies ORPHA:221145	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ACAP3;LMF2
Cutis marmorata telangiectatica congenita ORPHA:1556	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ERI1;OIP5
DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome ORPHA:494444	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC16A;ANP32B
DK1-CDG ORPHA:91131	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TLCD1;RRP9
DOCK2 deficiency ORPHA:447737	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:209341	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;CDC42BPB
DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion ORPHA:268261	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;OIP5
Deafness-lymphedema-leukemia syndrome ORPHA:3226	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GAS2L1;PDLIM7
Dermatopathia pigmentosa reticularis ORPHA:86920	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Desmosterolosis ORPHA:35107	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;TNKS1BP1
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency ORPHA:369891	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD14;SIRPB1
Diaphyseal medullary stenosis-bone malignancy syndrome ORPHA:85182	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDKN2B;SUGT1
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;VWA5B2
Dicarboxylic aminoaciduria ORPHA:2195	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;SYT7
Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome ORPHA:404437	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	WDR6;RRP9
Dihydropyrimidinuria ORPHA:38874	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Distal 17p13.3 microdeletion syndrome ORPHA:261257	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ACOT7;PTGES3
Distal arthrogryposis type 5D ORPHA:329457	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;CKB
Distal monosomy 12p ORPHA:280325	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;DIXDC1
Distal myopathy with anterior tibial onset ORPHA:178400	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDA;CD14
Dopamine beta-hydroxylase deficiency ORPHA:230	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CLSTN3;SPOCK2
Dyggve-Melchior-Clausen disease ORPHA:239	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;TRIM13
Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDA;CD14
Dyssegmental dysplasia, Silverman-Handmaker type ORPHA:1865	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;TNKS1BP1
Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;TNKS1BP1
EVEN-plus syndrome ORPHA:496751	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SYNCRIP;MRPL19
Early-onset generalized limb-onset dystonia ORPHA:256	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;MTHFS
Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;OIP5
Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome ORPHA:352654	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TUBB3;NES
Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome ORPHA:505237	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SYNCRIP;MRPL19
East Texas bleeding disorder ORPHA:391320	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	VNN1;CD14
Ectodermal dysplasia-skin fragility syndrome ORPHA:158668	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;CDH3
Enamel-renal syndrome ORPHA:1031	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPAR6;CD14
Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Epidermolytic palmoplantar keratoderma ORPHA:2199	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Episodic ataxia type 6 ORPHA:209967	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SLC25A27;DOCK4
Erythrocyte galactose epimerase deficiency ORPHA:308473	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GDF15;TLCD1
Estrogen resistance syndrome ORPHA:785	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SNX29;ABCG1
FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;WARS2
FG syndrome type 1 ORPHA:93932	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DIDO1;SEC16A
Fabry disease ORPHA:324	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	EIF4A3;PPIF
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion ORPHA:284169	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation ORPHA:466950	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Familial apolipoprotein A5 deficiency ORPHA:530849	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Familial atrial myxoma ORPHA:615	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;CHM
Familial cylindromatosis ORPHA:211	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Familial dyskinesia and facial myokymia ORPHA:324588	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RGS11;SYT7
Familial generalized lentiginosis ORPHA:231040	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;CDC42BPB
Familial multiple nevi flammei ORPHA:624	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KCTD12;ITM2B
Familial multiple trichoepithelioma ORPHA:867	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;NEURL3
Familial progressive hyper- and hypopigmentation ORPHA:280628	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;CDC42BPB
Familial progressive hyperpigmentation ORPHA:79146	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;CDC42BPB
Familial schizencephaly ORPHA:481986	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Fanconi-Bickel syndrome ORPHA:2088	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DIXDC1;SYNPO
Fetal Gaucher disease ORPHA:85212	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Fibronectin glomerulopathy ORPHA:84090	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;SERPINH1
Fleck corneal dystrophy ORPHA:98970	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome ORPHA:397618	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	VWA5B2;SYT7
Fragile X syndrome ORPHA:908	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Fragile X-associated tremor/ataxia syndrome ORPHA:93256	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Fraser syndrome ORPHA:2052	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;CDH3
Fried syndrome ORPHA:85335	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMEM170B;MAPRE2
Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;HOXB13
GM2 gangliosidosis, AB variant ORPHA:309246	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DHRS9;IFI30
Gabriele-de Vries syndrome ORPHA:506358	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SYNCRIP;CTCF
Gaucher disease type 2 ORPHA:77260	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Gaucher disease type 3 ORPHA:77261	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Generalized galactose epimerase deficiency ORPHA:308487	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GDF15;TLCD1
Genetic transient congenital hypothyroidism ORPHA:226316	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FAM83F;GCNT3
Germinoma of the central nervous system ORPHA:91352	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome ORPHA:404476	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Glutaric acidemia type 3 ORPHA:35706	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DEPDC7;SERPINH1
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	WDR6;REEP6
Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency ORPHA:284435	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PSIP1;NAE1
Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LMF2;PDLIM7
Glycogen storage disease due to muscle beta-enolase deficiency ORPHA:99849	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCAP;COQ10A
Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;NES
Glycogen storage disease due to phosphoglycerate mutase deficiency ORPHA:97234	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEMA6C;TCAP
Greenberg dysplasia ORPHA:1426	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ERI1;NUP50
Growth delay due to insulin-like growth factor I resistance ORPHA:73273	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;CDC42BPB
Guanidinoacetate methyltransferase deficiency ORPHA:382	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ECI2;REEP6
Gynandroblastoma ORPHA:99914	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
H syndrome ORPHA:168569	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STARD3;TCIRG1
HANAC syndrome ORPHA:73229	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
HNRNPDL-related  limb-girdle muscular dystrophy D3 ORPHA:55596	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
HSD10 disease, atypical type ORPHA:85295	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL54;RRP9
HSD10 disease, infantile type ORPHA:391428	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL54;RRP9
HSD10 disease, neonatal type ORPHA:391457	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL54;RRP9
HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;AHNAK2
Hawkinsinuria ORPHA:2118	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Helicoid peripapillary chorioretinal degeneration ORPHA:86813	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
Hemochromatosis type 3 ORPHA:225123	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C17ORF99;AKR1C4
Hemolytic anemia due to glucophosphate isomerase deficiency ORPHA:712	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ACOT7;PPFIA3
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency ORPHA:35120	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RIOK3;NMI
Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TRIM15;SERPINA6
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 ORPHA:137681	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PNPT1;MRPL19
Hepatoerythropoietic porphyria ORPHA:95159	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMED1;MRPL54
Hereditary angioedema type 1 ORPHA:100050	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MAFB;CD14
Hereditary angioedema type 2 ORPHA:100051	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MAFB;CD14
Hereditary central diabetes insipidus ORPHA:30925	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;RASGRP2
Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARHGAP11B;NDC80
Hereditary fructose intolerance ORPHA:469	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;CLDN2
Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RHPN2;CLDN2
Hereditary motor and sensory neuropathy type 5 ORPHA:64751	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FXR2;TAOK2
Hereditary neuroendocrine tumor of small intestine ORPHA:456333	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUP50;ZBTB33
Hereditary papillary renal cell carcinoma ORPHA:47044	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;ARHGAP29
Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PLK4;NDC80
Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Hermansky-Pudlak syndrome with neutropenia ORPHA:183678	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;ERI1
Histidinemia ORPHA:2157	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;SIRPB1
Hot water reflex epilepsy ORPHA:166412	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;SYT7
Huriez syndrome ORPHA:384	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
Hyaluronidase deficiency ORPHA:67041	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	EXOC3L4;SERPINA6
Hydranencephaly ORPHA:2177	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;ADA
Hyper-IgM syndrome type 3 ORPHA:101090	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;IFI30
Hyperlipidemia due to hepatic triacylglycerol lipase deficiency ORPHA:140905	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	VNN1;AKR1C4
Hyperparathyroidism-jaw tumor syndrome ORPHA:99880	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;CHM
Hyperprolinemia type 1 ORPHA:419	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TPPP;RALGPS1
Hypertryptophanemia ORPHA:2224	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Hyperzincemia and hypercalprotectinemia ORPHA:251523	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KCNE3;ITM2B
Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;ARHGAP29
Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome ORPHA:2250	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;STK17B
IRIDA syndrome ORPHA:209981	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement ORPHA:457375	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL54;RRP9
Ichthyosis follicularis-alopecia-photophobia syndrome ORPHA:2273	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;MRPL19
Infantile hypophosphatasia ORPHA:247651	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Infantile systemic hyalinosis ORPHA:2176	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;SH2B3
Infantile-onset periodic fever-panniculitis-dermatosis syndrome ORPHA:500062	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;NUP50
Intellectual disability syndrome due to a DYRK1A point mutation ORPHA:464311	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome ORPHA:529965	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome ORPHA:329224	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PITPNM1;IQSEC1
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency ORPHA:404440	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;UBAP2L
Intellectual disability-hyperkinetic movement-truncal ataxia syndrome ORPHA:369847	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMED1;LMF2
Interstitial lung disease due to SP-C deficiency ORPHA:440392	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GGTLC1;TPPP
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;AHNAK2
Isolated congenital adermatoglyphia ORPHA:289465	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
Isolated generalized anhidrosis with normal sweat glands ORPHA:468666	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Isolated hyperchlorhidrosis ORPHA:542657	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;AHNAK2
Isolated osteopoikilosis ORPHA:166119	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Isolated sedoheptulokinase deficiency ORPHA:440713	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;REEP6
Isolated sulfite oxidase deficiency ORPHA:99731	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;SLC46A1
Isovaleric acidemia ORPHA:33	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMEM129;WDR6
Jalili syndrome ORPHA:1873	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC16A;TAOK2
Juvenile hyaline fibromatosis ORPHA:2028	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;SH2B3
Keratolytic winter erythema ORPHA:50943	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD14;NDRG1
Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;FRY
Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;FRY
Laryngo-onycho-cutaneous syndrome ORPHA:2407	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;AHNAK2
Lathosterolosis ORPHA:46059	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;SPIN1
Lenz-Majewski hyperostotic dwarfism ORPHA:2658	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;RRP9
Leukocyte adhesion deficiency type I ORPHA:99842	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Leukocyte adhesion deficiency type III ORPHA:99844	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Lhermitte-Duclos disease ORPHA:65285	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Lipoid proteinosis ORPHA:530	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;TRIP10
Lissencephaly due to TUBA1A mutation ORPHA:171680	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MLLT11;PNMA1
Lysinuric protein intolerance ORPHA:470	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KCNE3;CD14
MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPON2;SNX18
MORM syndrome ORPHA:75858	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ACAP3;ZNF598
MRCS syndrome ORPHA:263347	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
MUTYH-related attenuated familial adenomatous polyposis ORPHA:247798	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;RRP9
Malignant Sertoli-Leydig cell tumor of the ovary ORPHA:99916	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Mandibulofacial dysostosis-microcephaly syndrome ORPHA:79113	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	EIF4A3;ZWINT
Marfan syndrome type 2 ORPHA:284973	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCIRG1;ITM2B
Martinique crinkled retinal pigment epitheliopathy ORPHA:466718	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PLIN3;TCIRG1
Medium chain acyl-CoA dehydrogenase deficiency ORPHA:42	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;CETN3
Melorheostosis with osteopoikilosis ORPHA:1879	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TP53I3;GDF15
Methylcobalamin deficiency type cblE ORPHA:2169	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;TADA1
Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DAZAP2;ITM2B
Microcephaly-capillary malformation syndrome ORPHA:294016	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTGES3;MRPL19
Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PLK4;NDC80
Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome ORPHA:457284	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARMC6;WDR6
Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome ORPHA:423306	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	WDR6;RRP9
Microcystic stromal tumor ORPHA:569248	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPIN1;TNKS1BP1
Microphthalmia with brain and digit anomalies ORPHA:139471	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;SERPINH1
Microtia ORPHA:83463	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;TNFRSF10B
Miyoshi myopathy ORPHA:45448	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDA;CD14
Monilethrix ORPHA:573	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;PPP1R13L
Monoamine oxidase A deficiency ORPHA:3057	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;SYT7
Monocytopenia with susceptibility to infections ORPHA:228423	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	GAS2L1;PDLIM7
Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome ORPHA:280679	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;NAE1
Mucolipidosis type II ORPHA:576	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Mucolipidosis type III alpha/beta ORPHA:423461	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NME6;ZNF689
Multiple mitochondrial dysfunctions syndrome type 4 ORPHA:457406	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MTHFS;RBX1
Multiple mitochondrial dysfunctions syndrome type 6 ORPHA:569290	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NSA2;NAE1
Multiple paragangliomas associated with polycythemia ORPHA:324299	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;SYNPO
Multiple symmetric lipomatosis ORPHA:2398	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FXR2;TAOK2
NDE1-related microhydranencephaly ORPHA:443162	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;ADA
NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AHNAK2;ARHGAP29
NON RARE IN EUROPE: Berger disease ORPHA:34145	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MAFB;RASA4
NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;VASN
NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
NON RARE IN EUROPE: Parkinson disease ORPHA:319705	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Nasopharyngeal carcinoma ORPHA:150	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ADAM8;OASL
Native American myopathy ORPHA:168572	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;SH2B2
Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect ORPHA:466784	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	EMG1;PSTK
Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion ORPHA:363700	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPAG9;PREPL
Neurofibromatosis type 2 ORPHA:637	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TUBB3;AHNAK2
Neurological conditions associated with aminoacylase 1 deficiency ORPHA:137754	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	REEP6;TLCD1
Niemann-Pick disease type A ORPHA:77292	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Niemann-Pick disease type B ORPHA:77293	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATP6V0D1;LMF2
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARID3B;CBL
OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;SYT7
Ocular albinism ORPHA:284804	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TAOK2;ZNF598
Oculoauricular syndrome, Schorderet type ORPHA:157962	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;CKB
Oculocerebrofacial syndrome, Kaufman type ORPHA:2707	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SNX29;PLEKHM1
Oculodentodigital dysplasia ORPHA:2710	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Oculopharyngeal muscular dystrophy ORPHA:270	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ANP32B;ZNF598
Odontohypophosphatasia ORPHA:247685	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Oligodontia-cancer predisposition syndrome ORPHA:300576	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEMA6C;RALGPS1
Optic atrophy-intellectual disability syndrome ORPHA:401777	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Oral-facial-digital syndrome with short stature and brachymesophalangy ORPHA:508501	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	UBE2Q2;CETN3
Osteofibrous dysplasia ORPHA:488265	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;ARHGAP29
Osteopathia striata-cranial sclerosis syndrome ORPHA:2780	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MDC1;ZBTB5
Osteopetrosis with renal tubular acidosis ORPHA:2785	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DHRS9;CD14
PDE4D haploinsufficiency syndrome ORPHA:439822	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPOCK2;LYST
PLIN1-related familial partial lipodystrophy ORPHA:280356	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SLC25A27;AOC3
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;MBNL2
Palmoplantar keratoderma, Nagashima type ORPHA:140966	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;AHNAK2
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;SERPINH1
Pancytopenia due to IKZF1 mutations ORPHA:317473	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Parathyroid carcinoma ORPHA:143	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;CHM
Peeling skin syndrome type B ORPHA:263553	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGFBP1;KLK8
Perinatal lethal hypophosphatasia ORPHA:247623	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMEM45B;VNN1
Phakomatosis pigmentokeratotica ORPHA:2874	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;ZNF598
Phosphoserine aminotransferase deficiency, infantile/juvenile form ORPHA:284417	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;ACOT7
Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;CDC42BPB
Pilomatrixoma ORPHA:91414	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPIN1;TNKS1BP1
Pleuropulmonary blastoma familial tumor susceptibility syndrome ORPHA:284343	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;HERC1
Polycythemia vera ORPHA:729	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LYST;SIRPB1
Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Pontocerebellar hypoplasia type 3 ORPHA:97249	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NOS1AP;SYT7
Pontocerebellar hypoplasia type 7 ORPHA:284339	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;RRP9
Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;TCIRG1
Prenatal benign hypophosphatasia ORPHA:247638	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AOC3;AATK
Primary ciliary dyskinesia-retinitis pigmentosa syndrome ORPHA:247522	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	USP16;SCAF11
Primary dystonia, DYT6 type ORPHA:98806	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ZNF830;METTL18
Primary familial polycythemia ORPHA:90042	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCND3;YIF1B
Progressive encephalopathy with leukodystrophy due to DECR deficiency ORPHA:431361	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;MRPL19
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome ORPHA:477814	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC16A;ANP32B
Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;SYT7
Proteus-like syndrome ORPHA:2969	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Pseudo-von Willebrand disease ORPHA:52530	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ATG16L2;ABCA7
Pseudohypoaldosteronism type 2E ORPHA:300530	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SYNCRIP;BCLAF1
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome ORPHA:505242	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;SPIN1
Pulmonary alveolar microlithiasis ORPHA:60025	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FAM83F;CDH1
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Pyridoxal phosphate-responsive seizures ORPHA:79096	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RWDD2B;MRPL19
REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	C11ORF52;GDF15
RERE-related neurodevelopmental syndrome ORPHA:494344	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MIDN;IQSEC1
RFT1-CDG ORPHA:244310	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;EMG1
Recessive X-linked ichthyosis ORPHA:461	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MBNL2;SYNPO
Refractory anemia ORPHA:98826	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;LYST
Refractory anemia with excess blasts ORPHA:86839	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;LYST
Regressive spondylometaphyseal dysplasia ORPHA:448267	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ERI1;NUP50
Renal coloboma syndrome ORPHA:1475	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BRSK2;VWA5B2
Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPON2;CD52
Reticular dysgenesis ORPHA:33355	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	OIP5;ZWINT
Reticular dystrophy of the retinal pigment epithelium ORPHA:99002	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPIN1;ZBTB33
Reticulate acropigmentation of Kitamura ORPHA:178307	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;CHM
Retinal arterial tortuosity ORPHA:75326	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Rett syndrome ORPHA:778	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;IQSEC1
Reynolds syndrome ORPHA:779	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ERI1;NUP50
Ribose-5-P isomerase deficiency ORPHA:440706	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;ANP32B
Roberts syndrome ORPHA:3103	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNA2;NDC80
Rubinstein-Taybi syndrome due to 16p13.3 microdeletion ORPHA:353281	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	IQSEC1;CBL
Rubinstein-Taybi syndrome due to CREBBP mutations ORPHA:353277	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	IQSEC1;CBL
SIX2-related frontonasal dysplasia ORPHA:488437	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:157965	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LMF2;PDLIM7
SLC39A8-CDG ORPHA:468699	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NMI;IFI30
SMARCA4-deficient sarcoma of thorax ORPHA:466962	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MDC1;UBAP2L
SPONASTRIME dysplasia ORPHA:93357	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CENPA;ZWINT
STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome ORPHA:502434	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Sanfilippo syndrome type C ORPHA:79271	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MAFB;ITM2B
Sanjad-Sakati syndrome ORPHA:2323	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CCNB1;OIP5
Schwartz-Jampel syndrome ORPHA:800	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;TNKS1BP1
Scott syndrome ORPHA:806	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SEC23A;TRAM2
Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome ORPHA:137608	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	STK17B;LYST
Severe combined immunodeficiency due to LCK deficiency ORPHA:280142	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
Severe early-onset axonal neuropathy due to MFN2 deficiency ORPHA:90118	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FXR2;TAOK2
Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome ORPHA:467176	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	COX19;ZNF830
Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPIN1;TNKS1BP1
Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;MBNL2
Severe neonatal-onset encephalopathy with microcephaly ORPHA:209370	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;IQSEC1
Short rib-polydactyly syndrome, Saldino-Noonan type ORPHA:93270	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;DIXDC1
Short stature due to growth hormone qualitative anomaly ORPHA:629	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;RASGRP2
Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	DDX17;DIDO1
Small cell carcinoma of the ovary ORPHA:370396	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MDC1;UBAP2L
Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SMYD5;RRP9
Spinocerebellar ataxia type 15/16 ORPHA:98769	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;LYST
Spinocerebellar ataxia type 17 ORPHA:98759	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TOE1;ZNF830
Spinocerebellar ataxia type 29 ORPHA:208513	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;LYST
Spinocerebellar ataxia type 36 ORPHA:276198	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ZWINT;RRP9
Spinocerebellar ataxia type 43 ORPHA:497764	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SPON2;SNX18
Spinocerebellar ataxia type 7 ORPHA:94147	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SCAF11;LYST
Spondyloenchondrodysplasia ORPHA:1855	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;IFI30
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MICAL2;PLIN3
Stuve-Wiedemann syndrome ORPHA:3206	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Steel syndrome ORPHA:438117	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Sturge-Weber syndrome ORPHA:3205	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KCTD12;ITM2B
Sudden infant death-dysgenesis of the testes syndrome ORPHA:168593	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;SPIN1
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C ORPHA:308400	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;SYT7
Susceptibility to localized juvenile periodontitis ORPHA:447740	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD14;SIRPB1
Symptomatic form of fragile X syndrome in female carrier ORPHA:449291	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Syndactyly type 3 ORPHA:93404	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	NUAK1;NES
Syndactyly type 5 ORPHA:93406	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
Syndromic recessive X-linked ichthyosis ORPHA:281090	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MBNL2;SYNPO
Synpolydactyly type 1 ORPHA:295195	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD52;CORO1A
TARP syndrome ORPHA:2886	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;ZNF598
TRAPPC11-related  limb-girdle muscular dystrophy R18 ORPHA:369840	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
TSH-secreting pituitary adenoma ORPHA:91347	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SH2D3C;RASGRP2
Thiamine-responsive megaloblastic anemia syndrome ORPHA:49827	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;SLC19A2
Thrombocythemia with distal limb defects ORPHA:329319	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINA6;SYT7
Toriello-Carey syndrome ORPHA:3338	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Toriello-Lacassie-Droste syndrome ORPHA:3339	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
Trisomy Xq28 ORPHA:1762	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;IQSEC1
Tubulinopathy-associated dysgyria ORPHA:467166	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TUBB3;NES
Tyrosinemia type 2 ORPHA:28378	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Tyrosinemia type 3 ORPHA:69723	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Ulnar-mammary syndrome ORPHA:3138	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;P4HA2
Urocanic aciduria ORPHA:210128	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	AKR1C4;SERPINA6
Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
VACTERL/VATER association ORPHA:887	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
Vein of Galen aneurysmal malformation ORPHA:1053	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	SERPINH1;TNKS1BP1
Ventriculomegaly-cystic kidney disease ORPHA:443988	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	APC2;RIMS3
Vitamin B12-responsive methylmalonic acidemia type cblA ORPHA:79310	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	LPAR6;ZNF277
Von Hippel-Lindau disease ORPHA:892	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ARHGAP11B;CBL
WARS2-related combined oxidative phosphorylation defect ORPHA:572798	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	MRPL19;WARS2
Wagner disease ORPHA:898	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ZNF516;KCTD12
Werner syndrome ORPHA:902	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
Wolman disease ORPHA:75233	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CD14;IFI30
Woodhouse-Sakati syndrome ORPHA:3464	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TCERG1;BCLAF1
Woolly hair nevus ORPHA:79414	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RPUSD1;ZNF598
Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	P4HA2;SERPINH1
X-linked Alport syndrome ORPHA:88917	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PTPRU;NUAK1
X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	FGD3;STK17B
X-linked dystonia-parkinsonism ORPHA:53351	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	PREPL;NUAK1
X-linked intellectual disability, Nascimento type ORPHA:163956	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	RAB9A;ATG4A
X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMEM170B;MAPRE2
X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome ORPHA:480907	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	HERC1;SCAF11
X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	TMEM170B;MAPRE2
X-linked intellectual disability-hypotonia-movement disorder syndrome ORPHA:457260	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;ZBTB33
X-linked intellectual disability-psychosis-macroorchidism syndrome ORPHA:3077	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	KIAA0513;IQSEC1
Xeroderma pigmentosum variant ORPHA:90342	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	ERI1;NDC80
Xq27.3q28 duplication syndrome ORPHA:261483	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	BCLAF1;SCAF11
Zygodactyly type 3 ORPHA:295191	2/101	0.6000814187672743	0.8922466888454011	0	0	0.9949494949494949	0.5081106929305726	CDX2;HOXB13
17p13.3 microduplication syndrome ORPHA:217385	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PREPL;SPIN1
17q24.2 microdeletion syndrome ORPHA:529962	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TCERG1;BCLAF1
3-methylglutaconic aciduria type 3 ORPHA:67047	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	RDH13;SLC25A44
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency ORPHA:443087	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AKR1C4;SERPINA6
Acquired idiopathic sideroblastic anemia ORPHA:75564	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	HERC1;SCAF11
Acral peeling skin syndrome ORPHA:263534	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	DHRS9;NMI
Acrodermatitis continua of Hallopeau ORPHA:163931	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Acrodysostosis ORPHA:950	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MBNL2;LYST
Acrodysostosis with multiple hormone resistance ORPHA:280651	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MBNL2;LYST
Acromicric dysplasia ORPHA:969	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SYNPO;VASN
Acute myeloblastic leukemia without maturation ORPHA:98833	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PLK4;SYNCRIP
Amelocerebrohypohidrotic syndrome ORPHA:1946	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FBXO44;BAIAP3
Anaplastic oligodendroglioma ORPHA:251630	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TADA1;OIP5
Atrial standstill ORPHA:1344	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SEMA6C;TCAP
Autosomal recessive infantile hypercalcemia ORPHA:300547	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;CLDN2
Autosomal recessive spastic paraplegia type 23 ORPHA:101003	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SPAG9;HERC1
Axenfeld anomaly ORPHA:98978	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PTPRU;SERPINH1
Axenfeld-Rieger syndrome ORPHA:782	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PTPRU;SERPINH1
Caudal regression sequence ORPHA:3027	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CCDC102A;ZWINT
Cerebral sinovenous thrombosis ORPHA:329217	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AKR1C4;SERPINA6
Cerebrofacioarticular syndrome ORPHA:314679	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Cholesterol-ester transfer protein deficiency ORPHA:79506	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AKR1C4;SERPINA6
Classic maple syrup urine disease ORPHA:268145	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MRPL19;DIS3L
Cole-Carpenter syndrome ORPHA:2050	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SERPINH1;TRAM2
Congenital diaphragmatic hernia ORPHA:2140	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;ARHGAP29
Congenital ptosis ORPHA:91411	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	DIXDC1;NES
Congenital sodium diarrhea ORPHA:103908	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOXA1;ATP2C2
Constitutional mismatch repair deficiency syndrome ORPHA:252202	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PLK4;CCNA2
Desmoid tumor ORPHA:873	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SPAG9;PREPL
Diffuse panbronchiolitis ORPHA:171700	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CDH1;ATP2C2
Distal hereditary motor neuropathy type 7 ORPHA:139589	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CTIF;PRRT2
Duchenne muscular dystrophy ORPHA:98896	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SH3PXD2A;SYNPO
Familial calcium pyrophosphate deposition ORPHA:1416	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SH3PXD2A;SYNPO
Fibrochondrogenesis ORPHA:2021	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SEMA6C;NES
Generalized pustular psoriasis ORPHA:247353	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Griscelli syndrome type 3 ORPHA:79478	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AHNAK2;ARHGAP29
HELLP syndrome ORPHA:244242	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MBNL2;DHRS3
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	ATG16L2;TUBGCP6
Hereditary renal hypouricemia ORPHA:94088	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	VNN1;CD14
Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SERPINH1;PDLIM7
Horizontal gaze palsy with progressive scoliosis ORPHA:2744	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	APC2;PRRT2
Hypocalcemic vitamin D-dependent rickets ORPHA:289157	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TOE1;ZWINT
Hypoplastic tibiae-postaxial polydactyly syndrome ORPHA:3332	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOS1AP;RHPN2
Hypotrichosis simplex of the scalp ORPHA:90368	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Infantile convulsions and choreoathetosis ORPHA:31709	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	BRSK2;PRRT2
Intermittent hydrarthrosis ORPHA:329967	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CD14;SIRPB1
Intermittent maple syrup urine disease ORPHA:268173	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MRPL19;DIS3L
Isolated anencephaly ORPHA:563609	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SEMA6C;RALGPS1
Isolated exencephaly ORPHA:563612	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SEMA6C;RALGPS1
Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Isolated growth hormone deficiency type II ORPHA:231679	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CD52;RASGRP2
Jervell and Lange-Nielsen syndrome ORPHA:90647	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	KCNE3;SIRPB1
Juvenile Paget disease ORPHA:2801	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	P4HA2;TNFRSF11A
Kabuki syndrome ORPHA:2322	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	DDX17;DIDO1
Lacrimoauriculodentodigital syndrome ORPHA:2363	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PTPRU;SYT7
Lafora disease ORPHA:501	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CYP2U1;TCAP
Maffucci syndrome ORPHA:163634	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	C11ORF52;REEP6
Malignant peripheral nerve sheath tumor ORPHA:3148	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;SH3PXD2A
Marie Unna hereditary hypotrichosis ORPHA:444	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	ENTPD2;TRIM15
Meesmann corneal dystrophy ORPHA:98954	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Mitochondrial myopathy and sideroblastic anemia ORPHA:2598	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TOE1;RRP9
Moebius syndrome ORPHA:570	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SPAG9;HERC1
Moyamoya disease ORPHA:2573	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SNX29;LPAR6
Myxoid/round cell liposarcoma ORPHA:99967	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NXF1;ANP32B
NON RARE IN EUROPE: Hyperlipoproteinemia type 4 ORPHA:413	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AKR1C4;SERPINA6
NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CDH3;CDH1
NON RARE IN EUROPE: Melanoma ORPHA:411533	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	BCLAF1;ZBTB33
Neonatal inflammatory skin and bowel disease ORPHA:294023	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AHNAK2;ARHGAP29
Nijmegen breakage syndrome-like disorder ORPHA:240760	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TCERG1;PHF14
Non-seminomatous germ cell tumor of testis ORPHA:363494	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Null pituitary adenoma ORPHA:314790	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	RPUSD1;LMF2
Oligodendroglioma ORPHA:251627	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TADA1;OIP5
Pachydermoperiostosis ORPHA:2796	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	C11ORF52;CDH1
Parkinson-dementia complex of Guam ORPHA:90020	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CETN3;NAE1
Partial hydatidiform mole ORPHA:254693	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	ARID3B;RASGRP2
Paternal uniparental disomy of chromosome 6 ORPHA:96191	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	ITPRIP;KCTD12
Pfeiffer syndrome type 1 ORPHA:93258	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Phakomatosis cesioflammea ORPHA:79483	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;CDC42BPB
Pituitary gigantism ORPHA:99725	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	RPUSD1;LMF2
Polydactyly of a triphalangeal thumb ORPHA:93336	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOS1AP;RHPN2
Postaxial polydactyly type B ORPHA:93335	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SERPINH1;NES
Prenatal-onset spinal muscular atrophy with congenital bone fractures ORPHA:486811	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PIGB;RBM7
Progressive cerebello-cerebral atrophy ORPHA:247198	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	HERC1;SCAF11
Pseudohypoparathyroidism type 1B ORPHA:94089	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SGSM2;RAB11FIP3
Pure hair and nail ectodermal dysplasia ORPHA:69084	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Pustulosis palmaris et plantaris ORPHA:163927	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	FGFBP1;KLK8
Radial hemimelia ORPHA:93321	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOS1AP;RHPN2
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	P4HA2;ARHGAP29
Renal-hepatic-pancreatic dysplasia ORPHA:294415	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SCAF11;CLK3
Rieger anomaly ORPHA:91483	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PTPRU;SERPINH1
Sclerosteosis ORPHA:3152	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Short rib-polydactyly syndrome, Beemer-Langer type ORPHA:93268	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PREPL;CCP110
Silent pituitary adenoma ORPHA:314786	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	RPUSD1;LMF2
Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;NES
Smith-McCort dysplasia ORPHA:178355	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	TRIM13;ZNF277
Spondylometaphyseal dysplasia, 'corner fracture' type ORPHA:93315	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SERPINH1;NES
Stevens-Johnson syndrome ORPHA:36426	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CD52;CORO1A
Syndactyly type 4 ORPHA:93405	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOS1AP;RHPN2
Tessier number 7 facial cleft ORPHA:141276	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	SPAG9;HERC1
Tetraamelia-multiple malformations syndrome ORPHA:3301	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NUAK1;TUBB3
Thiamine-responsive maple syrup urine disease ORPHA:268184	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MRPL19;DIS3L
Trichorhinophalangeal syndrome type 2 ORPHA:502	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	AHNAK2;ARHGAP29
Triphalangeal thumb-polysyndactyly syndrome ORPHA:2950	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	NOS1AP;RHPN2
Vogt-Koyanagi-Harada disease ORPHA:3437	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	STK17B;NMI
Wiskott-Aldrich syndrome ORPHA:906	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	CD52;CORO1A
X-linked hypohidrotic ectodermal dysplasia ORPHA:181	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	PTPRU;NUAK1
X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328	2/102	0.6054537045303646	0.8922466888454011	0	0	0.9849494949494949	0.4942251772217619	MBNL2;ITM2B
Activated PI3K-delta syndrome ORPHA:397596	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	STK17B;LYST
Adult-onset myasthenia gravis ORPHA:391490	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	CD52;TNFRSF11A
Atypical hypotonia-cystinuria syndrome ORPHA:238523	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PREPL;SUGT1
Auriculocondylar syndrome ORPHA:137888	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	P4HA2;ARHGAP29
Autosomal dominant secondary polycythemia ORPHA:247511	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SYNPO;NDRG1
BOR syndrome ORPHA:107	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PTPRU;SERPINH1
Brachydactyly type A2 ORPHA:93396	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	NUAK1;P4HA2
Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PTPRU;P4HA2
Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PTPRU;SYT7
Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	VNN1;ATG16L2
Hereditary elliptocytosis ORPHA:288	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SH2D3C;RASGRP2
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	STK17B;ARID5A
Immunodeficiency by defective expression of MHC class II ORPHA:572	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	TOE1;CORO1A
Immunodeficiency due to a late component of complement deficiency ORPHA:169150	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	AKR1C4;SERPINA6
Isolated aniridia ORPHA:250923	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PREPL;NUAK1
Isolated polycystic liver disease ORPHA:2924	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	TNKS1BP1;UBAP2L
Leber plus disease ORPHA:99718	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	MIDN;ANP32B
Lujan-Fryns syndrome ORPHA:776	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	MDC1;UBAP2L
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SH3PXD2A;SNPH
Melanoma of soft tissue ORPHA:97338	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	BCLAF1;NUP50
Miller-Dieker syndrome ORPHA:531	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	CTIF;SPIN1
Milroy disease ORPHA:79452	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SERPINH1;TNKS1BP1
Multiple synostoses syndrome ORPHA:3237	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SNPH;TSPAN5
NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	NUAK1;NES
Partial atrioventricular septal defect ORPHA:1330	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	PTPRU;P4HA2
Potocki-Shaffer syndrome ORPHA:52022	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	CYTH3;CTIF
Proximal spinal muscular atrophy type 1 ORPHA:83330	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	TCERG1;BCLAF1
Proximal spinal muscular atrophy type 2 ORPHA:83418	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	TCERG1;BCLAF1
Proximal spinal muscular atrophy type 3 ORPHA:83419	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	TCERG1;BCLAF1
Triple A syndrome ORPHA:869	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	SMYD5;RRP9
Unverricht-Lundborg disease ORPHA:308	2/103	0.610771206078591	0.8922466888454011	0	0	0.9751475147514751	0.4807797564902114	AHNAK2;CDC42BPB
2p21 microdeletion syndrome ORPHA:163693	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PREPL;SUGT1
Autosomal dominant Robinow syndrome ORPHA:3107	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	SERPINH1;TNKS1BP1
Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	ADAM8;OASL
Coloboma of eye lens ORPHA:98943	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PTPRU;CKB
Coloboma of eyelid ORPHA:98946	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PTPRU;CKB
Coloboma of macula ORPHA:98945	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PTPRU;CKB
Coloboma of optic disc ORPHA:98947	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PTPRU;CKB
Dejerine-Sottas syndrome ORPHA:64748	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	VAT1;MAPKAPK2
Epithelioid hemangioendothelioma ORPHA:157791	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	NUAK1;CDC42BPB
Giant cell arteritis ORPHA:397	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	CD52;P4HA2
Hereditary sensory and autonomic neuropathy type 2 ORPHA:970	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	SPAG9;PREPL
Homozygous familial hypercholesterolemia ORPHA:391665	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	TRIM15;SERPINA6
Inherited acute myeloid leukemia ORPHA:319465	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	MAFB;KLF4
Intermediate maple syrup urine disease ORPHA:268162	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	DIS3L;OMA1
Intrahepatic cholestasis of pregnancy ORPHA:69665	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	AKR1C4;SERPINA6
Isolated brachycephaly ORPHA:35099	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	DIXDC1;NES
Isolated plagiocephaly ORPHA:35098	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	DIXDC1;NES
NON RARE IN EUROPE: Alzheimer disease ORPHA:238616	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	ABCA7;CD14
Narcolepsy type 2 ORPHA:83465	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	CD52;CORO1A
Primary Fanconi renotubular syndrome ORPHA:3337	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	AKR1C4;SERPINA6
Primary myelofibrosis ORPHA:824	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	LYST;SIRPB1
Short rib-polydactyly syndrome, Verma-Naumoff type ORPHA:93271	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PREPL;DIXDC1
Weaver syndrome ORPHA:3447	2/104	0.6160339707718528	0.8922466888454011	0	0	0.9655377302436126	0.46775781379675785	PLK4;NDC80
46,XX testicular disorder of sex development ORPHA:393	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	TUBB3;NES
Athyreosis ORPHA:95713	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	FGFBP1;AHNAK2
Autosomal dominant macrothrombocytopenia ORPHA:140957	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	RNF24;SH2B3
Congenital non-bullous ichthyosiform erythroderma ORPHA:79394	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	FGFBP1;KLK8
Cornelia de Lange syndrome ORPHA:199	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	TCERG1;BCLAF1
Cystic fibrosis ORPHA:586	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	ATP2C2;CDC42BPB
Diffuse cutaneous systemic sclerosis ORPHA:220393	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	CD52;IFI30
Endometrial stromal sarcoma ORPHA:213711	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	IPO8;UBAP2L
Extraskeletal myxoid chondrosarcoma ORPHA:209916	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	TCERG1;UBAP2L
Facioscapulohumeral dystrophy ORPHA:269	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	NUP50;NDC80
Familial multiple meningioma ORPHA:263662	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	VAT1;TNKS1BP1
Fetal akinesia deformation sequence ORPHA:994	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	TCAP;CDH15
Hereditary hyperekplexia ORPHA:3197	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	PREPL;DIXDC1
Hyperphosphatasia-intellectual disability syndrome ORPHA:247262	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	TOE1;RRP9
Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	PLK4;CDC25C
NON RARE IN EUROPE: Ulcerative colitis ORPHA:771	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	FGD3;CD52
Posterior polymorphous corneal dystrophy ORPHA:98973	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	CDH1;ATP2C2
Usher syndrome type 2 ORPHA:231178	2/105	0.6212420657506587	0.8922466888454011	0	0	0.9561145434931843	0.45514348291625184	BRSK2;NOS1AP
Clear cell sarcoma of kidney ORPHA:457246	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	MDC1;UBAP2L
Congenital muscular dystrophy with cerebellar involvement ORPHA:370959	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	FXR2;WDR6
Hereditary late-onset Parkinson disease ORPHA:411602	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	SPAG9;IPO8
Hoyeraal-Hreidarsson syndrome ORPHA:3322	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	TOE1;RRP9
NON RARE IN EUROPE: Multiple sclerosis ORPHA:802	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	FGD3;CD52
Perrault syndrome ORPHA:2855	2/106	0.6263955772329548	0.8922466888454011	0	0	0.9468725718725719	0.44292160814775544	SMYD5;RRP9
Hereditary clear cell renal cell carcinoma ORPHA:422526	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	ATG16L2;SIRPB1
Hypotrichosis simplex ORPHA:55654	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	CDH1;LPAR6
Infantile nephronophthisis ORPHA:93591	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	TCERG1;BCLAF1
Joubert syndrome with oculorenal defect ORPHA:2318	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	DIXDC1;SPIN1
MiT family translocation renal cell carcinoma ORPHA:319308	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	UBAP2L;ZNF598
Myoclonic-astatic epilepsy ORPHA:1942	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	APC2;PRRT2
Periventricular nodular heterotopia ORPHA:98892	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	SPIN1;CDC42BPB
Semantic dementia ORPHA:100069	2/107	0.6314946094994149	0.8922466888454011	0	0	0.9378066378066378	0.43107770711105436	MAFB;ITM2B
Hirschsprung disease ORPHA:388	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	NUAK1;NES
MODY ORPHA:552	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	CDX2;VWA5B2
Mitochondrial non-syndromic sensorineural deafness ORPHA:90641	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	PTGES3;UBAP2L
Narcolepsy type 1 ORPHA:2073	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	CD52;CORO1A
Primary biliary cholangitis ORPHA:186	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	CD52;CORO1A
Senior-Loken syndrome ORPHA:3156	2/108	0.6365392842388893	0.8922466888454011	0	0	0.9289117591004383	0.41959793531268064	BCLAF1;CCP110
NON RARE IN EUROPE: Non rare thrombophilia ORPHA:64738	2/109	0.6415297399727844	0.8922466888454011	0	0	0.920183139809308	0.4084690527869331	AKR1C4;SERPINA6
Osteogenesis imperfecta type 4 ORPHA:216820	2/109	0.6415297399727844	0.8922466888454011	0	0	0.920183139809308	0.4084690527869331	SERPINH1;NES
Presynaptic congenital myasthenic syndromes ORPHA:98914	2/110	0.6464661311070917	0.8922466888454011	0	0	0.9116161616161617	0.3976783933077763	BRSK2;PRRT2
Hereditary breast and ovarian cancer syndrome ORPHA:145	2/111	0.6513486274220202	0.8922466888454011	0	0	0.9032063756834399	0.3872138348443573	PLK4;NDC80
Postsynaptic congenital myasthenic syndromes ORPHA:98913	2/111	0.6513486274220202	0.8922466888454011	0	0	0.9032063756834399	0.3872138348443573	SEMA6C;CDH15
Infantile Refsum disease ORPHA:772	2/112	0.6561774132303707	0.8922466888454011	0	0	0.8949494949494949	0.3770637722523127	SMYD5;MRPL19
Neonatal adrenoleukodystrophy ORPHA:44	2/112	0.6561774132303707	0.8922466888454011	0	0	0.8949494949494949	0.3770637722523127	SMYD5;MRPL19
Zellweger syndrome ORPHA:912	2/112	0.6561774132303707	0.8922466888454011	0	0	0.8949494949494949	0.3770637722523127	SMYD5;MRPL19
Lobar holoprosencephaly ORPHA:93924	2/113	0.6609526869872873	0.8922466888454011	0	0	0.8868413868413868	0.367217090976736	NUAK1;NES
Midline interhemispheric variant of holoprosencephaly ORPHA:93926	2/113	0.6609526869872873	0.8922466888454011	0	0	0.8868413868413868	0.367217090976736	NUAK1;NES
Septopreoptic holoprosencephaly ORPHA:280195	2/113	0.6609526869872873	0.8922466888454011	0	0	0.8868413868413868	0.367217090976736	NUAK1;NES
Bardet-Biedl syndrome ORPHA:110	2/114	0.6656746602616854	0.8922466888454011	0	0	0.8788780663780664	0.3576631431646018	PREPL;DIXDC1
Microform holoprosencephaly ORPHA:280200	2/114	0.6656746602616854	0.8922466888454011	0	0	0.8788780663780664	0.3576631431646018	NUAK1;NES
Retinitis pigmentosa ORPHA:791	3/174	0.676134628427687	0.8922466888454011	0	0	0.8630246502331779	0.33775597512426875	CCP110;REEP6;MERTK
Normosmic congenital hypogonadotropic hypogonadism ORPHA:432	2/117	0.6795230831235632	0.8922466888454011	0	0	0.8558190601668862	0.3306577397365955	BRSK2;HS6ST1
Kallmann syndrome ORPHA:478	2/120	0.6929005833865476	0.8922466888454011	0	0	0.8339325457969525	0.3059437893265808	HS6ST1;NES
Precursor B-cell acute lymphoblastic leukemia ORPHA:99860	2/121	0.6972563818666804	0.8922466888454011	0	0	0.8268822680587387	0.29817548198908816	SH2D3C;CORO1A
Williams syndrome ORPHA:904	2/124	0.7100178447350696	0.8922466888454011	0	0	0.8064249047855605	0.27617244681344877	BCL7B;ZNF598
Systemic lupus erythematosus ORPHA:536	2/128	0.726331243076191	0.8922466888454011	0	0	0.7806637806637806	0.24961654949063963	CD52;TREX1
Familial isolated dilated cardiomyopathy ORPHA:154	2/135	0.7530114823379914	0.8922466888454011	0	0	0.739310397205134	0.20972373092051347	TCAP;NES
Recurrent infections associated with rare immunoglobulin isotypes deficiency ORPHA:183675	1/91	0.8401186744431207	0.8922466888454011	0	0	0.546095717884131	0.09513649165685531	CD52
Acrofacial dysostosis, Weyers type ORPHA:952	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SH3PXD2A
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 ORPHA:98791	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	RASGRP2
Arthrogryposis-renal dysfunction-cholestasis syndrome ORPHA:2697	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	TOE1
Autosomal dominant Alport syndrome ORPHA:88918	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SYNPO
Autosomal recessive Alport syndrome ORPHA:88919	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SYNPO
Baraitser-Winter cerebrofrontofacial syndrome ORPHA:2995	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	RPUSD1
Bifunctional enzyme deficiency ORPHA:300	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	C11ORF52
C3 glomerulonephritis ORPHA:329931	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	AKR1C4
Cataract-intellectual disability-hypogonadism syndrome ORPHA:1387	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	CHM
Classical Ehlers-Danlos syndrome ORPHA:287	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SERPINH1
Combined deficiency of factor V and factor VIII ORPHA:35909	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SEC23A
De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SYNPO
Familial rhabdoid tumor ORPHA:231108	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	ZNF598
Hb Bart's hydrops fetalis ORPHA:163596	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	RASGRP2
Hemoglobin H disease ORPHA:93616	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	RASGRP2
Hemoglobin M disease ORPHA:330041	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	CD14
Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	CD14
Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	CD14
Joubert syndrome with renal defect ORPHA:220497	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	DIXDC1
Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	SERPINH1
Pleomorphic salivary gland adenoma ORPHA:454821	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	NDC80
Propionic acidemia ORPHA:35	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	MRPL19
Rh deficiency syndrome ORPHA:71275	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	C17ORF99
Sitosterolemia ORPHA:2882	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	AKR1C4
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ORPHA:169160	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	CD52
White sponge nevus ORPHA:171723	1/100	0.8666928654123558	0.8922466888454011	0	0	0.49622166246851385	0.07099473831435102	FGFBP1
15q11q13 microduplication syndrome ORPHA:238446	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
16q24.3 microdeletion syndrome ORPHA:261250	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC16A
17q21.31 microdeletion syndrome ORPHA:363958	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
2q23.1 microdeletion syndrome ORPHA:228402	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
2q32q33 microdeletion syndrome ORPHA:251019	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NOS1AP
3-methylglutaconic aciduria type 7 ORPHA:445038	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARMC6
45,X/46,XY mixed gonadal dysgenesis ORPHA:1772	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EIF1AY
46,XX ovarian dysgenesis-short stature syndrome ORPHA:444048	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
6q25 microdeletion syndrome ORPHA:251056	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
8p23.1 microdeletion syndrome ORPHA:251071	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
AApoAI amyloidosis ORPHA:93560	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
ADULT syndrome ORPHA:978	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
ALG2-CDG ORPHA:79326	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WARS2
ALG3-CDG ORPHA:79321	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RALGPS1
ATTRV122I amyloidosis ORPHA:85451	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
ATTRV30M amyloidosis ORPHA:85447	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Abetalipoproteinemia ORPHA:14	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Ablepharon macrostomia syndrome ORPHA:920	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Aceruloplasminemia ORPHA:48818	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Achondrogenesis type 1A ORPHA:93299	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Achondrogenesis type 2 ORPHA:93296	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Acrofacial dysostosis, Rodriguez type ORPHA:1788	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
Acromesomelic dysplasia, Maroteaux type ORPHA:40	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEMA6C
Action myoclonus-renal failure syndrome ORPHA:163696	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDC42BPB
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins ORPHA:217371	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TUBGCP6
Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Acute myeloid leukemia with 11q23 abnormalities ORPHA:98831	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Acute myeloid leukemia with minimal differentiation ORPHA:98832	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASGRP2
Acute undifferentiated leukemia ORPHA:98835	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Acyl-CoA dehydrogenase 9 deficiency ORPHA:99901	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Adenocarcinoma of ovary ORPHA:213504	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Adenylosuccinate lyase deficiency ORPHA:46	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	OIP5
Adult-onset autosomal recessive sideroblastic anemia ORPHA:255132	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDC34
Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SNX18
Allan-Herndon-Dudley syndrome ORPHA:59	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Angelman syndrome due to a point mutation ORPHA:411511	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Angelman syndrome due to paternal uniparental disomy of chromosome 15 ORPHA:98795	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
Aquagenic palmoplantar keratoderma ORPHA:498359	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH1
Argininemia ORPHA:90	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VNN1
Arterial tortuosity syndrome ORPHA:3342	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TOE1
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Ataxia with vitamin E deficiency ORPHA:96	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Atypical chronic myeloid leukemia ORPHA:98824	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Atypical teratoid rhabdoid tumor ORPHA:99966	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RALGPS1
Autoimmune interstitial lung disease-arthritis syndrome ORPHA:444092	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	UBAP2L
Autoimmune polyendocrinopathy type 1 ORPHA:3453	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATG16L2
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VNN1
Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANP32B
Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCNB1
Autosomal dominant Charcot-Marie-Tooth disease type 2E ORPHA:99939	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Autosomal dominant hyper-IgE syndrome ORPHA:2314	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Autosomal dominant hypophosphatemic rickets ORPHA:89937	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	LCMT2
Autosomal dominant mitochondrial myopathy with exercise intolerance ORPHA:457050	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	REEP6
Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Autosomal dominant optic atrophy plus syndrome ORPHA:1215	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Autosomal dominant spastic paraplegia type 17 ORPHA:100998	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CLU
Autosomal dominant spastic paraplegia type 42 ORPHA:171863	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Autosomal dominant spastic paraplegia type 73 ORPHA:444099	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PRRT2
Autosomal dominant spondylocostal dysostosis ORPHA:1797	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RHPN1
Autosomal dominant thrombocytopenia with platelet secretion defect ORPHA:466806	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Autosomal recessive brachyolmia ORPHA:448242	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency ORPHA:453521	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TOE1
Autosomal recessive omodysplasia ORPHA:93329	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity ORPHA:437552	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency ORPHA:420702	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency ORPHA:423384	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Autosomal recessive spastic ataxia with leukoencephalopathy ORPHA:314603	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Autosomal recessive spastic paraplegia type 18 ORPHA:209951	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TNKS1BP1
Autosomal recessive spastic paraplegia type 28 ORPHA:101008	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Autosomal recessive spastic paraplegia type 53 ORPHA:319199	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHM
Autosomal recessive spastic paraplegia type 56 ORPHA:320411	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CYP2U1
Autosomal recessive spastic paraplegia type 59 ORPHA:401795	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Autosomal recessive spastic paraplegia type 70 ORPHA:401835	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Autosomal recessive spastic paraplegia type 75 ORPHA:459056	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Autosomal spastic paraplegia type 30 ORPHA:101010	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
BNAR syndrome ORPHA:217266	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
BVES-related limb-girdle muscular dystrophy ORPHA:476084	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Barber-Say syndrome ORPHA:1231	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Becker muscular dystrophy ORPHA:98895	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Benign Samaritan congenital myopathy ORPHA:324581	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Benign paroxysmal torticollis of infancy ORPHA:71518	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
Benign recurrent intrahepatic cholestasis type 2 ORPHA:99961	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Beta-mannosidosis ORPHA:118	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Beta-thalassemia intermedia ORPHA:231222	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Beta-thalassemia major ORPHA:231214	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Bilateral parasagittal parieto-occipital polymicrogyria ORPHA:208441	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TMEM170B
Blepharophimosis-intellectual disability syndrome, SBBYS type ORPHA:3047	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Blomstrand lethal chondrodysplasia ORPHA:50945	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Borjeson-Forssman-Lehmann syndrome ORPHA:127	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PLK4
Brachydactyly-arterial hypertension syndrome ORPHA:1276	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Burkitt lymphoma ORPHA:543	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Butyrylcholinesterase deficiency ORPHA:132	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
C syndrome ORPHA:1308	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
CAD-CDG ORPHA:448010	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KIF20A
CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome ORPHA:566067	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
CHILD syndrome ORPHA:139	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
CHST3-related skeletal dysplasia ORPHA:263463	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
CINCA syndrome ORPHA:1451	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
CK syndrome ORPHA:251383	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
CLN1 disease ORPHA:228329	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	IFI30
CLN4A disease ORPHA:228340	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARMC6
CLN6 disease ORPHA:228363	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARMC6
COASY protein-associated neurodegeneration ORPHA:397725	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
COG4-CDG ORPHA:263501	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WDR6
COG5-CDG ORPHA:263487	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome ORPHA:2848	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Cardiomyopathy-hypotonia-lactic acidosis syndrome ORPHA:91130	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCNB1
Cardiospondylocarpofacial syndrome ORPHA:3238	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Carney complex-trismus-pseudocamptodactyly syndrome ORPHA:319340	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH15
Cataract-glaucoma syndrome ORPHA:162	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH15
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Catel-Manzke syndrome ORPHA:1388	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	METTL18
Central core disease ORPHA:597	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Cerebellar ataxia, Cayman type ORPHA:94122	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
Cerebrofaciothoracic dysplasia ORPHA:1394	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CETN3
Charcot-Marie-Tooth disease type 1A ORPHA:101081	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Charcot-Marie-Tooth disease type 1E ORPHA:90658	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Charcot-Marie-Tooth disease type 1F ORPHA:101085	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Charcot-Marie-Tooth disease type 2B5 ORPHA:228374	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Charcot-Marie-Tooth disease type 2R ORPHA:397968	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Charcot-Marie-Tooth disease type 4J ORPHA:139515	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TMEM170B
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency ORPHA:293955	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Childhood-onset benign chorea with striatal involvement ORPHA:494541	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome ORPHA:466921	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Childhood-onset spasticity with hyperglycinemia ORPHA:401866	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDC34
Chronic beryllium disease ORPHA:133	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Chronic neutrophilic leukemia ORPHA:86829	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome ORPHA:309854	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TRIM15
Classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325524	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	C17ORF99
Classic hairy cell leukemia ORPHA:58017	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Classic multiminicore myopathy ORPHA:324604	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Classic phenylketonuria ORPHA:79254	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Classic progressive supranuclear palsy syndrome ORPHA:240071	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AOC3
Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome ORPHA:444077	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SPAG9
Combined immunodeficiency due to STK4 deficiency ORPHA:314689	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	STK17B
Combined oxidative phosphorylation defect type 2 ORPHA:254920	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	OIP5
Combined oxidative phosphorylation defect type 25 ORPHA:447954	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Combined oxidative phosphorylation defect type 26 ORPHA:477684	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Combined oxidative phosphorylation defect type 29 ORPHA:478029	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Combined oxidative phosphorylation defect type 30 ORPHA:478042	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	METTL18
Combined oxidative phosphorylation defect type 39 ORPHA:565624	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Combined oxidative phosphorylation defect type 4 ORPHA:254925	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Complement component 3 deficiency ORPHA:280133	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Cone dystrophy with supernormal rod response ORPHA:209932	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP11B
Congenital alpha2-antiplasmin deficiency ORPHA:79	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Congenital alveolar capillary dysplasia ORPHA:210122	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Congenital cataract-hearing loss-severe developmental delay syndrome ORPHA:300313	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Congenital deficiency in alpha-fetoprotein ORPHA:168612	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Congenital dyserythropoietic anemia type II ORPHA:98873	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EIF4A3
Congenital factor VII deficiency ORPHA:327	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Congenital factor X deficiency ORPHA:328	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NMI
Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH3
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome ORPHA:352333	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TSPAN5
Congenital lactase deficiency ORPHA:53690	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP11B
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type ORPHA:70472	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Congenital multicore myopathy with external ophthalmoplegia ORPHA:98905	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Congenital muscular dystrophy, Fukuyama type ORPHA:272	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SPIN1
Congenital myopathy with excess of thin filaments ORPHA:98904	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Congenital myopathy with myasthenic-like onset ORPHA:424107	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Congenital myopathy with reduced type 2 muscle fibers ORPHA:544602	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH15
Congenital prekallikrein deficiency ORPHA:749	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Congenital sialidosis type 2 ORPHA:93400	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GDF15
Corpus callosum agenesis-abnormal genitalia syndrome ORPHA:2508	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome ORPHA:52055	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NSA2
Craniodiaphyseal dysplasia ORPHA:1513	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Craniosynostosis-microretrognathia-severe intellectual disability syndrome ORPHA:565858	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Crigler-Najjar syndrome type 1 ORPHA:79234	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Crigler-Najjar syndrome type 2 ORPHA:79235	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Curry-Jones syndrome ORPHA:1553	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Cyclic neutropenia ORPHA:2686	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Cystinuria type A ORPHA:93612	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GCNT3
Cystinuria type B ORPHA:93613	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
D,L-2-hydroxyglutaric aciduria ORPHA:356978	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
DDOST-CDG ORPHA:300536	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
DITRA ORPHA:404546	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
DPAGT1-CDG ORPHA:86309	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
DPM3-CDG ORPHA:263494	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Developmental delay with autism spectrum disorder and gait instability ORPHA:329195	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Diaphanospondylodysostosis ORPHA:66637	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Diffuse palmoplantar keratoderma with painful fissures ORPHA:369999	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
Dilated cardiomyopathy with ataxia ORPHA:66634	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EBAG9
Distal hereditary motor neuropathy, Jerash type ORPHA:139552	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Distal monosomy 15q ORPHA:1596	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	STK17B
Distal myopathy, Tateyama type ORPHA:488650	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Distal nebulin myopathy ORPHA:399103	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Dominant beta-thalassemia ORPHA:231226	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Drug- or toxin-induced pulmonary arterial hypertension ORPHA:275786	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDC42BPB
Dysbetalipoproteinemia ORPHA:412	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Dysspondyloenchondromatosis ORPHA:85198	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Dystonia 16 ORPHA:210571	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
EEC syndrome ORPHA:1896	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
Early-onset calcifying leukoencephalopathy-skeletal dysplasia ORPHA:556985	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Early-onset myopathy with fatal cardiomyopathy ORPHA:289377	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome ORPHA:496641	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WDR6
Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome ORPHA:313772	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Ebstein malformation of the tricuspid valve ORPHA:1880	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Eiken syndrome ORPHA:79106	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Endocrine-cerebro-osteodysplasia syndrome ORPHA:199332	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	IPO8
Endosteal sclerosis-cerebellar hypoplasia syndrome ORPHA:85186	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Enteric anendocrinosis ORPHA:83620	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDX2
Enzalutamide toxicity ORPHA:529828	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Epileptic encephalopathy with global cerebral demyelination ORPHA:353217	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PREPL
Exercise-induced malignant hyperthermia ORPHA:466650	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
FADD-related immunodeficiency ORPHA:306550	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
FKRP-related  limb-girdle muscular dystrophy R9 ORPHA:34515	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZNF628
FRAXF syndrome ORPHA:100974	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PNMA1
Familial GPIHBP1 deficiency ORPHA:535458	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Familial Mediterranean fever ORPHA:342	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Familial acute necrotizing encephalopathy ORPHA:88619	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Familial benign chronic pemphigus ORPHA:2841	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SPIN1
Familial benign flecked retina ORPHA:363989	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RGS11
Familial cold urticaria ORPHA:47045	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Familial drusen ORPHA:75376	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Familial encephalopathy with neuroserpin inclusion bodies ORPHA:85110	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PREPL
Familial lipoprotein lipase deficiency ORPHA:309015	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DOCK4
Familial mitral valve prolapse ORPHA:741	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEMA6C
Familial paroxysmal ataxia ORPHA:97	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement ORPHA:2196	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARID3B
Familial renal glucosuria ORPHA:69076	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DGAT1
Familial retinal arterial macroaneurysm ORPHA:284247	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Familial sick sinus syndrome ORPHA:166282	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Fatal post-viral neurodegenerative disorder ORPHA:391343	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Fatty acyl-CoA reductase 1 deficiency ORPHA:438178	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Female restricted epilepsy with intellectual disability ORPHA:101039	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Fetal encasement syndrome ORPHA:465824	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ERI1
Focal facial dermal dysplasia type III ORPHA:1807	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Focal palmoplantar keratoderma with joint keratoses ORPHA:370002	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
Formiminoglutamic aciduria ORPHA:51208	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KIF20A
Fukutin-related  limb-girdle muscular dystrophy R13 ORPHA:206554	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SPIN1
Fumaric aciduria ORPHA:24	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
GAPO syndrome ORPHA:2067	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
GCGR-related hyperglucagonemia ORPHA:438274	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
GNB5-related intellectual disability-cardiac arrhythmia syndrome ORPHA:542306	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5 ORPHA:353	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Genitopatellar syndrome ORPHA:85201	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Ghosal hematodiaphyseal dysplasia ORPHA:1802	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Giant axonal neuropathy ORPHA:643	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SUGT1
Gingival fibromatosis-hypertrichosis syndrome ORPHA:2026	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	LYST
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AHNAK2
Glomuvenous malformation ORPHA:83454	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
Glutamate-cysteine ligase deficiency ORPHA:33574	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH1
Glutathione synthetase deficiency with 5-oxoprolinuria ORPHA:289846	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Glutathione synthetase deficiency without 5-oxoprolinuria ORPHA:289849	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Glycerol kinase deficiency, adult form ORPHA:284414	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VNN1
Glycerol kinase deficiency, juvenile form ORPHA:284411	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VNN1
Glycogen storage disease due to LAMP-2 deficiency ORPHA:34587	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ITM2B
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia ORPHA:79258	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Glycogen storage disease due to glycogen debranching enzyme deficiency ORPHA:366	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Glycogen storage disease due to hepatic glycogen synthase deficiency ORPHA:2089	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency ORPHA:713	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EIF4A3
Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency ORPHA:263297	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATP6V0D1
Goldberg-Shprintzen megacolon syndrome ORPHA:66629	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Goldmann-Favre syndrome ORPHA:53540	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP29
Gollop-Wolfgang complex ORPHA:1986	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Gordon syndrome ORPHA:376	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Graham Little-Piccardi-Lassueur syndrome ORPHA:505	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Greig cephalopolysyndactyly syndrome ORPHA:380	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Hajdu-Cheney syndrome ORPHA:955	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SNX18
Hamel cerebro-palato-cardiac syndrome ORPHA:93946	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Hartsfield syndrome ORPHA:2117	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Hemoglobin C disease ORPHA:2132	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Hemoglobin C-beta-thalassemia syndrome ORPHA:231242	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Hemoglobin D disease ORPHA:90039	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Hemoglobin E disease ORPHA:2133	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Hemoglobin E-beta-thalassemia syndrome ORPHA:231249	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NMI
Hereditary arterial and articular multiple calcification syndrome ORPHA:289601	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Hereditary leiomyomatosis and renal cell cancer ORPHA:523	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Hereditary myopathy with early respiratory failure ORPHA:178464	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Hereditary neuropathy with liability to pressure palsies ORPHA:640	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Hereditary neutrophilia ORPHA:279943	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type ORPHA:86923	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
Hereditary persistence of alpha-fetoprotein ORPHA:168615	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency ORPHA:217467	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
High bone mass osteogenesis imperfecta ORPHA:314029	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Histiocytoid cardiomyopathy ORPHA:137675	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANP32B
Holocarboxylase synthetase deficiency ORPHA:79242	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TUBGCP5
Huntington disease-like 2 ORPHA:98934	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Hyaline body myopathy ORPHA:53698	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Hyper-IgM syndrome type 2 ORPHA:101089	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	C17ORF99
Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency ORPHA:209902	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Hyperinsulinism-hyperammonemia syndrome ORPHA:35878	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Hypermethioninemia encephalopathy due to adenosine kinase deficiency ORPHA:289290	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Hypochondrogenesis ORPHA:93297	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Hypodontia-dysplasia of nails syndrome ORPHA:2228	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome ORPHA:137639	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome ORPHA:447893	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CLIC3
Hypoplasminogenemia ORPHA:722	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome ORPHA:293864	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDX2
Hypotonia with lactic acidemia and hyperammonemia ORPHA:137908	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Hypoxanthine guanine phosphoribosyltransferase partial deficiency ORPHA:79233	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Idiopathic hypercalciuria ORPHA:2197	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Immunodeficiency due to CD25 deficiency ORPHA:169100	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Immunodeficiency due to MASP-2 deficiency ORPHA:331187	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DDX17
Immunodeficiency with factor I anomaly ORPHA:200418	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Infantile cerebellar-retinal degeneration ORPHA:313850	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	IGSF8
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly ORPHA:402364	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RBM7
Infantile epileptic-dyskinetic encephalopathy ORPHA:364063	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TUBB3
Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Intellectual disability, Birk-Barel type ORPHA:166108	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome ORPHA:397709	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome ORPHA:457279	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SMYD5
Intellectual disability-severe speech delay-mild dysmorphism syndrome ORPHA:391372	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	STK17B
Intermediate epidermolysis bullosa simplex with cardiomyopathy ORPHA:508529	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Ischiovertebral syndrome ORPHA:85200	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Isolated asymptomatic elevation of creatine phosphokinase ORPHA:206599	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Isolated delta-storage pool disease ORPHA:248340	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Jacobsen syndrome ORPHA:2308	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Johanson-Blizzard syndrome ORPHA:2315	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Juvenile cataract-microcornea-renal glucosuria syndrome ORPHA:247794	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP29
Juvenile sialidosis type 2 ORPHA:93399	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GDF15
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome ORPHA:445062	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERPUD1
KBG syndrome ORPHA:2332	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC16A
KCNQ2-related epileptic encephalopathy ORPHA:439218	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
KLHL9-related early-onset distal myopathy ORPHA:399081	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDKN2B
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation ORPHA:254534	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion ORPHA:254528	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 ORPHA:96334	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Kaposiform hemangioendothelioma ORPHA:2122	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	C11ORF52
Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome ORPHA:281201	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GTF3C6
Kindler epidermolysis bullosa ORPHA:2908	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
King-Denborough syndrome ORPHA:99741	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome ORPHA:447974	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Klippel-Trenaunay syndrome ORPHA:90308	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Kniest dysplasia ORPHA:485	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Koolen-De Vries syndrome due to a point mutation ORPHA:363965	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Kostmann syndrome ORPHA:99749	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
L-Arginine:glycine amidinotransferase deficiency ORPHA:35704	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHN2
LIMS2-related limb-girdle muscular dystrophy ORPHA:466801	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYNPO
Laing early-onset distal myopathy ORPHA:59135	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Langerhans cell histiocytosis ORPHA:389	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Legg-Calve-Perthes disease ORPHA:2380	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Lesch-Nyhan syndrome ORPHA:510	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VASN
Lethal ataxia with deafness and optic atrophy ORPHA:1187	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Lethal congenital contracture syndrome type 1 ORPHA:1486	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TOE1
Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome ORPHA:2570	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Lethal multiple pterygium syndrome ORPHA:33108	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH15
Letrozole toxicity ORPHA:529831	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Leukoencephalopathy-dystonia-motor neuropathy syndrome ORPHA:163684	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATG4A
Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome ORPHA:83629	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZWINT
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome ORPHA:314051	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Limb-mammary syndrome ORPHA:69085	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
Limited systemic sclerosis ORPHA:220407	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Lipoic acid synthetase deficiency ORPHA:401859	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PSTK
Lipoprotein glomerulopathy ORPHA:329481	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Lissencephaly syndrome, Norman-Roberts type ORPHA:89844	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Lower motor neuron syndrome with late-adult onset ORPHA:276435	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	REEP6
Lymphedema-distichiasis syndrome ORPHA:33001	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
MEND syndrome ORPHA:401973	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
MEPAN syndrome ORPHA:508093	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:485421	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
MPI-CDG ORPHA:79319	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DEAF1
MT-ATP6-related mitochondrial spastic paraplegia ORPHA:320360	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANP32B
MYH7-related late-onset scapuloperoneal muscular dystrophy ORPHA:437572	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome ORPHA:457485	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MDC1
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome ORPHA:487796	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	STK17B
Mal de Meleda ORPHA:87503	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
Malignant epithelial tumor of salivary glands ORPHA:276145	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Malonic aciduria ORPHA:943	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FRY
Marden-Walker syndrome ORPHA:2461	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Marshall syndrome ORPHA:560	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Maternal phenylketonuria ORPHA:2209	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Maternal riboflavin deficiency ORPHA:411712	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FAM83F
McKusick-Kaufman syndrome ORPHA:2473	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GTF3C6
McLeod neuroacanthocytosis syndrome ORPHA:59306	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PDZK1IP1
Megalencephaly-severe kyphoscoliosis-overgrowth syndrome ORPHA:457359	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency ORPHA:319552	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency ORPHA:319600	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Menkes disease ORPHA:565	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Menstrual cycle-dependent periodic fever ORPHA:498251	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Mesoaxial synostotic syndactyly with phalangeal reduction ORPHA:157801	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Metachondromatosis ORPHA:2499	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PREPL
Metaphyseal chondrodysplasia, Jansen type ORPHA:33067	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Methylcobalamin deficiency type cblG ORPHA:2170	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Microcephalic osteodysplastic dysplasia, Saul-Wilson type ORPHA:85172	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WDR6
Microcephaly-congenital cataract-psoriasiform dermatitis syndrome ORPHA:488168	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DUSP14
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom ORPHA:500159	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GAS2L1
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome ORPHA:457351	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP11B
Microcephaly-thin corpus callosum-intellectual disability syndrome ORPHA:397951	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome ORPHA:251279	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RGS11
Mild hemophilia B ORPHA:169799	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Mild hyperphenylalaninemia ORPHA:79651	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Mild phenylketonuria ORPHA:79253	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria ORPHA:1933	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies ORPHA:369897	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Mitochondrial pyruvate carrier deficiency ORPHA:447784	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATG4A
Moderate multiminicore disease with hand involvement ORPHA:178145	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RASA4
Moderately severe hemophilia B ORPHA:169796	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Mohr-Tranebjaerg syndrome ORPHA:52368	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	OIP5
Monosomy 13q14 ORPHA:1587	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZBTB33
Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	LYST
Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	LYST
Muckle-Wells syndrome ORPHA:575	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Multifocal pattern dystrophy simulating fundus flavimaculatus ORPHA:99003	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FRY
Multiple endocrine neoplasia type 2A ORPHA:247698	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYT7
Multiple endocrine neoplasia type 2B ORPHA:247709	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SYT7
Multiple epiphyseal dysplasia, Beighton type ORPHA:166011	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Multiple mitochondrial dysfunctions syndrome type 1 ORPHA:401869	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GTF3C6
Multiple mitochondrial dysfunctions syndrome type 5 ORPHA:569274	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TBPL1
Multiple self-healing squamous epithelioma ORPHA:65748	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZBTB33
Multiple system atrophy, cerebellar type ORPHA:227510	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	OIP5
Multiple system atrophy, parkinsonian type ORPHA:98933	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	OIP5
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Myeloperoxidase deficiency ORPHA:2587	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
NAD(P)HX epimerase deficiency ORPHA:555407	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
NARP syndrome ORPHA:644	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANP32B
NKX6-2-related autosomal recessive hypomyelinating leukodystrophy ORPHA:527497	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	APC2
NLRC4-related familial cold autoinflammatory syndrome ORPHA:576349	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
NLRP12-associated hereditary periodic fever syndrome ORPHA:247868	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
NON RARE IN EUROPE: Gilbert syndrome ORPHA:357	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
NON RARE IN EUROPE: Non rare obesity ORPHA:521399	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
NON RARE IN EUROPE: Rheumatoid arthritis ORPHA:284130	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
NON RARE IN EUROPE: Specific language impairment ORPHA:458713	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BCLAF1
NON RARE IN EUROPE: Trimethylaminuria ORPHA:35056	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
NPHP3-related Meckel-like syndrome ORPHA:3032	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Nager syndrome ORPHA:245	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
Nail-patella syndrome ORPHA:2614	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH3
Nail-patella-like renal disease ORPHA:2613	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH3
Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GGTLC1
Neonatal epileptic encephalopathy due to glutaminase deficiency ORPHA:557064	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHM
Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency ORPHA:88639	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SUGT1
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion ORPHA:352665	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation ORPHA:453504	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Neurogenic arthrogryposis multiplex congenita ORPHA:1143	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TRAM2
Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325529	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	C17ORF99
Obesity due to leptin receptor gene deficiency ORPHA:179494	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MBNL2
Occipital horn syndrome ORPHA:198	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Oculocutaneous albinism type 3 ORPHA:79433	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Oculocutaneous albinism type 4 ORPHA:79435	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SLC25A27
Oculotrichoanal syndrome ORPHA:2717	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Odontochondrodysplasia ORPHA:166272	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Odontoleukodystrophy ORPHA:77295	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
Ogden syndrome ORPHA:276432	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
Ornithine transcarbamylase deficiency ORPHA:664	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Orofaciodigital syndrome type 1 ORPHA:2750	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
Orofaciodigital syndrome type 2 ORPHA:2751	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCP110
Orofaciodigital syndrome type 3 ORPHA:2752	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RAB36
Osteoglosphonic dysplasia ORPHA:2645	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Osteosclerotic metaphyseal dysplasia ORPHA:500548	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FAM83F
Oxoglutaric aciduria ORPHA:31	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TAOK2
PEHO-like syndrome ORPHA:99807	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SPAG9
PGM1-CDG ORPHA:319646	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC23A
PGM3-CDG ORPHA:443811	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC23A
PLG-related hereditary angioedema with normal C1Inh ORPHA:537072	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
PMM2-CDG ORPHA:79318	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TLCD1
POGLUT1-related  limb-girdle muscular dystrophy R21 ORPHA:480682	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PSTK
PPARG-related familial partial lipodystrophy ORPHA:79083	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Pallister-Hall syndrome ORPHA:672	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Pancreatic insufficiency-anemia-hyperostosis syndrome ORPHA:199337	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AOC3
Paris-Trousseau thrombocytopenia ORPHA:851	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Partial chromosome Y deletion ORPHA:1646	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EIF1AY
Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
Partington syndrome ORPHA:94083	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
Pelizaeus-Merzbacher-like disease due to AIMP1 mutation ORPHA:280293	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NSA2
Pentosuria ORPHA:2843	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Periodic fever-infantile enterocolitis-autoinflammatory syndrome ORPHA:436166	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TPPP
Peripheral primitive neuroectodermal tumor ORPHA:370348	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Pierpont syndrome ORPHA:487825	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANGEL2
Platyspondylic dysplasia, Torrance type ORPHA:85166	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Poikiloderma with neutropenia ORPHA:221046	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ANP32B
Polyglucosan body myopathy type 2 ORPHA:456369	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATP6V0D1
Polysyndactyly ORPHA:93338	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Polyvalvular heart disease syndrome ORPHA:228410	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	N4BP1
Pontocerebellar hypoplasia type 4 ORPHA:166063	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RPUSD1
Pontocerebellar hypoplasia type 6 ORPHA:166073	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
Porphyria due to ALA dehydratase deficiency ORPHA:100924	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	IQSEC1
Posterior column ataxia-retinitis pigmentosa syndrome ORPHA:88628	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARHGAP11B
Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome ORPHA:572013	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Postural orthostatic tachycardia syndrome due to NET deficiency ORPHA:443236	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KLK8
Prader-Willi syndrome due to translocation ORPHA:177907	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MAPRE2
Primary CD59 deficiency ORPHA:169464	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Primary dystonia, DYT2 type ORPHA:99657	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Primary failure of tooth eruption ORPHA:412206	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Primary hyperoxaluria type 1 ORPHA:93598	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KCNE3
Primary immunodeficiency syndrome due to LAMTOR2 deficiency ORPHA:90023	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Progressive autosomal recessive ataxia-deafness syndrome ORPHA:448251	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC16A
Progressive familial intrahepatic cholestasis type 2 ORPHA:79304	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Progressive myoclonic epilepsy type 6 ORPHA:280620	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WARS2
Progressive myoclonic epilepsy type 7 ORPHA:435438	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Progressive retinal dystrophy due to retinol transport defect ORPHA:352718	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Progressive scapulohumeroperoneal distal myopathy ORPHA:447977	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome ORPHA:457395	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHM
Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Properdin deficiency ORPHA:2966	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Proximal myopathy with extrapyramidal signs ORPHA:401768	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATP6V0D1
Proximal myotonic myopathy ORPHA:606	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Pseudohypoaldosteronism type 2C ORPHA:88940	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Pterin-4 alpha-carbinolamine dehydratase deficiency ORPHA:1578	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	REEP6
Pulmonary capillary hemangiomatosis ORPHA:199241	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEC23A
Pyruvate dehydrogenase E2 deficiency ORPHA:79244	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Pyruvate dehydrogenase E3 deficiency ORPHA:2394	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Pyruvate dehydrogenase E3-binding protein deficiency ORPHA:255182	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHM
QRSL1-related combined oxidative phosphorylation defect ORPHA:570491	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PNPT1
RARS-related autosomal recessive hypomyelinating leukodystrophy ORPHA:438114	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCNB1
RIDDLE syndrome ORPHA:420741	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	KAT7
Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome ORPHA:280384	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TNKS1BP1
Renal pseudohypoaldosteronism type 1 ORPHA:171871	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATP8A1
Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome ORPHA:436245	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
Rhizomelic chondrodysplasia punctata type 2 ORPHA:309796	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
Rhizomelic chondrodysplasia punctata type 3 ORPHA:309803	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	IPO8
Ring dermoid of cornea ORPHA:91481	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINH1
Rippling muscle disease ORPHA:97238	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Rothmund-Thomson syndrome type 1 ORPHA:221008	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NOS1AP
SATB2-associated syndrome due to a pathogenic variant ORPHA:576283	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NOS1AP
SLC35A1-CDG ORPHA:238459	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	METTL18
SRD5A3-CDG ORPHA:324737	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TLCD1
SSR4-CDG ORPHA:370927	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
STAT3-related early-onset multisystem autoimmune disease ORPHA:438159	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
SURF1-related Charcot-Marie-Tooth disease type 4 ORPHA:391351	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
Schimke immuno-osseous dysplasia ORPHA:1830	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	UBAP2L
Sea-blue histiocytosis ORPHA:158029	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Seborrhea-like dermatitis with psoriasiform elements ORPHA:168606	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH1
Sensorineural deafness with dilated cardiomyopathy ORPHA:217622	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Severe X-linked mitochondrial encephalomyopathy ORPHA:238329	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZWINT
Severe combined immunodeficiency due to FOXN1 deficiency ORPHA:169095	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FGFBP1
Severe combined immunodeficiency due to IKK2 deficiency ORPHA:397787	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ATG16L2
Severe combined immunodeficiency due to LAT deficiency ORPHA:504523	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome ORPHA:488627	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	METTL18
Severe hemophilia B ORPHA:169793	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome ORPHA:466688	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome ORPHA:363686	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CBL
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome ORPHA:391307	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TOE1
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome ORPHA:369939	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TMED1
Severe neurodegenerative syndrome with lipodystrophy ORPHA:363400	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CLU
Severe phosphoribosylpyrophosphate synthetase superactivity ORPHA:411543	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
Severe primary trimethylaminuria ORPHA:468726	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Short rib-polydactyly syndrome type 5 ORPHA:498497	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PREPL
Short stature due to primary acid-labile subunit deficiency ORPHA:140941	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NXPH4
Short stature-delayed bone age due to thyroid hormone metabolism deficiency ORPHA:171706	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Short stature-optic atrophy-Pelger-Huet anomaly syndrome ORPHA:391677	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Sialidosis type 1 ORPHA:812	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GDF15
Sickle cell anemia ORPHA:232	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Sickle cell-beta-thalassemia disease syndrome ORPHA:251359	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Sickle cell-hemoglobin C disease syndrome ORPHA:251365	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Sickle cell-hemoglobin D disease syndrome ORPHA:251370	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Sickle cell-hemoglobin E disease syndrome ORPHA:251375	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
Sjogren-Larsson syndrome ORPHA:816	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SLC25A27
Smith-Lemli-Opitz syndrome ORPHA:818	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ACOT7
Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spastic ataxia-dysarthria due to glutaminase deficiency ORPHA:557056	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CHM
Spastic paraplegia-severe developmental delay-epilepsy syndrome ORPHA:464282	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCP110
Spinocerebellar ataxia type 11 ORPHA:98767	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Spinocerebellar ataxia type 2 ORPHA:98756	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TSC22D2
Spinocerebellar ataxia type 26 ORPHA:101112	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZNF598
Spinocerebellar ataxia type 27 ORPHA:98764	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Spinocerebellar ataxia type 28 ORPHA:101109	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Spinocerebellar ataxia type 34 ORPHA:1955	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TSPAN5
Spinocerebellar ataxia type 38 ORPHA:423296	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Spinocerebellar ataxia type 42 ORPHA:458803	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	BRSK2
Spinocerebellar ataxia type 6 ORPHA:98758	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DISP2
Split hand-split foot-deafness syndrome ORPHA:71271	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTPRU
Spondyloepimetaphyseal dysplasia congenita, Strudwick type ORPHA:93346	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spondyloepimetaphyseal dysplasia, Genevieve type ORPHA:168454	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	EIF4A3
Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Spondyloepiphyseal dysplasia congenita ORPHA:94068	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spondyloepiphyseal dysplasia, Stanescu type ORPHA:459051	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spondylometaphyseal dysplasia, Schmidt type ORPHA:93316	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Stickler syndrome type 1 ORPHA:90653	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Stickler syndrome type 2 ORPHA:90654	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Subcutaneous panniculitis-like T-cell lymphoma ORPHA:86884	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B ORPHA:308393	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Sweet syndrome ORPHA:3243	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Symptomatic form of hemophilia B in female carriers ORPHA:177929	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DIXDC1
Syringocystadenoma papilliferum ORPHA:840	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
T-B+ severe combined immunodeficiency due to CD45 deficiency ORPHA:169157	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	STK17B
T-cell immunodeficiency with epidermodysplasia verruciformis ORPHA:324294	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
T-cell large granular lymphocyte leukemia ORPHA:86872	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD14
TBCK-related intellectual disability syndrome ORPHA:488632	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
TCR-alpha-beta-positive T-cell deficiency ORPHA:397959	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
TMEM70-related mitochondrial encephalo-cardio-myopathy ORPHA:1194	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	GTF3C6
TRIM32-related  limb-girdle muscular dystrophy R8 ORPHA:1878	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SEMA6C
Tatton-Brown-Rahman syndrome ORPHA:404443	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ARID3B
Temple syndrome due to maternal uniparental disomy of chromosome 14 ORPHA:96184	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Temple syndrome due to paternal 14q32.2 hypomethylation ORPHA:254531	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Temple syndrome due to paternal 14q32.2 microdeletion ORPHA:254525	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NES
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria ORPHA:293284	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SERPINA6
Thomsen and Becker disease ORPHA:614	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Thrombocytopenia-absent radius syndrome ORPHA:3320	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PTGES3
Tibial aplasia-ectrodactyly syndrome ORPHA:3329	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCK
Tibial hemimelia ORPHA:93322	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
Tibial muscular dystrophy ORPHA:609	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Titin-related  limb-girdle muscular dystrophy R10 ORPHA:140922	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Transient familial neonatal hyperbilirubinemia ORPHA:2312	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AKR1C4
Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	AOC3
Trehalase deficiency ORPHA:103909	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	P4HA2
Tremor-ataxia-central hypomyelination syndrome ORPHA:447896	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
Trichorhinophalangeal syndrome type 1 and 3 ORPHA:77258	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Triose phosphate-isomerase deficiency ORPHA:868	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CCNB1
Trismus-pseudocamptodactyly syndrome ORPHA:3377	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CDH15
Tuberculosis ORPHA:3389	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Tufted angioma ORPHA:1063	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	C11ORF52
Vacuolar myopathy with sarcoplasmic reticulum protein aggregates ORPHA:88635	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
Vibratory urticaria ORPHA:493342	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SIRPB1
Vici syndrome ORPHA:1493	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Vitamin B12-responsive methylmalonic acidemia type cblB ORPHA:79311	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TLCD1
Vitamin B12-unresponsive methylmalonic acidemia type mut- ORPHA:79312	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Vitamin B12-unresponsive methylmalonic acidemia type mut0 ORPHA:289916	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL19
Von Willebrand disease type 1 ORPHA:166078	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Von Willebrand disease type 2A ORPHA:166084	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Von Willebrand disease type 2B ORPHA:166087	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Von Willebrand disease type 2M ORPHA:166090	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Von Willebrand disease type 2N ORPHA:166093	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Von Willebrand disease type 3 ORPHA:166096	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ESAM
Warsaw breakage syndrome ORPHA:280558	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZWINT
White-Sutton syndrome ORPHA:468678	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	DDX17
Wiedemann-Rautenstrauch syndrome ORPHA:3455	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCERG1
Wiedemann-Steiner syndrome ORPHA:319182	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	HERC1
Wolcott-Rallison syndrome ORPHA:1667	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZBTB5
Wrinkly skin syndrome ORPHA:2834	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
X-linked Charcot-Marie-Tooth disease type 4 ORPHA:101078	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZWINT
X-linked Charcot-Marie-Tooth disease type 5 ORPHA:99014	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
X-linked adrenal hypoplasia congenita ORPHA:95702	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TUBB3
X-linked agammaglobulinemia ORPHA:47	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
X-linked distal spinal muscular atrophy type 3 ORPHA:139557	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	SCAF11
X-linked dominant chondrodysplasia punctata ORPHA:35173	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
X-linked hereditary sensory and autonomic neuropathy with deafness ORPHA:139583	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ZWINT
X-linked hypophosphatemia ORPHA:89936	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	FANK1
X-linked intellectual disability, Golabi-Ito-Hall type ORPHA:93947	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
X-linked intellectual disability, Hedera type ORPHA:93952	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ITM2B
X-linked intellectual disability, Najm type ORPHA:163937	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
X-linked intellectual disability, Porteous type ORPHA:93945	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
X-linked intellectual disability, Sutherland-Haan type ORPHA:93950	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	MRPL54
X-linked intellectual disability, Van Esch type ORPHA:163976	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PLK4
X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome ORPHA:423479	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	RRP9
X-linked lissencephaly with abnormal genitalia ORPHA:452	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
X-linked lymphoproliferative disease due to SH2D1A deficiency ORPHA:538931	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	CD52
X-linked myopathy with excessive autophagy ORPHA:25980	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NAE1
X-linked osteoporosis with fractures ORPHA:391330	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	NUAK1
X-linked parkinsonism-spasticity syndrome ORPHA:363654	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	ITM2B
X-linked reticulate pigmentary disorder ORPHA:85453	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	PLK4
X-linked sideroblastic anemia and spinocerebellar ataxia ORPHA:2802	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	WARS2
X-linked spasticity-intellectual disability-epilepsy syndrome ORPHA:3175	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	VWA5B2
Zebra body myopathy ORPHA:97240	1/101	0.8693589726338644	0.8922466888454011	0	0	0.49123425692695216	0.06877237939240867	TCAP
12q14 microdeletion syndrome ORPHA:94063	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	BCLAF1
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) ORPHA:402020	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	P4HA2
Acute myeloid leukemia with t(9;11)(p22;q23) ORPHA:402017	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy ORPHA:329336	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	MRPL19
Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NES
Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PREPL
Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	DHRS3
Autosomal recessive polycystic kidney disease ORPHA:731	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ARHGAP29
Autosomal recessive sideroblastic anemia ORPHA:260305	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	RRP9
Bohring-Opitz syndrome ORPHA:97297	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TCERG1
Branchiootic syndrome ORPHA:52429	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PTPRU
Budd-Chiari syndrome ORPHA:131	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	LYST
Bullous pemphigoid ORPHA:703	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
CHARGE syndrome ORPHA:138	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NOS1AP
Classic mycosis fungoides ORPHA:2584	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Congenital cataract microcornea with corneal opacity ORPHA:289499	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NUAK1
Congenital communicating hydrocephalus ORPHA:269505	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NES
Craniopharyngioma ORPHA:54595	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SPAG9
Cushing disease ORPHA:96253	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
Dense deposit disease ORPHA:93571	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	AKR1C4
Dubowitz syndrome ORPHA:235	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SYNCRIP
Encephalocraniocutaneous lipomatosis ORPHA:2396	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SPIN1
Enlarged parietal foramina ORPHA:60015	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PTPRU
Familial porphyria cutanea tarda ORPHA:443062	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PLIN3
Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	KAT7
Freeman-Sheldon syndrome ORPHA:2053	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SPAG9
Frontometaphyseal dysplasia ORPHA:1826	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TRAM2
Gaucher disease type 1 ORPHA:77259	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	VAT1
Generalized arterial calcification of infancy ORPHA:51608	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SERPINA6
Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NOL3
Hartnup disease ORPHA:2116	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TRIM15
Hemimegalencephaly ORPHA:99802	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
Hereditary chronic pancreatitis ORPHA:676	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	GCNT3
Hereditary methemoglobinemia ORPHA:621	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	C11ORF52
Hereditary mixed polyposis syndrome ORPHA:157794	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	DIXDC1
Hutchinson-Gilford progeria syndrome ORPHA:740	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	DUSP14
Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PREPL
Hypotonia-cystinuria syndrome ORPHA:163690	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PREPL
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome ORPHA:363992	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	KLK8
Imerslund-Grasbeck syndrome ORPHA:35858	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SPOCK2
Infantile myofibromatosis ORPHA:2591	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NES
Isolated congenital anosmia ORPHA:88620	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SPOCK2
Isolated growth hormone deficiency type IA ORPHA:231662	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	RASGRP2
Isolated trigonocephaly ORPHA:3366	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NES
Juvenile primary lateral sclerosis ORPHA:247604	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	DIXDC1
Kleefstra syndrome due to a point mutation ORPHA:261652	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
LIG4 syndrome ORPHA:99812	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	METTL18
Leigh syndrome with nephrotic syndrome ORPHA:255249	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	WARS2
Limbic encephalitis with LGI1 antibodies ORPHA:163908	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Macrocephaly-intellectual disability-autism syndrome ORPHA:210548	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TRIM13
Matthew-Wood syndrome ORPHA:2470	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PTPRU
Microcephalic primordial dwarfism-insulin resistance syndrome ORPHA:436182	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	METTL18
Microcephaly-polymicrogyria-corpus callosum agenesis syndrome ORPHA:171703	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SIRPB1
Microphthalmia, Lenz type ORPHA:568	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ZNF598
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency ORPHA:254864	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TUBGCP6
Mixed phenotype acute leukemia ORPHA:530995	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
Myelodysplastic syndrome ORPHA:52688	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ARHGAP29
NON RARE IN EUROPE: Non-alcoholic fatty liver disease ORPHA:33271	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SERPINA6
Nasu-Hakola disease ORPHA:2770	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD14
Occipital pachygyria and polymicrogyria ORPHA:280640	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	BRSK2
Ochoa syndrome ORPHA:2704	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	HERC1
Oculootodental syndrome ORPHA:99806	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	RPUSD1
PEHO syndrome ORPHA:2836	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	BRSK2
Paroxysmal kinesigenic dyskinesia ORPHA:98809	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	PRRT2
Pediatric multiple sclerosis ORPHA:477738	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Periodic paralysis with later-onset distal motor neuropathy ORPHA:397750	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ANP32B
Persistent Mullerian duct syndrome ORPHA:2856	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	WFIKKN1
Polymerase proofreading-related adenomatous polyposis ORPHA:447877	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ZWINT
Posterior hypospadias ORPHA:95706	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NUAK1
Primary mediastinal large B-cell lymphoma ORPHA:98838	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	IPO8
Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome ORPHA:391408	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	ZBTB33
Proteus syndrome ORPHA:744	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TAOK2
Pseudoxanthoma elasticum ORPHA:758	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	SERPINA6
Pyruvate dehydrogenase E1-alpha deficiency ORPHA:79243	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	RRP9
Renal hypoplasia, bilateral ORPHA:97362	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NOS1AP
Restrictive dermopathy ORPHA:1662	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	DUSP14
Rigid spine syndrome ORPHA:97244	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	TCAP
Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NUAK1
Sezary syndrome ORPHA:3162	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Sarcoidosis ORPHA:797	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Senior-Boichis syndrome ORPHA:84081	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	RHPN2
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency ORPHA:397593	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	EMG1
Spinocerebellar ataxia with axonal neuropathy type 2 ORPHA:64753	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	CD52
Striate palmoplantar keratoderma ORPHA:50942	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	KLK8
Syndromic diarrhea ORPHA:84064	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	IPO8
Townes-Brocks syndrome ORPHA:857	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	NES
Tropical pancreatitis ORPHA:103918	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	GCNT3
Woolly hair ORPHA:170	1/102	0.871971888836152	0.8922466888454011	0	0	0.48634561189116393	0.06662842144875038	LPAR6
Adult-onset foveomacular vitelliform dystrophy ORPHA:99000	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	FRY
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	ERI1
Autosomal dominant epilepsy with auditory features ORPHA:101046	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	HERC1
Blackfan-Diamond anemia ORPHA:124	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	NSA2
Brachydactyly type A1 ORPHA:93388	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	P4HA2
Childhood-onset nemaline myopathy ORPHA:171439	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	TCAP
Chronic granulomatous disease ORPHA:379	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CD52
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome ORPHA:1369	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	REEP6
Dentin dysplasia type I ORPHA:99789	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SCAF11
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome ORPHA:306661	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	TMEM45B
Familial papillary or follicular thyroid carcinoma ORPHA:319487	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SERPINA6
Female infertility due to oocyte meiotic arrest ORPHA:488191	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	FGD3
Fundus albipunctatus ORPHA:227796	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	FRY
Geleophysic dysplasia ORPHA:2623	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SYNPO
Hereditary gingival fibromatosis ORPHA:2024	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SCAF11
Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	ERI1
Hypokalemic periodic paralysis ORPHA:681	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	KCNE3
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CD52
Intermediate nemaline myopathy ORPHA:171433	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	TCAP
Isolated succinate-CoQ reductase deficiency ORPHA:3208	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	MRPL54
Keratosis follicularis spinulosa decalvans ORPHA:2340	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CDC42BPB
Micro syndrome ORPHA:2510	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CHM
Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	P4HA2
NON RARE IN EUROPE: Barrett esophagus ORPHA:1232	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SUGT1
NON RARE IN EUROPE: Celiac disease ORPHA:555	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CD52
NON RARE IN EUROPE: Diabetes mellitus type 1 ORPHA:243377	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CD52
NON RARE IN EUROPE: Hidradenitis suppurativa ORPHA:387	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	ATP6V0D1
NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SERPINH1
Neonatal glycine encephalopathy ORPHA:289857	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CBS
Noonan syndrome with multiple lentigines ORPHA:500	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	HERC1
Preeclampsia ORPHA:275555	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	SUGT1
Subcortical band heterotopia ORPHA:99796	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	PREPL
Thyroid hypoplasia ORPHA:95720	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	LYST
Treacher-Collins syndrome ORPHA:861	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	EIF4A3
WAGR syndrome ORPHA:893	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	CLGN
X-linked non-syndromic sensorineural deafness type DFN ORPHA:90625	1/103	0.8745326726480094	0.8922466888454011	0	0	0.4815528226403912	0.06455967951313349	PTPRU
Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) ORPHA:98829	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RASGRP2
Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	MBNL2
Autosomal dominant hypohidrotic ectodermal dysplasia ORPHA:1810	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	TMEM45B
Autosomal recessive isolated optic atrophy ORPHA:98676	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RRP9
COFS syndrome ORPHA:1466	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	FCHSD1
Congenital or early infantile CACH syndrome ORPHA:157713	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RRP9
Cree leukoencephalopathy ORPHA:99854	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RRP9
Familial or sporadic hemiplegic migraine ORPHA:569	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	PRRT2
Hereditary sensory and autonomic neuropathy type 1 ORPHA:36386	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	CHM
Iminoglycinuria ORPHA:42062	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	GCNT3
Juvenile or adult CACH syndrome ORPHA:157719	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RRP9
Late infantile CACH syndrome ORPHA:157716	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	RRP9
Leigh syndrome with cardiomyopathy ORPHA:70474	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	MRPL54
MALT lymphoma ORPHA:52417	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	STK17B
NON RARE IN EUROPE: FG syndrome phenotypic spectrum ORPHA:323	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	TCERG1
NON RARE IN EUROPE: Familial hypobetalipoproteinemia ORPHA:426	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	SERPINA6
NON RARE IN EUROPE: Hereditary essential tremor ORPHA:862	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	BRSK2
Pontocerebellar hypoplasia type 1 ORPHA:2254	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	NAE1
Progressive symmetric erythrokeratodermia ORPHA:316	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	PPP1R13L
Renal agenesis, bilateral ORPHA:1848	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	NUAK1
Severe early-childhood-onset retinal dystrophy ORPHA:364055	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	DIXDC1
Severe intellectual disability and progressive spastic paraplegia ORPHA:280763	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	PIGB
Sheldon-Hall syndrome ORPHA:1147	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	TCAP
Shwachman-Diamond syndrome ORPHA:811	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	MRPL19
Xeroderma pigmentosum-Cockayne syndrome complex ORPHA:220295	1/104	0.8770423616003057	0.8922466888454011	0	0	0.47685309725856545	0.06256311917201296	PLK4
Acute myeloid leukemia with t(8;21)(q22;q22) translocation ORPHA:102724	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	FRY
Autoimmune lymphoproliferative syndrome ORPHA:3261	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	CD52
Autosomal systemic lupus erythematosus ORPHA:300345	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	CD14
Benign familial infantile epilepsy ORPHA:306	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	PRRT2
Congenital fiber-type disproportion myopathy ORPHA:2020	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	TCAP
Congenital myasthenic syndromes with glycosylation defect ORPHA:353327	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	TLCD1
Distal arthrogryposis type 1 ORPHA:1146	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	TCAP
Dysequilibrium syndrome ORPHA:1766	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	BRSK2
Familial cerebral saccular aneurysm ORPHA:231160	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	SYNPO
Granulomatosis with polyangiitis ORPHA:900	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	CD52
Idiopathic aplastic anemia ORPHA:88	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	CD52
Lamellar ichthyosis ORPHA:313	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	KLK8
Stargardt disease ORPHA:827	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	DIXDC1
Transient neonatal diabetes mellitus ORPHA:99886	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	RGS11
Waardenburg syndrome type 2 ORPHA:895	1/105	0.8795019725562425	0.8922466888454011	0	0	0.47224375121100565	0.06063584830679146	NES
Cervical spina bifida aperta ORPHA:268392	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Cervical spina bifida cystica ORPHA:268762	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Cervicothoracic spina bifida aperta ORPHA:268397	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Cervicothoracic spina bifida cystica ORPHA:268766	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Childhood absence epilepsy ORPHA:64280	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	BRSK2
Lumbosacral spina bifida aperta ORPHA:268388	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Lumbosacral spina bifida cystica ORPHA:268758	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Muscle-eye-brain disease ORPHA:588	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TRIP10
Ovarioleukodystrophy ORPHA:99853	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	RRP9
Postaxial polydactyly type A ORPHA:93334	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	HERC1
Thoracolumbosacral spina bifida aperta ORPHA:268384	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Thoracolumbosacral spina bifida cystica ORPHA:268752	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Total spina bifida aperta ORPHA:268377	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Total spina bifida cystica ORPHA:268748	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Upper thoracic spina bifida aperta ORPHA:268740	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Upper thoracic spina bifida cystica ORPHA:268770	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TNKS1BP1
Xeroderma pigmentosum ORPHA:910	1/106	0.8819125024818047	0.8922466888454011	0	0	0.46772220223101835	0.05877510916694406	TOE1
Achromatopsia ORPHA:49382	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	LYST
Autosomal dominant nocturnal frontal lobe epilepsy ORPHA:98784	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	DISP2
Catecholaminergic polymorphic ventricular tachycardia ORPHA:3286	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	PREPL
Combined pituitary hormone deficiencies, genetic forms ORPHA:95494	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	CLGN
Frontotemporal dementia with motor neuron disease ORPHA:275872	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	PTGES3
NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	SYNPO
Oligoarticular juvenile idiopathic arthritis ORPHA:85410	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	CD52
Pilomyxoid astrocytoma ORPHA:251615	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	PREPL
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408	1/107	0.8842749282236851	0.8922466888454011	0	0	0.4632859654959365	0.05697827145505601	CD52
Isolated ATP synthase deficiency ORPHA:254913	1/108	0.8865902074146086	0.8939858547904395	0	0	0.45893264907365994	0.05524282524806308	ANP32B
NON RARE IN EUROPE: Crohn disease ORPHA:206	1/108	0.8865902074146086	0.8939858547904395	0	0	0.45893264907365994	0.05524282524806308	CD52
Behavioral variant of frontotemporal dementia ORPHA:275864	1/109	0.8888592786180388	0.8953775799945711	0	0	0.45465994962216627	0.05356637473992624	ATP6V0D1
Cowden syndrome ORPHA:201	1/109	0.8888592786180388	0.8953775799945711	0	0	0.45465994962216627	0.05356637473992624	OMA1
Malignant migrating focal seizures of infancy ORPHA:293181	1/109	0.8888592786180388	0.8953775799945711	0	0	0.45465994962216627	0.05356637473992624	BRSK2
B-cell chronic lymphocytic leukemia ORPHA:67038	1/110	0.8910830617563921	0.896422440954666	0	0	0.45046564832574587	0.0519466322159669	CD52
Left ventricular noncompaction ORPHA:54260	1/110	0.8910830617563921	0.896422440954666	0	0	0.45046564832574587	0.0519466322159669	NES
MERRF ORPHA:551	1/110	0.8910830617563921	0.896422440954666	0	0	0.45046564832574587	0.0519466322159669	ANP32B
Meningioma ORPHA:2495	1/110	0.8910830617563921	0.896422440954666	0	0	0.45046564832574587	0.0519466322159669	ZNF598
Leber hereditary optic neuropathy ORPHA:104	1/111	0.8932624585322846	0.8977183736895791	0	0	0.4463476070528967	0.05038141239009418	ANP32B
Meckel syndrome ORPHA:564	1/111	0.8932624585322846	0.8977183736895791	0	0	0.4463476070528967	0.05038141239009418	CEP41
Mitochondrial DNA-associated Leigh syndrome ORPHA:255210	1/111	0.8932624585322846	0.8977183736895791	0	0	0.4463476070528967	0.05038141239009418	ANP32B
Alobar holoprosencephaly ORPHA:93925	1/113	0.8974916104308167	0.9016687655325558	0	0	0.4383321338611011	0.04740628056867736	NES
Behcet disease ORPHA:117	1/114	0.8995430806225976	0.9025296114347576	0	0	0.43443079735182005	0.045992464220546786	CD52
MELAS ORPHA:550	1/114	0.8995430806225976	0.9025296114347576	0	0	0.43443079735182005	0.045992464220546786	ANP32B
Noonan syndrome ORPHA:648	1/114	0.8995430806225976	0.9025296114347576	0	0	0.43443079735182005	0.045992464220546786	CBL
Semilobar holoprosencephaly ORPHA:220386	1/114	0.8995430806225976	0.9025296114347576	0	0	0.43443079735182005	0.045992464220546786	NES
Infantile spasms syndrome ORPHA:3451	1/115	0.9015535956725238	0.9039465713743752	0	0	0.43059790534270187	0.04462535256167373	WDR45
Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805	1/115	0.9015535956725238	0.9039465713743752	0	0	0.43059790534270187	0.04462535256167373	ARHGAP11B
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155	1/117	0.9054550059665678	0.9075572232275184	0	0	0.4231303743594198	0.04202433245220423	TCAP
Romano-Ward syndrome ORPHA:101016	1/118	0.907347484147598	0.9091525520868837	0	0	0.4194923464444875	0.04078715212736868	NOS1AP
Brugada syndrome ORPHA:130	1/122	0.9145469615360138	0.9157590847454717	0	0	0.40554156171284633	0.036225592222617634	KCNE3
Cone rod dystrophy ORPHA:1872	1/122	0.9145469615360138	0.9157590847454717	0	0	0.40554156171284633	0.036225592222617634	UNC119
Genetic steroid-resistant nephrotic syndrome ORPHA:656	1/129	0.9258291034298058	0.9267491058512334	0	0	0.3832257556675063	0.029533528505873888	KIF20A
X-linked non-syndromic intellectual disability ORPHA:777	1/132	0.9301972793543773	0.9308133040426916	0	0	0.3743919087815102	0.02709046950097853	PREPL
Amyotrophic lateral sclerosis ORPHA:803	1/137	0.9369146902876438	0.937224824246693	0	0	0.360534894058379	0.02349355205658272	PTGES3
Non-specific early-onset epileptic encephalopathy ORPHA:442835	1/138	0.9381787052130178	0.9381787052130178	0	0	0.3578848664251963	0.022838362210174486	PREPL
